Processing 00000000.tx.1: Increased Vulnerability of Brain Mitochondria in Diabetic (Goto-Kakizaki) Rats With Aging and Amyloid- Exposure Paula I. 

Phrase: "Increased Vulnerability of Brain Mitochondria"

Phrase: "in Diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "(Goto-Kakizaki) Rats With Aging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]

Phrase: "and"

Phrase: "Amyloid- Exposure Paula I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.2: Moreira1, Maria S. 

Phrase: "Moreira1,"

Phrase: "Maria S."
Processing 00000000.tx.3: Santos1, Antnio M. 

Phrase: "Santos1,"

Phrase: "Antnio M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.4: Moreno1, Raquel Seia2, and Catarina R. 

Phrase: "Moreno1,"

Phrase: "Raquel Seia2,"

Phrase: "and"

Phrase: "Catarina R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.5: Oliveira2 1 Center for Neuroscience of Coimbra, Department of Zoology, University of Coimbra, Coimbra, Portugal 2 Faculty of Medicine, University of Coimbra, Coimbra, Portugal  ABSTRACT TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  This study evaluated the respiratory indexes (respiratory control ratio [RCR] and ADP/O ratio), mitochondrial transmembrane potential (m), repolarization lag phase, repolarization level, ATP/ADP ratio, and induction of the permeability transition pore of brain mitochondria isolated from normal Wistar and GK diabetic rats of different ages (1.5, 12, and 24 months of age). 

Phrase: "Oliveira2 1 Center for Neuroscience of Coimbra,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205099:Center [Spatial Concept]

Phrase: "Department of Zoology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "University of Coimbra,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0041740:University [Manufactured Object,Organization]

Phrase: "Coimbra,"

Phrase: "Portugal 2 Faculty of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0015535:Faculty [Professional or Occupational Group]

Phrase: "University of Coimbra,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0041740:University [Manufactured Object,Organization]

Phrase: "Coimbra,"

Phrase: "Portugal  ABSTRACT TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0035171:Research Design [Research Activity]
   795   C0035168:research [Research Activity]
   795   C0242481:Research [Research Activity]
   795   C1707689:Design [Activity]
   795   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the respiratory indexes"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   966   C0451423:Respiratory index [Intellectual Product]
   861   C0521346:respiratory [Functional Concept]
   861   C0600653:Indexes [Intellectual Product]
   861   C0918012:indexes [Intellectual Product]
   861   C1546767:Respiratory [Intellectual Product]
   827 E C1552854:index [Idea or Concept]
   827 E C1637833:% index [Quantitative Concept]

Phrase: "(respiratory control ratio [RCR]"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   913   C0429743:Respiratory ratio [Finding]
   827   C0243148:control [Qualitative Concept]
   827   C0456603:Ratio [Quantitative Concept]
   827   C0521346:respiratory [Functional Concept]
   827   C1546767:Respiratory [Intellectual Product]
   827   C1547037:Ratio [Intellectual Product]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "ADP/O ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "mitochondrial transmembrane potential"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0025251:Transmembrane Potential [Cell Function]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C1167322:transmembrane [Cell Component]
   827   C2752508:transmembrane [Cell Component]
   827   C3245505:Potential [Qualitative Concept]

Phrase: "("

Phrase: "m)"

Phrase: ","

Phrase: "repolarization lag phase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205390:Phase [Temporal Concept]
   827   C1416797:Lag [Gene or Genome]

Phrase: "repolarization level,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "ATP/ADP ratio,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: "induction of the permeability transition pore of brain mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205263:Induction [Functional Concept]
   742   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "isolated from normal Wistar"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0205307:Normal [Qualitative Concept]
   770   C0205409:Isolated [Functional Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C2347086:% Normal [Quantitative Concept]
   770   C2700262:Wistar [Mammal]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "GK diabetic rats of different ages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0241863:DIABETIC [Finding]

Phrase: "(1.5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "12,"

Phrase: "and"

Phrase: "24 months of age"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C1510828:Age-Months [Organism Attribute]
   770   C0439231:months [Temporal Concept]
   737 E C0439507:/month [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.6: The effect of amyloid -peptides, 50 mol/l A2535 or 2 mol/l A140, on mitochondrial function was also analyzed. 

Phrase: "The effect of amyloid -peptides,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "50 mol/l A2535"

Phrase: "or"

Phrase: "2 mol/l A140,"

Phrase: "on mitochondrial function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "was"

Phrase: "also"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.7: Aging of diabetic mice induced a decrease in brain mitochondrial RCR, ADP/O, and ATP/ADP ratios but induced an increase in the repolarization lag phase. 

Phrase: "Aging of diabetic mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0001811:Ageing [Organism Function]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a decrease in brain mitochondrial RCR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]

Phrase: "ADP/O,"

Phrase: "and"

Phrase: "ATP/ADP ratios"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0456603:Ratios [Quantitative Concept]
   827   C1610540:*Ratios [Quantitative Concept]
   793 E C1547037:Ratio [Intellectual Product]

Phrase: "but"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "an increase in the repolarization lag phase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]
Processing 00000000.tx.8: Brain mitochondria from older diabetic rats were more prone to the induction of the permeability transition pore, i.e., mitochondria from 24-month-old diabetic rats accumulated much less Ca2+ (20 mol/l) than those isolated from 12-month-old rats (50 mol/l) or 1.5-month-old rats (100 mol/l). 

Phrase: "Brain mitochondria from older diabetic rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0026237:Mitochondria [Cell Component]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "more prone to the induction of the permeability transition pore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0033422:Prone [Spatial Concept]

Phrase: "i.e.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "mitochondria from 24-month-old diabetic rats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0026237:Mitochondria [Cell Component]

Phrase: "accumulated"

Phrase: "much less Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(20 mol/l) than those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0347982:mol/L [Quantitative Concept]

Phrase: "isolated from 12-month-old rats"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0205409:Isolated [Functional Concept]
   753   C0439231:month [Temporal Concept]
   753   C0439507:/month [Temporal Concept]
   753   C0580836:Old [Temporal Concept]
   753   C1548221:Isolated [Idea or Concept]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(50 mol/l)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0347982:mol/L [Quantitative Concept]

Phrase: "or"

Phrase: "1.5-month-old rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]

Phrase: "(100 mol/l)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0347982:mol/L [Quantitative Concept]
Processing 00000000.tx.9: In the presence of 50 mol/l A2535 or 2 mol/l A140, age-related mitochondrial effects were potentiated. 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 50 mol/l A2535"

Phrase: "or"

Phrase: "2 mol/l A140,"

Phrase: "age-related mitochondrial effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1280500:effects [Qualitative Concept]
   779 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "potentiated."
Processing 00000000.tx.10: These results indicate that diabetes-related mitochondrial dysfunction is exacerbated by aging and/or by the presence of neurotoxic agents such as amyloid -peptides, supporting the idea that diabetes and aging are risk factors for the neurodegeneration induced by these peptides.  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that diabetes-related mitochondrial dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0031847:dysfunction [Functional Concept]
   812   C0277785:Dysfunction, NOS [Qualitative Concept]
   756 E C0231174:Malfunction [Functional Concept]
   756 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "is"

Phrase: "exacerbated by aging"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0001811:Ageing [Organism Function]
   790   C0436331:Exacerbated [Finding]
   790   C1444749:Exacerbated [Qualitative Concept]

Phrase: "and/or by the presence of neurotoxic agents"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0260049:Neurotoxic agents [Hazardous or Poisonous Substance]
   770   C1706528:And/Or [Conceptual Entity]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C1515981:And [Idea or Concept]
   711   C0450442:Agent [Chemical Viewed Functionally]
   711   C1254351:Agent [Pharmacologic Substance]
   711   C1521826:Agent [Intellectual Product]

Phrase: "such as amyloid -peptides,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "that diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "are"

Phrase: "risk factors for the neurodegeneration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0035648:risk factors [Quantitative Concept]
   806   C1553898:risk factors [Idea or Concept]
   760   C0035647:Risk [Qualitative Concept]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "induced by these peptides."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C0205263:Induced [Functional Concept]
Processing 00000000.tx.11: INTRODUCTION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Type 2 diabetes accounts for 90% of the existing cases of diabetes and is characterized by defects in both insulin action and secretion (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "accounts for 90% of the existing cases of diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   742   C0011847:Diabetes [Disease or Syndrome]
   742   C0011849:Diabetes [Disease or Syndrome]
   742   C0439083:>90 [Quantitative Concept]
   742   C0439087:<90 [Quantitative Concept]
   742   C0868928:Cases [Functional Concept]
   742   C1533148:Cases [Quantitative Concept]
   742   C1551359:account [Idea or Concept]
   742   C2741673:Account # [Clinical Attribute]
   742   C2981730:Account [Classification]
   708 E C1706255:CASE [Medical Device]
   708 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "is"

Phrase: "characterized by defects"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0243067:defects [Functional Concept]
   790   C1880022:Characterized [Activity]
   756 E C1457869:Defect [Functional Concept]
   756 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "in both insulin action"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.12: Many studies demonstrated that diabetes produces molecular, cellular, morphological, and behavioral changes in the central nervous system (CNS) (2). 

Phrase: "Many studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "demonstrated"

Phrase: "that diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "produces"

Phrase: "molecular, cellular, morphological,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   865   C0243091:cellular morphology [Qualitative Concept]
   865   C1521816:Cellular Morphology [Clinical Attribute]
   865   C2700385:Cellular Morphology [Biomedical Occupation or Discipline]
   827   C0543482:morphological [Spatial Concept]
   755 E C0332437:Morphology [Qualitative Concept]
   755 E C0700329:Morphology, NOS [Finding]
   755 E C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "behavioral changes in the central nervous system (CNS)"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   823   C2499075:Central Nervous System, Change [Therapeutic or Preventive Procedure]
   778   C0542299:Behavioral changes [Individual Behavior]
   777   C0542115:NEUROLOGIC CHANGES [Finding]
   748   C0004927:Behavioral [Individual Behavior]
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   748   C2986890:Behavioral [Idea or Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.13: Pardridge et al (3) showed the existence of insulin receptors in the endothelium of the human blood-brain barrier, allowing receptor-mediated active transport of insulin into the brain. 

Phrase: "Pardridge et al (3"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the existence of insulin receptors"

Phrase: "in the endothelium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014257:Endothelium [Tissue]

Phrase: "of the human blood-brain barrier,"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   923   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
   923   C1305865:Blood-brain barrier [Organ or Tissue Function]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C0229664:Blood [Body Substance]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1706912:BARRIER [Medical Device]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "receptor-mediated active transport of insulin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0005529:Active Transport [Physiologic Function]
   753   C0005528:Transport, NOS [Cell Function]
   753   C0205177:Active [Functional Concept]
   753   C1317949:Transport [Manufactured Object]
   753   C3495449:transport [Medical Device]

Phrase: "into the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.14: Insulin-sensitive glucose transporters are found not only at the blood-brain barrier but also in glia expressing partially insulin-sensitive GLUT1 (4,5) and in some neurons expressing GLUT1 (4) and/or GLUT4 (6,7). 

Phrase: "Insulin-sensitive glucose transporters"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0596902:transporters [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "not only at the blood-brain barrier"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   814   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
   814   C1305865:Blood-brain barrier [Organ or Tissue Function]
   748   C0005767:Blood [Tissue]
   748   C0005768:blood [Body Substance]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0205171:Only [Quantitative Concept]
   748   C0229664:Blood [Body Substance]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1518422:Not [Functional Concept]
   748   C1706912:BARRIER [Medical Device]
   748   C1720467:Only [Intellectual Product]

Phrase: "but"

Phrase: "also in glia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0027836:Glia [Cell]
   790   C1087003:Glia [Plant]

Phrase: "expressing"

Phrase: "partially insulin-sensitive GLUT1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1335837:GLUT1 [Gene or Genome]
   812   C1504631:Glut-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1705603:GLUT1 [Gene or Genome]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and in some neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0027882:Neurons [Cell]
   770   C1515981:And [Idea or Concept]

Phrase: "expressing"

Phrase: "GLUT1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1335837:GLUT1 [Gene or Genome]
  1000   C1504631:Glut-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1705603:GLUT1 [Gene or Genome]

Phrase: "(4"

Phrase: ")"

Phrase: "and/or"

Phrase: "GLUT4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420175:GLUT4 [Gene or Genome]
  1000   C2982484:GLUT4 [Gene or Genome]

Phrase: "(6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.15: Recently, Bingham et al. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "Bingham et al."
Processing 00000000.tx.16: (8) showed that insulin has a significant effect on global brain glucose metabolism, mainly in the cerebral cortex. 

Phrase: "(8"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "a significant effect on global brain glucose metabolism,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1158774:glucose effect [Genetic Function]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "mainly in the cerebral cortex."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2700441:Cortex [Plant]
Processing 00000000.tx.17: The authors suggest that this effect may be either a direct effect of insulin, stimulating glucose uptake and metabolism, or an indirect effect achieved via insulin-stimulated neuronal activation with secondary increment in cell glucose metabolism. 

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "either"

Phrase: "a direct effect of insulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "stimulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulating [Natural Phenomenon or Process]

Phrase: "glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1159527:glucose uptake [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "metabolism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "or"

Phrase: "an indirect effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "achieved via insulin-stimulated neuronal activation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0521390:Neuronal [Immunologic Factor]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1879547:Activation [Activity]
   753   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "with secondary increment in cell glucose metabolism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C0260000:Secondary Metabolism [Molecular Function]
   827   C0596620:glucose metabolism [Molecular Function]
   799   C0025519:Metabolism [Organism Function]
   799   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.18: These results raise the hypothesis that insulin can access the insulin receptors in the brain and have a metabolic effect in this organ, which may be maximal at basal circulating insulin concentrations. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "raise"

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "can"

Phrase: "access"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0444454:Access [Spatial Concept]
  1000   C1554204:access [Idea or Concept]

Phrase: "the insulin receptors in the brain"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   756 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "and"

Phrase: "have"

Phrase: "a metabolic effect in this organ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "which"

Phrase: "may"

Phrase: "be"

Phrase: "maximal at basal circulating insulin concentrations."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205289:Maximal [Qualitative Concept]
   753   C0806909:Maximal [Quantitative Concept]
   731   C2347813:Concentration Maximum [Quantitative Concept]
Processing 00000000.tx.19: Diabetes is often associated with mitochondrial diseases characterized by defects in the mitochondrial genome (9). 

Phrase: "Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "is"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "associated with mitochondrial diseases"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C0751651:Mitochondrial Diseases [Disease or Syndrome]
   802   C0243083:associated disease [Pathologic Function]
   770   C0012634:Diseases [Disease or Syndrome]
   770   C0026237:Mitochondrial [Cell Component]
   770   C0521451:Mitochondrial [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "characterized by defects"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0243067:defects [Functional Concept]
   790   C1880022:Characterized [Activity]
   756 E C1457869:Defect [Functional Concept]
   756 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "in the mitochondrial genome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1819716:Genome, Mitochondrial [Gene or Genome]
   861   C0017428:Genome [Gene or Genome]
   861   C2338314:Genome [Conceptual Entity]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.20: Mitochondria play a central role in the development of type 2 diabetes by regulating energy balance and the generation of reactive oxygen species (10). 

Phrase: "Mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a central role in the development of type 2 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "by"

Phrase: "regulating"

Phrase: "energy balance"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0597987:Energy Balance [Organism Function]
   861   C0014653:Balance [Organism Function]
   861   C0205415:Balance [Functional Concept]
   861   C0424589:Energy [Finding]
   861   C0542479:Energy [Natural Phenomenon or Process]
   861   C0560184:Balance [Finding]
   861   C1442080:Energy [Quantitative Concept]

Phrase: "and"

Phrase: "the generation of reactive oxygen species"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.21: In Alzheimers disease (AD), a major imbalance between glucose and oxygen consumption has been found in the incipient stage, whereas in the advanced stage, both glucose and oxygen consumption are diminished (11). 

Phrase: "In Alzheimers disease (AD),"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "a major imbalance between glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1397014:Imbalance [Sign or Symptom]

Phrase: "and"

Phrase: "oxygen consumption"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0030055:Oxygen Consumption [Clinical Attribute]
  1000   C1305742:oxygen consumption [Diagnostic Procedure]
   861   C0009830:Consumption [Activity]
   861   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1947907:Consumption [Physiologic Function]

Phrase: "has"

Phrase: "been"

Phrase: "found in the incipient stage,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0150312:Found [Quantitative Concept]
   760   C0205256:Incipient [Temporal Concept]
   760   C0205390:Stage [Temporal Concept]
   760   C1300072:Stage [Clinical Attribute]
   760   C1306673:Stage [Qualitative Concept]
   726 E C0243095:Find [Finding]

Phrase: "whereas in the advanced stage,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0205179:Advanced [Qualitative Concept]
   760   C0205390:Stage [Temporal Concept]
   760   C1300072:Stage [Clinical Attribute]
   760   C1306673:Stage [Qualitative Concept]
   726 E C0725066:Advance [Medical Device]

Phrase: "both glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "oxygen consumption"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0030055:Oxygen Consumption [Clinical Attribute]
  1000   C1305742:oxygen consumption [Diagnostic Procedure]
   861   C0009830:Consumption [Activity]
   861   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1947907:Consumption [Physiologic Function]

Phrase: "are"

Phrase: "diminished"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:Diminished [Quantitative Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.22: This could be a consequence of deviant insulin action or brain insulin receptor function, which can affect brain energy metabolism (11). 

Phrase: "This"

Phrase: "could"

Phrase: "be"

Phrase: "a consequence of deviant insulin action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "or"

Phrase: "brain insulin receptor function,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   902   C0678908:brain function [Organ or Tissue Function]
   861   C0920644:receptor function [Molecular Function]
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1705273:Function [Intellectual Product]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]

Phrase: "which"

Phrase: "can"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "brain energy metabolism"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C0596215:brain metabolism [Organ or Tissue Function]
   901   C0014272:Energy Metabolism [Physiologic Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   827   C0424589:Energy [Finding]
   827   C0542479:Energy [Natural Phenomenon or Process]
   827   C1442080:Energy [Quantitative Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.23: These abnormalities in insulin metabolism may account for the pathological changes (formation of senile plaques and neurofibrillary tangles) found in AD (12,13). 

Phrase: "These abnormalities in insulin metabolism"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   726 E C1704258:Abnormality [Finding]

Phrase: "may"

Phrase: "account for the pathological changes"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0030664:Pathological [Biomedical Occupation or Discipline]
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   760   C1521733:Pathological [Functional Concept]
   760   C1551359:account [Idea or Concept]
   760   C2741673:Account # [Clinical Attribute]
   760   C2981730:Account [Classification]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "(formation of senile plaques"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   865   C1849249:SENILE PLAQUE FORMATION [Pathologic Function]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: ")"

Phrase: "found in AD"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.24: Several lines of evidence suggest that amyloid deposition in the brain contributes to neuronal degeneration in AD (14) just as amyloid formation in the pancreas is believed to contribute to -cell loss in type 2 diabetes (15). 

Phrase: "Several lines of evidence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205132:lines [Spatial Concept]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that amyloid deposition in the brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011560:Amyloid deposition [Pathologic Function]
   790   C1705760:Amyloid Deposition [Finding]
   753   C0333562:Deposition [Functional Concept]

Phrase: "contributes to neuronal degeneration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0027746:Neuron Degeneration [Cell or Molecular Dysfunction]
   770   C0011164:Degeneration [Pathologic Function]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1880177:Contribute [Activity]
   770   C1880269:Degeneration [Functional Concept]

Phrase: "in AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(14"

Phrase: ")"

Phrase: "just as amyloid formation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1522492:Formation [Functional Concept]

Phrase: "in the pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contribute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "to -cell loss in type 2 diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1517945:Loss [Quantitative Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.25: Hoyer (16) argued that in late-onset AD, a disturbance in the control of neuronal glucose metabolism consequent to impaired insulin signaling strongly resembles the pathophysiology of type 2 diabetes in nonneural tissue. 

Phrase: "Hoyer"

Phrase: "(16"

Phrase: ")"

Phrase: "argued"

Phrase: "that in late-onset AD,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   882   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   814   C0814122:late disease onset [Finding]
   790   C0002395:Alzheimers disease [Disease or Syndrome]
   783   C0277793:disease onset [Temporal Concept]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0205087:Late [Temporal Concept]
   753   C0332162:Onset [Qualitative Concept]

Phrase: "a disturbance in the control of neuronal glucose metabolism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2699787:Disturbance [Qualitative Concept]

Phrase: "consequent to impaired insulin"

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "strongly"

Phrase: "resembles"

Phrase: "the pathophysiology of type 2 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031847:pathophysiology [Functional Concept]
   753   C0277785:Pathophysiology [Qualitative Concept]

Phrase: "in nonneural tissue."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.26: Two recent prospective studies have established that diabetes increases the risk of dementia in general and AD in particular (17,18). 

Phrase: "Two recent prospective studies"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0033522:Prospective Studies [Research Activity]
   827 E C1709709:Prospective Study [Research Activity]
   812   C0023981:prospective [Research Activity]
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the risk of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: "in general"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205246:General [Spatial Concept]
  1000   C1553889:General [Idea or Concept]

Phrase: "and"

Phrase: "AD in particular"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.27: Several animal models are available for experimental investigation on type 2 diabetes. 

Phrase: "Several animal models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0599779:Models, Animal [Animal]
   827   C0003062:Animal [Animal]
   827   C3161035:Models [Intellectual Product]

Phrase: "are"

Phrase: "available for experimental investigation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0470187:Available [Functional Concept]

Phrase: "on type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.28: One of those models is the Goto-Kakizaki (GK) rat: a nonobese, spontaneously diabetic animal (19) produced by selective breeding of Wistar rats and first characterized by Goto and Kakizaki (20). 

Phrase: "One of those models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "the Goto-Kakizaki (GK) rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]

Phrase: ":"

Phrase: "a nonobese, spontaneously diabetic animal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animal [Animal]

Phrase: "(19"

Phrase: ")"

Phrase: "produced by selective breeding of Wistar rats"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0034716:Rats, Wistar [Mammal]
   778   C0678952:selective breeding [Genetic Function]
   748   C0006159:Breeding [Organism Function]
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C2700262:Wistar [Mammal]

Phrase: "and"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "characterized by Goto"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1880022:Characterized [Activity]

Phrase: "and"

Phrase: "Kakizaki"

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.29: The aim of this work was to analyze the impact of aging and/or the presence of amyloid -peptides (A) on the function of brain mitochondria isolated from diabetic GK rats. 

Phrase: "The aim of this work"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1947946:Aim [Idea or Concept]
   760   C2948600:Aim [Pharmacologic Substance]
   760   C3540471:AIM [Gene or Genome]
   760   C3540472:AIM [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "the impact of aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1825598:IMPACT [Gene or Genome]

Phrase: "and/or"

Phrase: "the presence of amyloid -peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(A) on the function of brain mitochondria"

Phrase: "isolated from diabetic GK rats."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0205409:Isolated [Functional Concept]
   753   C0241863:DIABETIC [Finding]
   753   C1548221:Isolated [Idea or Concept]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.30: For this purpose, the following parameters were examined: mitochondrial respiration, mitochondrial transmembrane potential, levels of ATP, and the induction of the permeability transition pore. 

Phrase: "For this purpose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285529:Purpose [Functional Concept]

Phrase: "the following parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0449381:Parameters [Finding]
   827 E C0549193:Parameter [Spatial Concept]
   827 E C1704769:Parameter [Conceptual Entity]
   827 E C2350001:Parameter [Quantitative Concept]

Phrase: "were"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: ":"

Phrase: "mitochondrial respiration,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035203:Respiration [Physiologic Function]
   861   C0282636:respiration [Cell Function]
   861   C1160636:respiration [Biologic Function]

Phrase: "mitochondrial transmembrane potential,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0025251:Transmembrane Potential [Cell Function]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C1167322:transmembrane [Cell Component]
   827   C2752508:transmembrane [Cell Component]
   827   C3245505:Potential [Qualitative Concept]

Phrase: "levels of ATP,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "the induction of the permeability transition pore."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205263:Induction [Functional Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.31: Studies on aging in an animal model of type 2 diabetes may identify a key metabolic feature common to that disorder and late-onset AD. 

Phrase: "Studies on aging"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0947630:studies [Laboratory Procedure]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "in an animal model"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599779:Animal Model [Animal]
   861   C0003062:Animal [Animal]
   861   C3161035:Model [Intellectual Product]

Phrase: "of type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "may"

Phrase: "identify"

Phrase: "a key metabolic feature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "common to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0205214:Common [Quantitative Concept]
   833   C1522138:Common [Functional Concept]
   833   C3245511:common [Intellectual Product]

Phrase: "that disorder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012634:Disorder [Disease or Syndrome]

Phrase: "and"

Phrase: "late-onset AD."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimers disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.32: One such feature could be a mitochondria-associated oxidative stress in AD brain (21,22) and in the brain of GK rats, as demonstrated previously in our laboratory (23).  

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "such feature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1521970:Feature [Qualitative Concept]
  1000   C1706388:Feature [Conceptual Entity]
  1000   C2346469:Feature [Qualitative Concept]
  1000   C2348519:Feature [Qualitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "a mitochondria-associated oxidative stress in AD brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   742   C0038435:Stress [Finding]
   742   C0311404:Oxidative [Functional Concept]

Phrase: "(21,"

Phrase: "22"

Phrase: ")"

Phrase: "and in the brain of GK rats,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   750   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   744   C0006104:Brain [Body Part, Organ, or Organ Component]
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C1269537:Brain [Body Part, Organ, or Organ Component]
   744   C1515981:And [Idea or Concept]

Phrase: "as"

Phrase: "demonstrated"

Phrase: "previously in our laboratory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C3244292:laboratory [Functional Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.33: RESEARCH DESIGN AND METHODS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Materials. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   876   C0086912:methods research [Research Activity]
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]
Processing 00000000.tx.34: A2535 and A140 were obtained from Bachem AG (Bubendorf, Germany). 

Phrase: "A2535"

Phrase: "and"

Phrase: "A140"

Phrase: "were"

Phrase: "obtained from Bachem AG (Bubendorf,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.35: Protease (Subtilisin Carlsberg) type VIII was obtained from Sigma (Sintra, Portugal). 

Phrase: "Protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Protease [Enzyme]

Phrase: "(Subtilisin Carlsberg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038597:Subtilisin Carlsberg [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0038601:Subtilisin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0752243:Subtilisin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "type VIII"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0445599:VIII [Intellectual Product]
   861   C1413661:VIII [Gene or Genome]

Phrase: "was"

Phrase: "obtained from Sigma"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1301820:Obtained [Functional Concept]
   790   C1719918:Sigma [Intellectual Product]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(Sintra,"

Phrase: "Portugal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032729:Portugal [Geographic Area]

Phrase: ")."
Processing 00000000.tx.36: Digitonin was obtained from Calbiochem. 

Phrase: "Digitonin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012256:Digitonin [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "obtained from Calbiochem."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.37: All the other chemicals were of the highest grade of purity commercially available. 

Phrase: "All"

Phrase: "the other chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0220806:Chemicals [Chemical]
   966 E C3272558:Chemical [Intellectual Product]

Phrase: "were of the highest grade of purity"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   762   C0205082:High grade [Qualitative Concept]
   748   C0441800:Grade [Classification]
   748   C0919553:Grade [Classification]
   748   C1522410:Highest [Qualitative Concept]
   748   C1882508:Purity [Quantitative Concept]
   748   C3244287:grade [Finding]
   714 E C0205250:High [Qualitative Concept]
   714 E C1299351:High [Qualitative Concept]
   714 E C2700149:HIGH [Intellectual Product]

Phrase: "commercially available"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0470187:Available [Functional Concept]

Phrase: "."
Processing 00000000.tx.38: Animals. 

Phrase: "Animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]
Processing 00000000.tx.39: Male GK and control Wistar rats that were 1.5, 12, and 24 months of age were housed in our animal colony (Laboratory Research Center, University Hospital, Coimbra, Portugal). 

Phrase: "Male GK"

Phrase: "and"

Phrase: "control Wistar rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034716:Rats, Wistar [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700262:Wistar [Mammal]

Phrase: "that"

Phrase: "were"

Phrase: "1.5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "12,"

Phrase: "and"

Phrase: "24 months of age"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C1510828:Age-Months [Organism Attribute]
   770   C0439231:months [Temporal Concept]
   737 E C0439507:/month [Temporal Concept]

Phrase: "were"

Phrase: "housed in our animal colony"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0596092:Animal Colony [Group]
   760   C0003062:Animal [Animal]
   760   C0020056:Housed [Manufactured Object]
   760   C0439158:colony [Quantitative Concept]
   760   C1947989:Colony [Cell]
   726 E C0442519:house [Conceptual Entity]
   726 E C2003847:House [Manufactured Object]

Phrase: "(Laboratory Research Center,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0683939:research center [Manufactured Object,Organization]
   827   C0205099:Center [Spatial Concept]
   734   C0022886:Laboratory Research [Research Activity]

Phrase: "University Hospital,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0020028:university hospital [Health Care Related Organization,Manufactured Object]
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C0041740:University [Manufactured Object,Organization]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Coimbra,"

Phrase: "Portugal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032729:Portugal [Geographic Area]

Phrase: ")."
Processing 00000000.tx.40: They were maintained under controlled light and humidity with free access to water and powdered rodent diet (diet C.R.F. 20, Charles River, LArbresle, France). 

Phrase: "They"

Phrase: "were"

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "under controlled light"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0023693:Light [Natural Phenomenon or Process]
   827   C1306462:Light [Functional Concept]
   827   C1881376:Light [Qualitative Concept]

Phrase: "and"

Phrase: "humidity with free access"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020167:Humidity [Natural Phenomenon or Process]
   770   C0869465:Humidity [Natural Phenomenon or Process]

Phrase: "to water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "and"

Phrase: "powdered rodent diet"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0012155:Diet [Food]
   827   C1442959:Diet [Organism Function]
   827   C1519433:DIET [Therapeutic or Preventive Procedure]
   827   C2983588:DIET [Food]
   755 E C2699635:DIETARY [Functional Concept]

Phrase: "(diet C.R.F. 20,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0012155:Diet [Food]
   804   C1442959:Diet [Organism Function]
   804   C1519433:DIET [Therapeutic or Preventive Procedure]
   804   C2983588:DIET [Food]
   733 E C2699635:DIETARY [Functional Concept]

Phrase: "Charles River,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337050:River [Natural Phenomenon or Process]

Phrase: "LArbresle,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")."
Processing 00000000.tx.41: Glucose tolerance tests were used to select GK rats for study. 

Phrase: "Glucose tolerance tests"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
  1000   C0017741:Glucose tolerance tests [Diagnostic Procedure]
   913   C0595310:glucose tests [Medical Device]
   901   C0178665:Glucose tolerance [Physiologic Function]
   896 E C0337438:glucose test [Laboratory Procedure]
   867   C0201777:Tolerance test [Laboratory Procedure]
   827   C0013220:Tolerance [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0020963:Tolerance [Pathologic Function]
   827   C0022885:Tests [Laboratory Procedure]
   827   C0220929:tolerance [Mental Process]
   827   C0231197:Tolerance [Physiologic Function]
   827   C0392366:Tests [Intellectual Product]
   827   C1704410:Tolerance [Qualitative Concept]
   793 E C0039593:Test [Functional Concept]
   771 E C0680282:toleration [Social Behavior]
   755 E C0231198:Tolerant [Functional Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "select"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Select [Activity]

Phrase: "GK rats for study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
Processing 00000000.tx.42: Adhering to procedures approved by the Institutional Animal Care and Use Committee, the animals were killed by cervical displacement and decapitation. 

Phrase: "Adhering to procedures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0231441:Adhere [Finding]

Phrase: "approved by the Institutional Animal Care"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0178478:animal care [Occupation or Discipline]
   783   C0868975:Institutional care [Health Care Activity]
   753   C0003062:Animal [Animal]
   753   C0205540:Approved [Qualitative Concept]
   753   C1947933:Care [Activity]

Phrase: "and"

Phrase: "Use Committee,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2699414:Committee [Group]

Phrase: "the animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "killed by cervical displacement"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0238939:CERVICAL DISPLACEMENT [Finding]
   770   C0012725:Displacement [Mental Process]
   770   C0012727:Displacement [Spatial Concept]
   770   C0027530:Cervical [Body Location or Region]
   770   C0162388:killed [Social Behavior]
   770   C0205064:Cervical [Spatial Concept]
   770   C0456080:Displacement [Qualitative Concept]
   770   C2347509:Displacement [Phenomenon or Process]
   737 E C0681205:Kill [Idea or Concept]
   737 E C1550555:kill [Functional Concept]

Phrase: "and"

Phrase: "decapitation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0152232:Decapitation [Injury or Poisoning]
  1000   C0413398:Decapitation [Injury or Poisoning]
Processing 00000000.tx.43: Determination of blood glucose and glycated hemoglobin (HbA1c, GHb) levels. 

Phrase: "Determination of blood glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1148554:determination [Laboratory Procedure]

Phrase: "and"

Phrase: "glycated hemoglobin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017853:Glycated haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0019046:Haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(HbA1c,"

Phrase: "GHb) levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.44: Immediately after the animals were killed, blood glucose was determined by a glucose oxidase reaction, using a glucometer and compatible reactive tests. 

Phrase: "Immediately after the animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003062:Animals [Animal]
   770   C0205548:Immediately [Temporal Concept]

Phrase: "were"

Phrase: "killed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: ","

Phrase: "blood glucose"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "determined by a glucose oxidase reaction,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0017735:GLUCOSE OXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a glucometer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0472226:Glucometer [Medical Device]

Phrase: "and"

Phrase: "compatible reactive tests."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022885:Tests [Laboratory Procedure]
   827   C0392366:Tests [Intellectual Product]
   793 E C0039593:Test [Functional Concept]
Processing 00000000.tx.45: GHb and HbA1c levels were determined through ionic change chromatographic assay. 

Phrase: "GHb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000503:GHB [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "HbA1c levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined through ionic change chromatographic assay."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1510438:Assay [Laboratory Procedure]
   753   C1705241:Change [Quantitative Concept]
Processing 00000000.tx.46: GHb is a common term for posttranslationally modified molecules of HbA, resulting from a nonenzymatic binding of glucose (glycation) to the amino acid residues in - and/or -globin chains. 

Phrase: "GHb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000503:GHB [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "a common term for posttranslationally modified molecules of HbA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1515273:Term [Temporal Concept]
   742   C1705313:Term [Idea or Concept]
   742   C2826302:TERM [Intellectual Product]

Phrase: "resulting from a nonenzymatic binding of glucose"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   774   C1148590:glucose binding [Molecular Function]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0243122:binding [Functional Concept]
   748   C0678226:resulting [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "(glycation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598528:glycation [Phenomenon or Process]

Phrase: ")"

Phrase: "to the amino acid residues"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "in -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:In [Quantitative Concept]
  1000   C0332285:In [Spatial Concept]

Phrase: "and/or -"

Phrase: "globin chains."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0443781:Globin chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0017645:Globin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0337112:chains [Manufactured Object]
   861   C1149093:globin [Molecular Function]
   861   C1524075:Chains [Idea or Concept]
Processing 00000000.tx.47: Approximately 80% of GHb is HbA1c, which is hemoglobin irreversibly glycated at one or both NH2-terminal valine amino acid of each -chain. 

Phrase: "Approximately 80% of GHb"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0000503:GHB [Organic Chemical,Pharmacologic Substance]
   770   C0332232:Approximately [Qualitative Concept]

Phrase: "is"

Phrase: "HbA1c,"

Phrase: "which"

Phrase: "is"

Phrase: "hemoglobin irreversibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019046:Haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "glycated at one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "both NH2-terminal valine amino acid of each -chain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   764   C2917660:Amino Acid [Pharmacologic Substance]
   742   C0001128:Acid [Chemical]
   742   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.48: Isolation of brain mitochondria. 

Phrase: "Isolation of brain mitochondria."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0204727:Isolation [Therapeutic or Preventive Procedure]
   770   C0205409:Isolation [Functional Concept]
   770   C0220862:isolation [Laboratory Procedure]
Processing 00000000.tx.49: Brain mitochondria were isolated from male Wistar and GK rats by the method of Rosenthal et al. 

Phrase: "Brain mitochondria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0026237:Mitochondria [Cell Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "isolated from male Wistar"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0024554:Male [Finding]
   770   C0086582:male [Population Group]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C1706180:Male [Qualitative Concept]
   770   C1706428:Male [Qualitative Concept]
   770   C1706429:Male [Organism Attribute]
   770   C2700262:Wistar [Mammal]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "GK rats by the method of Rosenthal et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0034693:rats [Mammal]
   739   C0034721:Rats [Mammal]
Processing 00000000.tx.50: (24), with slight modifications, using 0.02% digitonin to free mitochondria from the synaptosomal fraction. 

Phrase: "(24"

Phrase: ")"

Phrase: ","

Phrase: "with slight modifications,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "0.02% digitonin to free mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0012256:Digitonin [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]

Phrase: "from the synaptosomal fraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.51: In brief, a rat was decapitated, and the whole brain minus the cerebellum was rapidly removed, washed, minced, and homogenized at 4C in 10 ml of isolation medium (225 mmol/l mannitol, 75 mmol/l sucrose, 5 mmol/l HEPES, 1 mmol/l EGTA, 1 mg/ml BSA [pH 7.4]) containing 5 mg of the bacterial protease. 

Phrase: "In brief,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282927:brief [Qualitative Concept]
  1000   C1879313:Brief [Temporal Concept]

Phrase: "a rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "was"

Phrase: "decapitated"

Phrase: ","

Phrase: "and"

Phrase: "the whole brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "minus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332288:Minus [Qualitative Concept]

Phrase: "the cerebellum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "was"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "minced"

Phrase: ","

Phrase: "and"

Phrase: "homogenized at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0450376:4c [Intellectual Product]

Phrase: "in 10 ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "of isolation medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "(225 mmol/l mannitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024730:Mannitol [Carbohydrate,Pharmacologic Substance]

Phrase: "75 mmol/l sucrose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "5 mmol/l HEPES,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   708   C2348935:.5 L [Quantitative Concept]

Phrase: "1 mmol/l EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "1 mg/ml BSA [pH 7.4"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   877   C3541329:1-7 [Gene or Genome]
   845   C0128666:ML 7 [Organic Chemical]
   829   C2678549:PH-4 [Gene or Genome]
   818   C0439294:mg ml [Quantitative Concept]
   818   C1882074:pH 7 [Qualitative Concept]
   795   C0020283:[pH] [Quantitative Concept]
   795   C0439269:mg% [Quantitative Concept]
   795   C0439526:/mL [Quantitative Concept]
   795   C0450407:ph+ [Finding]
   795   C0450408:ph++ [Finding]
   795   C0450409:ph+++ [Finding]
   795   C1960952:mg % [Quantitative Concept]
   795   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   795   C2827734:1+ [Quantitative Concept]
   795   C2981698:1+ [Classification]

Phrase: "]"

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5 mg of the bacterial protease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439269:mg% [Quantitative Concept]
   753   C1960952:mg % [Quantitative Concept]
   753   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.52: Single brain homogenates were brought to 30 ml and then centrifuged at 2,000g for 3 min. 

Phrase: "Single brain homogenates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "brought to 30 ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332302:brought [Functional Concept]
   770   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "at 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516077:At [Spatial Concept]

Phrase: "000g for 3 min."
Processing 00000000.tx.53: The pellet, including the fluffy synaptosomal layer, was resuspended in 10 ml of the isolation medium containing 0.02% digitonin and centrifuged at 12,000g for 8 min. 

Phrase: "The pellet,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the fluffy synaptosomal layer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0934502:Layer [Body Part, Organ, or Organ Component]
   827   C1522408:Layer [Qualitative Concept]
   827   C1561599:Layer [Intellectual Product]

Phrase: "was"

Phrase: "resuspended in 10 ml of the isolation medium"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0009458:Medium [Intellectual Product]
   744   C0204727:Isolation [Therapeutic or Preventive Procedure]
   744   C0205409:Isolation [Functional Concept]
   744   C0220862:isolation [Laboratory Procedure]
   744   C0439526:/mL [Quantitative Concept]
   744   C0439536:Medium [Quantitative Concept]
   744   C1705217:Medium [Substance]
   744   C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.02% digitonin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012256:Digitonin [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "centrifuged at 12,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "000g for 8 min."
Processing 00000000.tx.54: The brown mitochondrial pellet without the synaptosomal layer was then resuspended again in 10 ml of medium and recentrifuged at 12,000g for 10 min. 

Phrase: "The brown mitochondrial pellet without the synaptosomal layer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0441436:Pellet [Manufactured Object]
   744   C0993610:Pellet [Biomedical or Dental Material]
   744   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "resuspended"

Phrase: "again in 10 ml of medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0009458:Medium [Intellectual Product]
   753   C0439526:/mL [Quantitative Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "recentrifuged at 12,"

Phrase: "000g for 10 min."
Processing 00000000.tx.55: The mitochondrial pellet was resuspended in 300 l of resuspension medium (225 mmol/l mannitol, 75 mmol/l sucrose, 5 mmol/l HEPES [pH 7.4]). 

Phrase: "The mitochondrial pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441436:Pellet [Manufactured Object]
   861   C0993610:Pellet [Biomedical or Dental Material]
   861   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "resuspended in 300 l of resuspension medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0009458:Medium [Intellectual Product]
   748   C0439536:Medium [Quantitative Concept]
   748   C1705217:Medium [Substance]
   748   C3244283:medium [Intellectual Product]

Phrase: "(225 mmol/l mannitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024730:Mannitol [Carbohydrate,Pharmacologic Substance]

Phrase: "75 mmol/l sucrose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "5 mmol/l HEPES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   708   C2348935:.5 L [Quantitative Concept]

Phrase: "[pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "]"

Phrase: ")."
Processing 00000000.tx.56: Mitochondrial protein was determined by the biuret method calibrated with BSA (25). 

Phrase: "Mitochondrial protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0949610:Mitochondrial Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "determined by the biuret method"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0005667:Biuret [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0025663:Method [Intellectual Product]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]

Phrase: "calibrated with BSA (25"

Phrase: ")."
Processing 00000000.tx.57: Membrane potential measurements. 

Phrase: "Membrane potential measurements."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0242485:measurements [Functional Concept]
   734   C0025251:Membrane Potential [Cell Function]
Processing 00000000.tx.58: The mitochondrial transmembrane potential (m) was monitored by evaluating the transmembrane distribution of tetraphenylphosphonium (TPP+) with a TPP+-selective electrode prepared according to Kamo et al. 

Phrase: "The mitochondrial transmembrane potential"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0025251:Transmembrane Potential [Cell Function]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C1167322:transmembrane [Cell Component]
   827   C2752508:transmembrane [Cell Component]
   827   C3245505:Potential [Qualitative Concept]

Phrase: "("

Phrase: "m)"

Phrase: "was"

Phrase: "monitored by evaluating"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   756   C0030695:monitor [Health Care Activity]
   756   C0150369:monitor [Health Care Activity]
   756   C0181904:Monitor [Medical Device]
   756   C0220825:Evaluate [Functional Concept]
   756   C0596972:Monitor [Medical Device]
   756   C1521743:Monitor [Professional or Occupational Group]
   756   C1704646:Monitor [Manufactured Object]

Phrase: "the transmembrane distribution of tetraphenylphosphonium (TPP+)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "with a TPP+-selective electrode"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013812:electrode [Medical Device]
   827   C1705652:Electrode [Medical Device]

Phrase: "prepared according to Kamo et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0680240:according [Social Behavior]
   719   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.59: (26) using an Ag/AgCl2 electrode as reference. 

Phrase: "(26"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an Ag/AgCl2 electrode as reference."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0013812:electrode [Medical Device]
   753   C1705652:Electrode [Medical Device]
Processing 00000000.tx.60: Reactions were carried out in a chamber with magnetic stirring in 1 ml of reaction medium (100 mmol/l sucrose, 100 mmol/l KCl, 2 mmol/l KH2PO4, 5 mmol/l HEPES, 10 mol/l EGTA [pH 7.4]) supplemented with 3 mol/l TPP+. 

Phrase: "Reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in a chamber"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]
   770   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "with magnetic stirring"

Phrase: "in 1 ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "of reaction medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "(100 mmol/l sucrose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "100 mmol/l KCl,"

Phrase: "2 mmol/l KH2PO4,"

Phrase: "5 mmol/l HEPES,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   708   C2348935:.5 L [Quantitative Concept]

Phrase: "10 mol/l EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "[pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "]"

Phrase: ")"

Phrase: "supplemented with 3 mol/l TPP+."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0347982:mol/L [Quantitative Concept]
   753   C0027960:Mole [Neoplastic Process]
   753   C0076326:tetraphenylphosphonium [Indicator, Reagent, or Diagnostic Aid,Organophosphorus Compound]
   753   C0324740:Mole [Mammal]
   753   C0439189:Mole [Quantitative Concept]
   753   C1456781:mole [Neoplastic Process]
   753   C1824986:mol [Gene or Genome]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.61: The experiments were started by adding 5 mmol/l succinate to mitochondria in suspension at 0.8 mg protein/ml. 

Phrase: "The experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "started by adding 5 mmol/l succinate"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C1532563:mmol/L [Quantitative Concept]
   748   C0038617:succinate [Organic Chemical]
   748   C0220918:succinate [Organic Chemical,Pharmacologic Substance]
   748   C0439190:MMOLE [Quantitative Concept]
   748   C1272689:Started [Qualitative Concept]
   714 E C0439659:Start [Temporal Concept]
   714   C1883712:Add [Functional Concept]

Phrase: "to mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "in suspension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038960:Suspension [Biomedical or Dental Material]
  1000   C1382107:Suspension [Substance]
  1000   C1705537:Suspension [Functional Concept]

Phrase: "at 0.8 mg protein/ml."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0439294:mg ml [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.62: After a steady-state distribution of TPP+ had been reached (ca. 2 min of recording), Ca2+ was added and m was recorded. m was estimated from the decrease of TPP+ concentration in the reaction medium as described elsewhere (27). 

Phrase: "After a steady-state distribution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0520511:distribution [Idea or Concept]
   827   C1704711:Distribution [Functional Concept]
   734   C0678587:steady state [Natural Phenomenon or Process]

Phrase: "of TPP+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076326:tetraphenylphosphonium [Indicator, Reagent, or Diagnostic Aid,Organophosphorus Compound]

Phrase: "had"

Phrase: "been"

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "(ca. 2 min of recording"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0702093:/min [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "was"

Phrase: "recorded. m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "was"

Phrase: "estimated from the decrease of TPP+ concentration"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0076326:tetraphenylphosphonium [Indicator, Reagent, or Diagnostic Aid,Organophosphorus Compound]
   748   C0086045:Concentration [Mental Process]
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]
   748   C0750572:Estimated [Quantitative Concept]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "in the reaction medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "elsewhere"

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.63: Homogenates were incubated with 50 mol/l A2535 or 2 mol/l A140 for 5 min before succinate addition. 

Phrase: "Homogenates"

Phrase: "were"

Phrase: "incubated with 50 mol/l A2535"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0347982:mol/L [Quantitative Concept]
   753   C0027960:Mole [Neoplastic Process]
   753   C0324740:Mole [Mammal]
   753   C0439189:Mole [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1456781:mole [Neoplastic Process]
   753   C1824986:mol [Gene or Genome]

Phrase: "or"

Phrase: "2 mol/l A140 for 5 min"

Phrase: "before succinate addition."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1883712:Addition [Functional Concept]
   789 E C1524062:Additional [Functional Concept]
Processing 00000000.tx.64: Mitochondrial respiration. 

Phrase: "Mitochondrial respiration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035203:Respiration [Physiologic Function]
   861   C0282636:respiration [Cell Function]
   861   C1160636:respiration [Biologic Function]
Processing 00000000.tx.65: Oxygen consumption of isolated mitochondria was monitored polarographically with a Clark oxygen electrode (28) connected to a suitable recorder in a 1-ml, thermostated, water-jacketed closed chamber, with magnetic stirring. 

Phrase: "Oxygen consumption of isolated mitochondria"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0030055:Oxygen Consumption [Clinical Attribute]
   806   C1305742:oxygen consumption [Diagnostic Procedure]
   760   C0009830:Consumption [Activity]
   760   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1947907:Consumption [Physiologic Function]

Phrase: "was"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "polarographically with a Clark oxygen electrode"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0013812:electrode [Medical Device]
   753   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1705652:Electrode [Medical Device]

Phrase: "(28"

Phrase: ")"

Phrase: "connected to a suitable recorder"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0182913:Recorder [Medical Device]
   760   C1705115:Recorder [Medical Device]
   726   C2986575:Connect [Activity]

Phrase: "in a 1-ml,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: "thermostated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710386:Thermostat [Manufactured Object]

Phrase: ","

Phrase: "water-jacketed closed chamber,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "with magnetic stirring."
Processing 00000000.tx.66: The reactions were carried out at 30C in 1 ml of the reaction medium with 0.8 mg of protein. 

Phrase: "The reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out at 30C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]

Phrase: "in 1 ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "of the reaction medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "with 0.8 mg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "of protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.67: Homogenates were incubated with 50 mol/l A2535 or 2 mol/l A140 for 5 min before succinate addition. 

Phrase: "Homogenates"

Phrase: "were"

Phrase: "incubated with 50 mol/l A2535"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0347982:mol/L [Quantitative Concept]
   753   C0027960:Mole [Neoplastic Process]
   753   C0324740:Mole [Mammal]
   753   C0439189:Mole [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1456781:mole [Neoplastic Process]
   753   C1824986:mol [Gene or Genome]

Phrase: "or"

Phrase: "2 mol/l A140 for 5 min"

Phrase: "before succinate addition."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1883712:Addition [Functional Concept]
   789 E C1524062:Additional [Functional Concept]
Processing 00000000.tx.68: Analysis of ATP. 

Phrase: "Analysis of ATP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]
Processing 00000000.tx.69: At the end of the m experiments, each mitochondrial suspension was rapidly centrifuged at 14,000 rpm for 6 min with 0.3 mol/l perchloric acid. 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the m experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "each mitochondrial suspension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0038960:Suspension [Biomedical or Dental Material]
   861   C1382107:Suspension [Substance]
   861   C1705537:Suspension [Functional Concept]

Phrase: "was"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "centrifuged at 14,000 rpm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0582523:rpm [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 6 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "with 0.3 mol/l perchloric acid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030981:Perchloric acid [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   799   C0001128:Acid [Chemical]
   799   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.70: The supernatants were neutralized with 10 mol/l KOH in 5 mol/l Tris and centrifuged at 14,000 rpm for 5 min. 

Phrase: "The supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "neutralized with 10 mol/l KOH"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0347982:mol/L [Quantitative Concept]
   753   C0027960:Mole [Neoplastic Process]
   753   C0071767:KOH [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0324740:Mole [Mammal]
   753   C0439189:Mole [Quantitative Concept]
   753   C1456781:mole [Neoplastic Process]
   753   C1824986:mol [Gene or Genome]

Phrase: "in 5 mol/l Tris"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   812   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   812   C0814229:TRI [Intellectual Product]
   708   C2348935:.5 L [Quantitative Concept]

Phrase: "and"

Phrase: "centrifuged at 14,000 rpm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0582523:rpm [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.71: The resulting supernatants were assayed for ATP by separation in a reverse-phase high-performance liquid chromatography. 

Phrase: "The resulting supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "assayed for ATP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]

Phrase: "by separation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036679:Separation [Pathologic Function]
  1000   C0237868:Separation [Social Behavior]
  1000   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "in a reverse-phase high-performance liquid chromatography."
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   913   C2717789:Reverse-Phase Liquid Chromatography [Laboratory Procedure]
   904   C0597410:Chromatography, Reverse-Phase [Laboratory Procedure]
   901   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
   901   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
   901   C1579831:High performance liquid chromatography [Functional Concept]
   827   C0008565:Liquid Chromatography [Laboratory Procedure]
   799   C0008550:Chromatography [Laboratory Procedure]
   799   C0205250:High [Qualitative Concept]
   799   C0205390:Phase [Temporal Concept]
   799   C0302908:Liquid [Substance]
   799   C0597198:Performance [Individual Behavior]
   799   C1299351:High [Qualitative Concept]
   799   C1304698:Liquid [Finding]
   799   C1546699:Liquid NOS [Intellectual Product]
   799   C1555029:Reverse [Idea or Concept]
   799   C1561501:Liquid NOS [Substance]
   799   C1882330:Performance [Activity]
   799   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.72: The chromatography apparatus was a Beckman-System Gold, consisting of a 126 Binary Pump Model and 166 Variable UV detector controlled by a computer. 

Phrase: "The chromatography apparatus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243111:apparatus [Manufactured Object]
   861   C1947951:Apparatus [Anatomical Structure]

Phrase: "was"

Phrase: "a Beckman-System Gold,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0018026:Gold [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1304897:Gold [Functional Concept]

Phrase: "consisting of a 126 Binary Pump Model"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0182537:Pump [Medical Device]
   748   C1706421:Pump [Manufactured Object]
   748   C1706942:Binary [Qualitative Concept]
   748   C3161035:Model [Intellectual Product]
   714   C0332529:CONSIST [Qualitative Concept]

Phrase: "and"

Phrase: "166 Variable UV detector"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0180392:Detector [Medical Device]
   812   C1705235:Detector [Manufactured Object]

Phrase: "controlled by a computer."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   833   C0332298:Controlled by [Functional Concept]
   770   C0009622:Computer [Manufactured Object]
   770   C2587213:Controlled [Functional Concept]
   737 E C0243148:control [Qualitative Concept]
   737 E C1550141:Control [Substance]
   737 E C1882979:Control [Conceptual Entity]
   737 E C3274648:Control [Qualitative Concept]
Processing 00000000.tx.73: The detection wavelength was 254 nm, and the column was a Lichrosphere 100 RP-18 (5 m) from Merck. 

Phrase: "The detection wavelength"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449819:Wavelength [Quantitative Concept]

Phrase: "was"

Phrase: "254 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "the column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]

Phrase: "was"

Phrase: "a Lichrosphere 100 RP-18"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1538326:RP [Gene or Genome]
   812   C3541325:RP [Idea or Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "m) from Merck."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.74: An isocratic elution with 100 mmol/l phosphate buffer (KH2PO4; pH 6.5) and 1.0% methanol was performed with a flow rate of 1 ml/min. 

Phrase: "An isocratic elution with 100 mmol/l phosphate buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1441565:Elution [Laboratory Procedure]

Phrase: "(KH2PO4"

Phrase: "; pH 6.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "1.0% methanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "performed with a flow rate of 1 ml/min."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   764   C0439445:mL/min [Quantitative Concept]
   764   C2826285:Flow Rate [Quantitative Concept]
   762   C1301862:Min 1 [Temporal Concept]
   742   C0439526:/mL [Quantitative Concept]
   742   C0702093:/min [Temporal Concept]
   742   C0806140:Flow [Natural Phenomenon or Process]
   742   C0871208:Rate [Activity]
   742   C0884358:Performed [Functional Concept]
   742   C1521828:Rate [Quantitative Concept]
   708 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.75: The required time for each analysis was 6 min. 

Phrase: "The required time for each analysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040223:Time [Temporal Concept]
   753   C3541383:Time [Temporal Concept]

Phrase: "was"

Phrase: "6 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.76: Statistical analysis. 

Phrase: "Statistical analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.77: Results are presented as mean  SE of the indicated number of experiments. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "presented as mean  SE of the indicated number of experiments."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   739   C0237753:*Number [Quantitative Concept]
   739   C0444504:Mean [Quantitative Concept]
   739   C0449450:Presented [Idea or Concept]
   739   C0449788:Number [Quantitative Concept]
   739   C0681814:Experiments [Research Activity]
   739   C1444656:Indicated [Finding]
   739   C2347634:Mean [Quantitative Concept]
   739   C2348143:Mean [Quantitative Concept]
   706 E C0150312:Present [Quantitative Concept]
   706 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.78: Statistical significance was determined using the one-way ANOVA test for multiple comparisons, followed by the post hoc Tukey-Kramer test. 

Phrase: "Statistical significance"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the one-way ANOVA test for multiple comparisons,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0022885:Test [Laboratory Procedure]
   744   C0039593:Test [Functional Concept]
   744   C0392366:test [Intellectual Product]

Phrase: "followed by the post hoc Tukey-Kramer test."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0332283:Followed by [Temporal Concept]
           followed
   744   C0022885:Test [Laboratory Procedure]
   744   C0039593:Test [Functional Concept]
   744   C0331847:Kramer [Health Care Related Organization]
   744   C0392366:test [Intellectual Product]
   744   C0687676:Post [Temporal Concept]
   744   C1704687:Post [Manufactured Object]
   711 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.79: P < 0.05 was considered significant.  

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "significant."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.80: RESULTS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Glycemia and HbA1c levels in Wistar control and GK rats. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Glycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005802:glycemia [Carbohydrate]

Phrase: "and"

Phrase: "HbA1c levels in Wistar control"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "GK rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.81: For confirming diabetes in GK rats, glycemia and the glycated hemoglobin (HbA1c, GHb) levels were determined (Table 1). 

Phrase: "For confirming diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "in GK rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "glycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005802:glycemia [Carbohydrate]

Phrase: "and"

Phrase: "the glycated hemoglobin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017853:Glycated haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0019046:Haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(HbA1c,"

Phrase: "GHb) levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined"

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.82: The percentage of hemoglobin in glycated form (GHb and HbA1C) was significantly higher in GK than in Wistar control rats (Table 1). 

Phrase: "The percentage of hemoglobin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]

Phrase: "in glycated form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "(GHb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000503:GHB [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "HbA1C"

Phrase: ")"

Phrase: "was"

Phrase: "significantly higher in GK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "than"

Phrase: "in Wistar control rats"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   913   C0034716:Rats, Wistar [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.83: Similarly, blood glucose levels increased in GK rats when compared with Wistar control rats. 

Phrase: "Similarly,"

Phrase: "blood glucose levels"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
  1000   C0428554:blood glucose levels [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "increased in GK rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]

Phrase: "when"

Phrase: "compared with Wistar control rats."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   797   C0034716:Rats, Wistar [Mammal]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2700262:Wistar [Mammal]
   760   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.84: However, the glycemia of 12-month-old GK rats was higher than that of 24-month-old rats. 

Phrase: "However,"

Phrase: "the glycemia of 12-month-old GK rats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0005802:glycemia [Carbohydrate]

Phrase: "was"

Phrase: "higher than that of 24-month-old rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C0205250:High [Qualitative Concept]
   711   C1299351:High [Qualitative Concept]
   711   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.85: View this table: [in this window] [in a new window]  TABLE 1 Characterization of Wistar control and GK rats  Effect of aging and A on brain mitochondrial respiration. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1 Characterization of Wistar control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "GK rats  Effect of aging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "A on brain mitochondrial respiration."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0026237:Mitochondrial [Cell Component]
   760   C0035203:Respiration [Physiologic Function]
   760   C0282636:respiration [Cell Function]
   760   C0521451:Mitochondrial [Functional Concept]
   760   C1160636:respiration [Biologic Function]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.86: Respiratory control ratio (RCR) is the ratio between mitochondrial respiration states 3 (consumption of oxygen in the presence of substrate and ADP) and 4 (consumption of oxygen after ADP has been consumed). 

Phrase: "Respiratory control ratio"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   913   C0429743:Respiratory ratio [Finding]
   827   C0243148:control [Qualitative Concept]
   827   C0456603:Ratio [Quantitative Concept]
   827   C0521346:respiratory [Functional Concept]
   827   C1546767:Respiratory [Intellectual Product]
   827   C1547037:Ratio [Intellectual Product]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(RCR"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   913   C0429743:Respiratory ratio [Finding]
   827   C0243148:control [Qualitative Concept]
   827   C0456603:Ratio [Quantitative Concept]
   827   C0521346:respiratory [Functional Concept]
   827   C1546767:Respiratory [Intellectual Product]
   827   C1547037:Ratio [Intellectual Product]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "is"

Phrase: "the ratio between mitochondrial respiration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "states"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1301808:State [Geographic Area]
  1000   C1442792:State [Functional Concept]
  1000   C3148680:State [Geographic Area]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(consumption of oxygen"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C0030055:Oxygen Consumption [Clinical Attribute]
   858   C1305742:consumption oxygen [Diagnostic Procedure]
   790   C0009830:Consumption [Activity]
   790   C1947907:Consumption [Physiologic Function]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "ADP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523452:ADP [Laboratory Procedure]

Phrase: ")"

Phrase: "and"

Phrase: "4"

Phrase: "(consumption of oxygen"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C0030055:Oxygen Consumption [Clinical Attribute]
   858   C1305742:consumption oxygen [Diagnostic Procedure]
   790   C0009830:Consumption [Activity]
   790   C1947907:Consumption [Physiologic Function]

Phrase: "after ADP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523452:ADP [Laboratory Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "consumed"

Phrase: ")."
Processing 00000000.tx.87: RCR decreased with aging (Fig. 1A). 

Phrase: "RCR"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   913   C0429743:Respiratory ratio [Finding]
   827   C0243148:control [Qualitative Concept]
   827   C0456603:Ratio [Quantitative Concept]
   827   C0521346:respiratory [Functional Concept]
   827   C1546767:Respiratory [Intellectual Product]
   827   C1547037:Ratio [Intellectual Product]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "decreased with aging"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0001811:Ageing [Organism Function]
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.88: The ADP/O ratio also showed a significant decrease with age (Fig. 2A). 

Phrase: "The ADP/O ratio also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a significant decrease with age (Fig. 2A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.89: The ADP/O ratio, an indicator of oxidative phosphorylation efficiency, is expressed by the ratio between the amount of ADP added and the oxygen consumed during state 3 respiration. 

Phrase: "The ADP/O ratio,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: "an indicator of oxidative phosphorylation efficiency,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
   753   C1235732:Indicator [Bird]
   753   C1522602:Indicator [Functional Concept]

Phrase: "is"

Phrase: "expressed by the ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]

Phrase: "between the amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:Amount [Quantitative Concept]

Phrase: "of ADP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523452:ADP [Laboratory Procedure]

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "the oxygen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "consumed during state 3 respiration."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0035203:Respiration [Physiologic Function]
   760   C0282636:respiration [Cell Function]
   760   C1160636:respiration [Biologic Function]
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C3148680:State [Geographic Area]
Processing 00000000.tx.90: In the presence of 50 mol/l A2535 or 2 mol/l A140, the effects of age on both respiratory indexes were exacerbated: the decreases on RCR (Fig. 1A) and ADP/O ratio (Fig. 2A) were potentiated. 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 50 mol/l A2535"

Phrase: "or"

Phrase: "2 mol/l A140,"

Phrase: "the effects of age"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on both respiratory indexes"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   966   C0451423:Respiratory index [Intellectual Product]
   861   C0521346:respiratory [Functional Concept]
   861   C0600653:Indexes [Intellectual Product]
   861   C0918012:indexes [Intellectual Product]
   861   C1546767:Respiratory [Intellectual Product]
   827 E C1552854:index [Idea or Concept]
   827 E C1637833:% index [Quantitative Concept]

Phrase: "were"

Phrase: "exacerbated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0436331:Exacerbated [Finding]
  1000   C1444749:Exacerbated [Qualitative Concept]

Phrase: ":"

Phrase: "the decreases on RCR"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0547047:decreases [Quantitative Concept]
   719 E C0392756:Decrease [Qualitative Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "ADP/O ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: "(Fig. 2A"

Phrase: ")"

Phrase: "were"

Phrase: "potentiated."
Processing 00000000.tx.91: A similar pattern occurred in Wistar control rats (Fig. 1B and 2B). 

Phrase: "A similar pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Pattern [Spatial Concept]

Phrase: "occurred in Wistar control rats"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   797   C0034716:Rats, Wistar [Mammal]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1709305:Occurred [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2700262:Wistar [Mammal]
   760   C3274648:Control [Qualitative Concept]
   726 E C2745955:OCCUR [Temporal Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "and"

Phrase: "2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450354:2b [Intellectual Product]
  1000   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.92: However, the effects of aging and A peptides were less pronounced than those observed in 12- and 24-month-old GK rats. 

Phrase: "However,"

Phrase: "the effects of aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "A peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "pronounced than those"

Phrase: "observed in 12-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "24-month-old GK rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0034693:rats [Mammal]
   799   C0034721:Rats [Mammal]
Processing 00000000.tx.93: View larger version (38K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(38K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.94: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.95: Effect of age and A peptides on RCR of brain mitochondria isolated from GK (A) and Wistar control (B) rats. 

Phrase: "Effect of age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "A peptides on RCR of brain mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "isolated from GK"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(A)"

Phrase: "and"

Phrase: "Wistar control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(B) rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.96: Freshly isolated brain mitochondria (0.8 mg) in 1 ml of the standard medium supplemented with 2 mol/l rotenone were energized with 5 mmol/l succinate. 

Phrase: "Freshly isolated brain mitochondria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C0026237:Mitochondria [Cell Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(0.8 mg) in 1 ml of the standard medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0439294:mg ml [Quantitative Concept]
   739   C0439269:mg% [Quantitative Concept]
   739   C1960952:mg % [Quantitative Concept]
   739   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "supplemented with 2 mol/l rotenone"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0347982:mol/L [Quantitative Concept]
   753   C0027960:Mole [Neoplastic Process]
   753   C0035871:Rotenone [Hazardous or Poisonous Substance,Organic Chemical]
   753   C0324740:Mole [Mammal]
   753   C0439189:Mole [Quantitative Concept]
   753   C1456781:mole [Neoplastic Process]
   753   C1824986:mol [Gene or Genome]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "were"

Phrase: "energized with 5 mmol/l succinate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0038617:succinate [Organic Chemical]
   753   C0220918:succinate [Organic Chemical,Pharmacologic Substance]
   753   C0439190:MMOLE [Quantitative Concept]
Processing 00000000.tx.97: Isolates were preincubated with 50 mol/l A2535 and 2 mol/l A140 for 5 min at 30C before mitochondria energization. 

Phrase: "Isolates"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0370215:isolates [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "were"

Phrase: "preincubated with 50 mol/l A2535"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0347982:mol/L [Quantitative Concept]
   753   C0027960:Mole [Neoplastic Process]
   753   C0324740:Mole [Mammal]
   753   C0439189:Mole [Quantitative Concept]
   753   C1456781:mole [Neoplastic Process]
   753   C1824986:mol [Gene or Genome]

Phrase: "and"

Phrase: "2 mol/l A140 for 5 min"

Phrase: "at 30C"

Phrase: "before mitochondria energization."
Processing 00000000.tx.98: aP < 0.001; 

Phrase: "aP < 0.001"

Phrase: ";"
Processing 00000000.tx.99: bP < 0.01, when compared with mitochondria isolated from 1.5-month-old GK rats. 

Phrase: "bP < 0.01,"

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 1.5-month-old GK rats."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   745   C1514732:Rat-1 [Cell]
   742   C0034693:rats [Mammal]
   742   C0034721:Rats [Mammal]
   742   C0205409:Isolated [Functional Concept]
   742   C0439231:month [Temporal Concept]
   742   C0439507:/month [Temporal Concept]
   742   C0580836:Old [Temporal Concept]
   742   C1548221:Isolated [Idea or Concept]
   708 E C0370215:Isolate [Substance]
   708 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.100: eP < 0.01, when compared with mitochondria isolated from 1.5-month-old GK rats, in the presence of 2 mol/l A140. 

Phrase: "eP < 0.01,"

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 1.5-month-old GK rats,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   745   C1514732:Rat-1 [Cell]
   742   C0034693:rats [Mammal]
   742   C0034721:Rats [Mammal]
   742   C0205409:Isolated [Functional Concept]
   742   C0439231:month [Temporal Concept]
   742   C0439507:/month [Temporal Concept]
   742   C0580836:Old [Temporal Concept]
   742   C1548221:Isolated [Idea or Concept]
   708 E C0370215:Isolate [Substance]
   708 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 2 mol/l A140."
Processing 00000000.tx.101: gP < 0.001; 

Phrase: "gP < 0.001"

Phrase: ";"
Processing 00000000.tx.102: hP < 0.01, when compared with mitochondria isolated from 12-month-old GK rats. 

Phrase: "hP < 0.01,"

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 12-month-old GK rats."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0205409:Isolated [Functional Concept]
   744   C0439231:month [Temporal Concept]
   744   C0439507:/month [Temporal Concept]
   744   C0580836:Old [Temporal Concept]
   744   C1548221:Isolated [Idea or Concept]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.103: kP < 0.05, when compared with mitochondria isolated from 12-month-old GK rats, in the presence of 50 mol/l A2535. 

Phrase: "kP < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022772:KP [Geographic Area]
   827   C1881334:kp [Quantitative Concept]

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 12-month-old GK rats,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0205409:Isolated [Functional Concept]
   744   C0439231:month [Temporal Concept]
   744   C0439507:/month [Temporal Concept]
   744   C0580836:Old [Temporal Concept]
   744   C1548221:Isolated [Idea or Concept]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 50 mol/l A2535."
Processing 00000000.tx.104: lP < 0.001, when compared with mitochondria isolated from 24-month-old GK rats. 

Phrase: "lP < 0.001,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037943:LP [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C0228341:LP [Body Part, Organ, or Organ Component]
   827   C2239920:LP [Gene or Genome]

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 24-month-old GK rats."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0205409:Isolated [Functional Concept]
   744   C0439231:month [Temporal Concept]
   744   C0439507:/month [Temporal Concept]
   744   C0580836:Old [Temporal Concept]
   744   C1548221:Isolated [Idea or Concept]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.105: nP < 0.001, when compared with mitochondria isolated from 1.5-month-old Wistar control rats. 

Phrase: "nP < 0.001,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706141:NP [Gene or Genome]

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 1.5-month-old Wistar control rats."
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   762   C0034716:Rats, Wistar [Mammal]
   745   C1514732:Rat-1 [Cell]
   742   C0034693:rats [Mammal]
   742   C0034721:Rats [Mammal]
   742   C0205409:Isolated [Functional Concept]
   742   C0243148:control [Qualitative Concept]
   742   C0439231:month [Temporal Concept]
   742   C0439507:/month [Temporal Concept]
   742   C0580836:Old [Temporal Concept]
   742   C1548221:Isolated [Idea or Concept]
   742   C1550141:Control [Substance]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C2700262:Wistar [Mammal]
   742   C3274648:Control [Qualitative Concept]
   708 E C0370215:Isolate [Substance]
   708 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.106: rP < 0.05, when compared with mitochondria isolated from 1.5-month-old Wistar control rats, in the presence of 50 mol/l A2535. 

Phrase: "rP < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1538326:RP [Gene or Genome]
   827   C3541325:RP [Idea or Concept]

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 1.5-month-old Wistar control rats,"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   762   C0034716:Rats, Wistar [Mammal]
   745   C1514732:Rat-1 [Cell]
   742   C0034693:rats [Mammal]
   742   C0034721:Rats [Mammal]
   742   C0205409:Isolated [Functional Concept]
   742   C0243148:control [Qualitative Concept]
   742   C0439231:month [Temporal Concept]
   742   C0439507:/month [Temporal Concept]
   742   C0580836:Old [Temporal Concept]
   742   C1548221:Isolated [Idea or Concept]
   742   C1550141:Control [Substance]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C2700262:Wistar [Mammal]
   742   C3274648:Control [Qualitative Concept]
   708 E C0370215:Isolate [Substance]
   708 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 50 mol/l A2535."
Processing 00000000.tx.107: sP < 0.001, when compared with mitochondria isolated from 1.5-month-old Wistar control rats, in the presence of 2 mol/l A140. 

Phrase: "sP < 0.001,"

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 1.5-month-old Wistar control rats,"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   762   C0034716:Rats, Wistar [Mammal]
   745   C1514732:Rat-1 [Cell]
   742   C0034693:rats [Mammal]
   742   C0034721:Rats [Mammal]
   742   C0205409:Isolated [Functional Concept]
   742   C0243148:control [Qualitative Concept]
   742   C0439231:month [Temporal Concept]
   742   C0439507:/month [Temporal Concept]
   742   C0580836:Old [Temporal Concept]
   742   C1548221:Isolated [Idea or Concept]
   742   C1550141:Control [Substance]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C2700262:Wistar [Mammal]
   742   C3274648:Control [Qualitative Concept]
   708 E C0370215:Isolate [Substance]
   708 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 2 mol/l A140."
Processing 00000000.tx.108: uP < 0.001; 

Phrase: "uP < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0547043:Up [Spatial Concept]
   827   C1282911:Up [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.109: vP < 0.05, when compared with mitochondria isolated from 12-month-old Wistar control rats. 

Phrase: "vP < 0.05,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1883540:{VP} [Quantitative Concept]

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 12-month-old Wistar control rats."
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   767   C0034716:Rats, Wistar [Mammal]
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0205409:Isolated [Functional Concept]
   744   C0243148:control [Qualitative Concept]
   744   C0439231:month [Temporal Concept]
   744   C0439507:/month [Temporal Concept]
   744   C0580836:Old [Temporal Concept]
   744   C1548221:Isolated [Idea or Concept]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C2700262:Wistar [Mammal]
   744   C3274648:Control [Qualitative Concept]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.110: wP < 0.05, when compared with mitochondria isolated from 12-month-old Wistar control rats, in the presence of 50 mol/l A2535. 

Phrase: "wP < 0.05,"

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 12-month-old Wistar control rats,"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   767   C0034716:Rats, Wistar [Mammal]
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0205409:Isolated [Functional Concept]
   744   C0243148:control [Qualitative Concept]
   744   C0439231:month [Temporal Concept]
   744   C0439507:/month [Temporal Concept]
   744   C0580836:Old [Temporal Concept]
   744   C1548221:Isolated [Idea or Concept]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C2700262:Wistar [Mammal]
   744   C3274648:Control [Qualitative Concept]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 50 mol/l A2535."
Processing 00000000.tx.111: xP < 0.001, when compared with mitochondria isolated from 24-month-old Wistar control rats.  

Phrase: "xP < 0.001,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1520168:Xp [Nucleotide Sequence]

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 24-month-old Wistar control rats."
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   767   C0034716:Rats, Wistar [Mammal]
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0205409:Isolated [Functional Concept]
   744   C0243148:control [Qualitative Concept]
   744   C0439231:month [Temporal Concept]
   744   C0439507:/month [Temporal Concept]
   744   C0580836:Old [Temporal Concept]
   744   C1548221:Isolated [Idea or Concept]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C2700262:Wistar [Mammal]
   744   C3274648:Control [Qualitative Concept]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.112: View larger version (37K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(37K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.113: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.114: Effect of aging and A peptides on ADP/O ratio of brain mitochondria isolated from GK (A) and Wistar control (B) rats. 

Phrase: "Effect of aging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "A peptides on ADP/O ratio of brain mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "isolated from GK"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(A)"

Phrase: "and"

Phrase: "Wistar control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(B) rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.115: Freshly isolated brain mitochondria (0.8 mg) in 1 ml of the standard medium supplemented with 2 mol/l rotenone were energized with 5 mmol/l succinate. 

Phrase: "Freshly isolated brain mitochondria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C0026237:Mitochondria [Cell Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(0.8 mg) in 1 ml of the standard medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0439294:mg ml [Quantitative Concept]
   739   C0439269:mg% [Quantitative Concept]
   739   C1960952:mg % [Quantitative Concept]
   739   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "supplemented with 2 mol/l rotenone"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0347982:mol/L [Quantitative Concept]
   753   C0027960:Mole [Neoplastic Process]
   753   C0035871:Rotenone [Hazardous or Poisonous Substance,Organic Chemical]
   753   C0324740:Mole [Mammal]
   753   C0439189:Mole [Quantitative Concept]
   753   C1456781:mole [Neoplastic Process]
   753   C1824986:mol [Gene or Genome]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "were"

Phrase: "energized with 5 mmol/l succinate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0038617:succinate [Organic Chemical]
   753   C0220918:succinate [Organic Chemical,Pharmacologic Substance]
   753   C0439190:MMOLE [Quantitative Concept]
Processing 00000000.tx.116: Isolates were preincubated with 50 mol/l A2535 and 2 mol/l A140 for 5 min at 30C before mitochondria energization. 

Phrase: "Isolates"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0370215:isolates [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "were"

Phrase: "preincubated with 50 mol/l A2535"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0347982:mol/L [Quantitative Concept]
   753   C0027960:Mole [Neoplastic Process]
   753   C0324740:Mole [Mammal]
   753   C0439189:Mole [Quantitative Concept]
   753   C1456781:mole [Neoplastic Process]
   753   C1824986:mol [Gene or Genome]

Phrase: "and"

Phrase: "2 mol/l A140 for 5 min"

Phrase: "at 30C"

Phrase: "before mitochondria energization."
Processing 00000000.tx.117: aP < 0.001, when compared with mitochondria isolated from 1.5-month-old GK rats. 

Phrase: "aP < 0.001,"

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 1.5-month-old GK rats."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   745   C1514732:Rat-1 [Cell]
   742   C0034693:rats [Mammal]
   742   C0034721:Rats [Mammal]
   742   C0205409:Isolated [Functional Concept]
   742   C0439231:month [Temporal Concept]
   742   C0439507:/month [Temporal Concept]
   742   C0580836:Old [Temporal Concept]
   742   C1548221:Isolated [Idea or Concept]
   708 E C0370215:Isolate [Substance]
   708 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.118: cP < 0.001; 

Phrase: "cP < 0.001"

Phrase: ";"
Processing 00000000.tx.119: dP < 0.01, when compared with mitochondria isolated from 1.5-month-old GK rats, in the presence of A2535. 

Phrase: "dP < 0.01,"

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 1.5-month-old GK rats,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   745   C1514732:Rat-1 [Cell]
   742   C0034693:rats [Mammal]
   742   C0034721:Rats [Mammal]
   742   C0205409:Isolated [Functional Concept]
   742   C0439231:month [Temporal Concept]
   742   C0439507:/month [Temporal Concept]
   742   C0580836:Old [Temporal Concept]
   742   C1548221:Isolated [Idea or Concept]
   708 E C0370215:Isolate [Substance]
   708 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of A2535."
Processing 00000000.tx.120: eP < 0.01; 

Phrase: "eP < 0.01"

Phrase: ";"
Processing 00000000.tx.121: fP < 0.05, when compared with mitochondria isolated from 1.5-month-old GK rats, in the presence of A140. 

Phrase: "fP < 0.05,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1419068:FP [Gene or Genome]
   827   C1419906:FP [Gene or Genome]
   827   C3541238:Fp [Amino Acid, Peptide, or Protein,Enzyme]
   827   C3541412:FP [Gene or Genome]

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 1.5-month-old GK rats,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   745   C1514732:Rat-1 [Cell]
   742   C0034693:rats [Mammal]
   742   C0034721:Rats [Mammal]
   742   C0205409:Isolated [Functional Concept]
   742   C0439231:month [Temporal Concept]
   742   C0439507:/month [Temporal Concept]
   742   C0580836:Old [Temporal Concept]
   742   C1548221:Isolated [Idea or Concept]
   708 E C0370215:Isolate [Substance]
   708 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of A140."
Processing 00000000.tx.122: gP < 0.001; 

Phrase: "gP < 0.001"

Phrase: ";"
Processing 00000000.tx.123: iP < 0.05, when compared with mitochondria isolated from 12-month-old GK rats. 

Phrase: "iP < 0.05,"

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 12-month-old GK rats."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0205409:Isolated [Functional Concept]
   744   C0439231:month [Temporal Concept]
   744   C0439507:/month [Temporal Concept]
   744   C0580836:Old [Temporal Concept]
   744   C1548221:Isolated [Idea or Concept]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.124: nP < 0.001; 

Phrase: "nP < 0.001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706141:NP [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.125: oP < 0.01; 

Phrase: "oP < 0.01"

Phrase: ";"
Processing 00000000.tx.126: pP < 0.05, when compared with mitochondria isolated from 1.5-month-old Wistar control rats. 

Phrase: "pP < 0.05,"

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 1.5-month-old Wistar control rats."
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   762   C0034716:Rats, Wistar [Mammal]
   745   C1514732:Rat-1 [Cell]
   742   C0034693:rats [Mammal]
   742   C0034721:Rats [Mammal]
   742   C0205409:Isolated [Functional Concept]
   742   C0243148:control [Qualitative Concept]
   742   C0439231:month [Temporal Concept]
   742   C0439507:/month [Temporal Concept]
   742   C0580836:Old [Temporal Concept]
   742   C1548221:Isolated [Idea or Concept]
   742   C1550141:Control [Substance]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C2700262:Wistar [Mammal]
   742   C3274648:Control [Qualitative Concept]
   708 E C0370215:Isolate [Substance]
   708 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.127: qP < 0.01, when compared with mitochondria isolated from 1.5-month-old Wistar control rats, in the presence of A2535. 

Phrase: "qP < 0.01,"

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 1.5-month-old Wistar control rats,"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   762   C0034716:Rats, Wistar [Mammal]
   745   C1514732:Rat-1 [Cell]
   742   C0034693:rats [Mammal]
   742   C0034721:Rats [Mammal]
   742   C0205409:Isolated [Functional Concept]
   742   C0243148:control [Qualitative Concept]
   742   C0439231:month [Temporal Concept]
   742   C0439507:/month [Temporal Concept]
   742   C0580836:Old [Temporal Concept]
   742   C1548221:Isolated [Idea or Concept]
   742   C1550141:Control [Substance]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C2700262:Wistar [Mammal]
   742   C3274648:Control [Qualitative Concept]
   708 E C0370215:Isolate [Substance]
   708 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of A2535."
Processing 00000000.tx.128: tP < 0.01, when compared with mitochondria isolated from 1.5-month-old Wistar control rats, in the presence of A140. 

Phrase: "tP < 0.01,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3541334:TP [Gene or Genome]

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 1.5-month-old Wistar control rats,"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   762   C0034716:Rats, Wistar [Mammal]
   745   C1514732:Rat-1 [Cell]
   742   C0034693:rats [Mammal]
   742   C0034721:Rats [Mammal]
   742   C0205409:Isolated [Functional Concept]
   742   C0243148:control [Qualitative Concept]
   742   C0439231:month [Temporal Concept]
   742   C0439507:/month [Temporal Concept]
   742   C0580836:Old [Temporal Concept]
   742   C1548221:Isolated [Idea or Concept]
   742   C1550141:Control [Substance]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C2700262:Wistar [Mammal]
   742   C3274648:Control [Qualitative Concept]
   708 E C0370215:Isolate [Substance]
   708 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of A140."
Processing 00000000.tx.129: vP < 0.05, when compared with mitochondria isolated from 12-month-old Wistar control rats. 

Phrase: "vP < 0.05,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1883540:{VP} [Quantitative Concept]

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 12-month-old Wistar control rats."
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   767   C0034716:Rats, Wistar [Mammal]
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0205409:Isolated [Functional Concept]
   744   C0243148:control [Qualitative Concept]
   744   C0439231:month [Temporal Concept]
   744   C0439507:/month [Temporal Concept]
   744   C0580836:Old [Temporal Concept]
   744   C1548221:Isolated [Idea or Concept]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C2700262:Wistar [Mammal]
   744   C3274648:Control [Qualitative Concept]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.130: yP < 0.01, when compared with mitochondria isolated from 24-month-old Wistar control rats.  

Phrase: "yP < 0.01,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1520214:Yp [Nucleotide Sequence]

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 24-month-old Wistar control rats."
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   767   C0034716:Rats, Wistar [Mammal]
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0205409:Isolated [Functional Concept]
   744   C0243148:control [Qualitative Concept]
   744   C0439231:month [Temporal Concept]
   744   C0439507:/month [Temporal Concept]
   744   C0580836:Old [Temporal Concept]
   744   C1548221:Isolated [Idea or Concept]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C2700262:Wistar [Mammal]
   744   C3274648:Control [Qualitative Concept]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.131: Effect of aging and A on m, repolarization lag phase, repolarization level, and ATP/ADP ratio. 

Phrase: "Effect of aging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "A on m,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C2346751:A/m [Quantitative Concept]
   790   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0441923:M+ [Intellectual Product]

Phrase: "repolarization lag phase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205390:Phase [Temporal Concept]
   827   C1416797:Lag [Gene or Genome]

Phrase: "repolarization level,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "ATP/ADP ratio."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]
Processing 00000000.tx.132: The mitochondrial m is fundamental for the phenomenon of oxidative phosphorylation, the conversion of ADP to ATP via ATP synthase. 

Phrase: "The mitochondrial m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "is"

Phrase: "fundamental for the phenomenon of oxidative phosphorylation,"

Phrase: "the conversion of ADP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439836:Conversion [Functional Concept]

Phrase: "to ATP"

Phrase: "via ATP synthase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.133: Mitochondrial respiratory chain pumps H+ out of the mitochondrial matrix across the inner mitochondrial membrane. 

Phrase: "Mitochondrial respiratory chain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1325653:mitochondrial respiratory chain [Cell Component]
           respiratory chain
   901   C0162362:Respiratory Chain [Molecular Function]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0337112:Chain [Manufactured Object]
   827   C0521346:respiratory [Functional Concept]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C1524075:Chain [Idea or Concept]
   827   C1546767:Respiratory [Intellectual Product]

Phrase: "pumps"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0182537:Pump [Medical Device]
  1000   C1706421:Pump [Manufactured Object]

Phrase: "H+ out of the mitochondrial matrix"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]

Phrase: "across the inner mitochondrial membrane."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0230840:Inner mitochondrial membrane [Cell Component]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0205102:Inner [Spatial Concept]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.134: The H+ gradient establishes an electrochemical potential (p) resulting in a pH (pH) and a voltage gradient (m) across the mitochondrial inner membrane. 

Phrase: "The H+ gradient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439182:% gradient [Quantitative Concept]
   861   C0812409:Gradient [Quantitative Concept]

Phrase: "establishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "an electrochemical potential (p)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "resulting in a pH (pH)"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0332294:Resulting in [Functional Concept]
   760   C0020283:[pH] [Quantitative Concept]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]
   760   C0678226:resulting [Functional Concept]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "a voltage gradient"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439182:% gradient [Quantitative Concept]
   861   C0598352:Voltage [Quantitative Concept]
   861   C0812409:Gradient [Quantitative Concept]

Phrase: "("

Phrase: "m) across the mitochondrial inner membrane."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0230840:Mitochondrial Inner Membrane [Cell Component]
   783   C0596952:Mitochondrial membrane [Cell Component]
   753   C0025255:Membrane [Tissue]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0205102:Inner [Spatial Concept]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.135: Figure 3 is a representative trace of the effect of A2535 on m (decreased), lag phase (increased), and repolarization phase (decreased) of mitochondria isolated from 1.5-month-old diabetic rats. 

Phrase: "Figure 3"

Phrase: "is"

Phrase: "a representative trace of the effect of A2535"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0442822:Trace [Quantitative Concept]
   744   C1524031:Trace [Qualitative Concept]
   744   C1883002:Trace [Functional Concept]

Phrase: "on"

Phrase: "m ("

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "lag phase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205390:Phase [Temporal Concept]
   861   C1416797:Lag [Gene or Genome]

Phrase: "(increased"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "repolarization phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "(decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: ")"

Phrase: "of mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "isolated from 1.5-month-old diabetic rats."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   750   C1514732:Rat-1 [Cell]
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0205409:Isolated [Functional Concept]
   744   C0241863:DIABETIC [Finding]
   744   C0439231:month [Temporal Concept]
   744   C0439507:/month [Temporal Concept]
   744   C0580836:Old [Temporal Concept]
   744   C1548221:Isolated [Idea or Concept]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.136: As shown in Table 2, age did not affect substantially the m. 

Phrase: "As"

Phrase: "shown in Table 2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "substantially"

Phrase: "the m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.137: However, the presence of 50 mol/l A2535 or 2 mol/l A140 led to a significant decrease of m in mitochondria isolated from 24-month-old rats (Table 2). 

Phrase: "However,"

Phrase: "the presence of 50 mol/l A2535"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "2 mol/l A140"

Phrase: "led to a significant decrease of m"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   748   C0237881:significant [Quantitative Concept]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0392756:Decrease [Qualitative Concept]
   748   C0441923:M+ [Intellectual Product]
   748   C0547047:Decrease [Quantitative Concept]
   748   C0750502:Significant [Idea or Concept]
   748   C1546944:Significant [Qualitative Concept]
   748   C1708698:LED [Manufactured Object]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C1522538:Lead [Functional Concept]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "isolated from 24-month-old rats"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0205409:Isolated [Functional Concept]
   753   C0439231:month [Temporal Concept]
   753   C0439507:/month [Temporal Concept]
   753   C0580836:Old [Temporal Concept]
   753   C1548221:Isolated [Idea or Concept]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.138: View larger version (16K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.139: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.140: Representative trace of the effect of A2535 on m, repolarization lag phase, and repolarization level of mitochondria isolated from 24-month-old GK rats. 

Phrase: "Representative trace of the effect of A2535"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0442822:Trace [Quantitative Concept]
   748   C1524031:Trace [Qualitative Concept]
   748   C1883002:Trace [Functional Concept]

Phrase: "on m,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "repolarization lag phase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205390:Phase [Temporal Concept]
   827   C1416797:Lag [Gene or Genome]

Phrase: "and"

Phrase: "repolarization level of mitochondria"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "isolated from 24-month-old GK rats."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0205409:Isolated [Functional Concept]
   744   C0439231:month [Temporal Concept]
   744   C0439507:/month [Temporal Concept]
   744   C0580836:Old [Temporal Concept]
   744   C1548221:Isolated [Idea or Concept]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.141: Freshly isolated brain mitochondria (0.8 mg) in 1 ml of the standard medium supplemented with 3 mol/l TPP+ and 2 mol/l rotenone were energized with 5 mmol/l succinate. 

Phrase: "Freshly isolated brain mitochondria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C0026237:Mitochondria [Cell Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(0.8 mg) in 1 ml of the standard medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0439294:mg ml [Quantitative Concept]
   739   C0439269:mg% [Quantitative Concept]
   739   C1960952:mg % [Quantitative Concept]
   739   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "supplemented with 3 mol/l TPP+"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0347982:mol/L [Quantitative Concept]
   753   C0027960:Mole [Neoplastic Process]
   753   C0076326:tetraphenylphosphonium [Indicator, Reagent, or Diagnostic Aid,Organophosphorus Compound]
   753   C0324740:Mole [Mammal]
   753   C0439189:Mole [Quantitative Concept]
   753   C1456781:mole [Neoplastic Process]
   753   C1824986:mol [Gene or Genome]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "2 mol/l rotenone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035871:Rotenone [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "were"

Phrase: "energized with 5 mmol/l succinate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0038617:succinate [Organic Chemical]
   753   C0220918:succinate [Organic Chemical,Pharmacologic Substance]
   753   C0439190:MMOLE [Quantitative Concept]
Processing 00000000.tx.142: Isolates were preincubated with 50 mol/l A2535 for 5 min at 30C before mitochondria energization.  

Phrase: "Isolates"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0370215:isolates [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "were"

Phrase: "preincubated with 50 mol/l A2535"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0347982:mol/L [Quantitative Concept]
   753   C0027960:Mole [Neoplastic Process]
   753   C0324740:Mole [Mammal]
   753   C0439189:Mole [Quantitative Concept]
   753   C1456781:mole [Neoplastic Process]
   753   C1824986:mol [Gene or Genome]

Phrase: "for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 30C"

Phrase: "before mitochondria energization."
Processing 00000000.tx.143: View this table: [in this window] [in a new window]  TABLE 2 Effect of age and A on mitochondrial m, repolarization lag phase, and repolarization level  Similarly, aging did not affect either repolarization lag phase (corresponding to ADP phosphorylation) or repolarization level (time necessary for mitochondria to reestablish the m, after ADP phosphorylation) of diabetic brain mitochondria (Table 2). 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 2 Effect of age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "A on mitochondrial m,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C2346751:A/m [Quantitative Concept]
   770   C0026237:Mitochondrial [Cell Component]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C0521451:Mitochondrial [Functional Concept]

Phrase: "repolarization lag phase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205390:Phase [Temporal Concept]
   827   C1416797:Lag [Gene or Genome]

Phrase: "and"

Phrase: "repolarization level  Similarly,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "either repolarization lag phase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205390:Phase [Temporal Concept]
   812   C1416797:Lag [Gene or Genome]

Phrase: "("

Phrase: "corresponding to ADP phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1157224:ADP phosphorylation [Molecular Function]
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0523452:ADP [Laboratory Procedure]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: ")"

Phrase: "or"

Phrase: "repolarization level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "(time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "necessary for mitochondria to"

Phrase: "reestablish"

Phrase: "the m,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "after"

Phrase: "ADP phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1157224:ADP phosphorylation [Molecular Function]
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: ")"

Phrase: "of diabetic brain mitochondria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0026237:Mitochondria [Cell Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.144: However, the presence of 50 mol/l A2535 or 2 mol/l A140 led to a significant decrease of both parameters. 

Phrase: "However,"

Phrase: "the presence of 50 mol/l A2535"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "2 mol/l A140"

Phrase: "led to a significant decrease of both parameters."
Meta Candidates (Total=15; Excluded=8; Pruned=0; Remaining=7)
   744   C0237881:significant [Quantitative Concept]
   744   C0392756:Decrease [Qualitative Concept]
   744   C0449381:Parameters [Finding]
   744   C0547047:Decrease [Quantitative Concept]
   744   C0750502:Significant [Idea or Concept]
   744   C1546944:Significant [Qualitative Concept]
   744   C1708698:LED [Manufactured Object]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C0549193:Parameter [Spatial Concept]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C1522538:Lead [Functional Concept]
   711 E C1704769:Parameter [Conceptual Entity]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C2350001:Parameter [Quantitative Concept]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.145: In the presence of 2 mol/l A140, those parameters could not be evaluated in mitochondria isolated from 24-month-old rats because after depolarization induced by ADP, the basal m could not be reestablished as a result of the inability of mitochondria to phosphorylate all of the ADP added, in the presence of the peptide. 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 2 mol/l A140,"

Phrase: "those parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0449381:Parameters [Finding]
   966 E C0549193:Parameter [Spatial Concept]
   966 E C1704769:Parameter [Conceptual Entity]
   966 E C2350001:Parameter [Quantitative Concept]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "evaluated in mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C0220825:Evaluated [Functional Concept]

Phrase: "isolated from 24-month-old rats"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0205409:Isolated [Functional Concept]
   753   C0439231:month [Temporal Concept]
   753   C0439507:/month [Temporal Concept]
   753   C0580836:Old [Temporal Concept]
   753   C1548221:Isolated [Idea or Concept]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "because"

Phrase: "after depolarization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231290:After [Temporal Concept]
   861   C0687676:After [Temporal Concept]

Phrase: "induced by ADP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205263:Induced [Functional Concept]
   790   C0523452:ADP [Laboratory Procedure]

Phrase: "the basal m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "reestablished as a result of the inability of mitochondria to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0026237:Mitochondria [Cell Component]
   739   C1274040:Result [Functional Concept]
   739   C1546471:Result [Idea or Concept]
   739   C2825142:Result [Finding]

Phrase: "phosphorylate"

Phrase: "all of the ADP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444868:All [Quantitative Concept]
   770   C0523452:ADP [Laboratory Procedure]
   770   C3539085:All [Idea or Concept]

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: ","

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of the peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.146: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.147: 4A, an age-related decrease in ATP/ADP ratio of diabetic brain mitochondria was observed. 

Phrase: "4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450373:4a [Intellectual Product]
  1000   C1553636:4a [Medical Device]

Phrase: "an age-related decrease in ATP/ADP ratio of diabetic brain mitochondria"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   736   C0001779:Age [Organism Attribute]
   736   C0392756:Decrease [Qualitative Concept]
   736   C0439849:Related [Qualitative Concept]
   736   C0445223:Related [Finding]
   736   C0547047:Decrease [Quantitative Concept]
   703 E C0163712:Relate [Organic Chemical]

Phrase: "was"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.148: The presence of 50 mol/l A2535 or 2 mol/l A140 exacerbated the decrease on ATP levels, this effect being more pronounced in the presence of 2 mol/l A140. 

Phrase: "The presence of 50 mol/l A2535"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "2 mol/l A140"

Phrase: "exacerbated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0436331:Exacerbated [Finding]
  1000   C1444749:Exacerbated [Qualitative Concept]

Phrase: "the decrease on ATP levels,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "being"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "pronounced in the presence of 2 mol/l A140."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0347982:mol/L [Quantitative Concept]
   742   C0027960:Mole [Neoplastic Process]
   742   C0324740:Mole [Mammal]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0439189:Mole [Quantitative Concept]
   742   C1456781:mole [Neoplastic Process]
   742   C1824986:mol [Gene or Genome]
Processing 00000000.tx.149: A similar pattern occurred with Wistar control rats (Fig. 4B). 

Phrase: "A similar pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Pattern [Spatial Concept]

Phrase: "occurred with Wistar control rats"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   797   C0034716:Rats, Wistar [Mammal]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1709305:Occurred [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2700262:Wistar [Mammal]
   760   C3274648:Control [Qualitative Concept]
   726 E C2745955:OCCUR [Temporal Concept]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.150: However, the effects of aging and A were less pronounced than those observed in 12- and 24-month-old GK rats. 

Phrase: "However,"

Phrase: "the effects of aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "A"

Phrase: "were"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "pronounced than those"

Phrase: "observed in 12-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "24-month-old GK rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0034693:rats [Mammal]
   799   C0034721:Rats [Mammal]
Processing 00000000.tx.151: View larger version (33K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(33K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.152: 4. 

Phrase: "4."
Processing 00000000.tx.153: Effect of age and A peptides on ATP/ADP ratio of brain mitochondria isolated from GK (A) and Wistar control (B) rats. 

Phrase: "Effect of age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "A peptides on ATP/ADP ratio of brain mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "isolated from GK"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(A)"

Phrase: "and"

Phrase: "Wistar control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(B) rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.154: At the end of incubations such as those described in Figs. 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of incubations"

Phrase: "such as those"

Phrase: "described in Figs."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0349966:Figs [Food]
   790   C1552738:described [Idea or Concept]
   756 E C1337208:FIG [Food]
Processing 00000000.tx.155: 1, 2, and 3, mitochondrial suspensions were centrifuged and processed for ATP levels analysis as described in RESEARCH DESIGN AND METHODS. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "mitochondrial suspensions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0038960:Suspensions [Biomedical or Dental Material]
   827 E C1382107:Suspension [Substance]
   827 E C1705537:Suspension [Functional Concept]

Phrase: "were"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "and"

Phrase: "processed for ATP levels analysis"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0441889:Levels [Qualitative Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1522240:Processed [Phenomenon or Process]
   760   C1524024:analysis [Functional Concept]
   726 E C0456079:Level [Classification]
   726 E C1184743:Process [Body Part, Organ, or Organ Component]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "as"

Phrase: "described in RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0035171:Research Design [Research Activity]
   770   C0035168:research [Research Activity]
   770   C0242481:Research [Research Activity]
   770   C1552738:described [Idea or Concept]
   770   C1707689:Design [Activity]
   770   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.156: Isolates were preincubated with 50 mol/l A2535 and 2 mol/l A140 for 5 min at 30C before mitochondria energization. 

Phrase: "Isolates"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0370215:isolates [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "were"

Phrase: "preincubated with 50 mol/l A2535"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0347982:mol/L [Quantitative Concept]
   753   C0027960:Mole [Neoplastic Process]
   753   C0324740:Mole [Mammal]
   753   C0439189:Mole [Quantitative Concept]
   753   C1456781:mole [Neoplastic Process]
   753   C1824986:mol [Gene or Genome]

Phrase: "and"

Phrase: "2 mol/l A140 for 5 min"

Phrase: "at 30C"

Phrase: "before mitochondria energization."
Processing 00000000.tx.157: aP < 0.001; 

Phrase: "aP < 0.001"

Phrase: ";"
Processing 00000000.tx.158: bP < 0.05, when compared with mitochondria isolated from 1.5-month-old GK rats; 

Phrase: "bP < 0.05,"

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 1.5-month-old GK rats"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   745   C1514732:Rat-1 [Cell]
   742   C0034693:rats [Mammal]
   742   C0034721:Rats [Mammal]
   742   C0205409:Isolated [Functional Concept]
   742   C0439231:month [Temporal Concept]
   742   C0439507:/month [Temporal Concept]
   742   C0580836:Old [Temporal Concept]
   742   C1548221:Isolated [Idea or Concept]
   708 E C0370215:Isolate [Substance]
   708 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.159: cP < 0.01, dP < 0.05, when compared with mitochondria isolated from rats 1.5-month-old GK rats, in the presence of A2535; 

Phrase: "cP < 0.01,"

Phrase: "dP < 0.05,"

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "from rats 1.5-month-old GK rats,"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of A2535"

Phrase: ";"
Processing 00000000.tx.160: eP < 0.01, when compared with mitochondria isolated from rats 1.5-month-old GK rats, in the presence of A140; 

Phrase: "eP < 0.01,"

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "from rats 1.5-month-old GK rats,"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of A140"

Phrase: ";"
Processing 00000000.tx.161: fP < 0.05, when compared with mitochondria isolated from rats 12-month-old GK rats. 

Phrase: "fP < 0.05,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1419068:FP [Gene or Genome]
   827   C1419906:FP [Gene or Genome]
   827   C3541238:Fp [Amino Acid, Peptide, or Protein,Enzyme]
   827   C3541412:FP [Gene or Genome]

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from rats 12-month-old GK rats."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   742   C0034693:rats [Mammal]
   742   C0034721:Rats [Mammal]
   742   C0205409:Isolated [Functional Concept]
   742   C0439231:month [Temporal Concept]
   742   C0439507:/month [Temporal Concept]
   742   C0580836:Old [Temporal Concept]
   742   C1548221:Isolated [Idea or Concept]
   708 E C0370215:Isolate [Substance]
   708 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.162: gP < 0.001; 

Phrase: "gP < 0.001"

Phrase: ";"
Processing 00000000.tx.163: hP < 0.01, when compared with mitochondria isolated from 1.5-month-old Wistar control rats; 

Phrase: "hP < 0.01,"

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 1.5-month-old Wistar control rats"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   762   C0034716:Rats, Wistar [Mammal]
   745   C1514732:Rat-1 [Cell]
   742   C0034693:rats [Mammal]
   742   C0034721:Rats [Mammal]
   742   C0205409:Isolated [Functional Concept]
   742   C0243148:control [Qualitative Concept]
   742   C0439231:month [Temporal Concept]
   742   C0439507:/month [Temporal Concept]
   742   C0580836:Old [Temporal Concept]
   742   C1548221:Isolated [Idea or Concept]
   742   C1550141:Control [Substance]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C2700262:Wistar [Mammal]
   742   C3274648:Control [Qualitative Concept]
   708 E C0370215:Isolate [Substance]
   708 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.164: iP < 0.001; 

Phrase: "iP < 0.001"

Phrase: ";"
Processing 00000000.tx.165: jP < 0.01, when compared with mitochondria isolated from 1.5-month-old Wistar control rats, in the presence of A2535; 

Phrase: "jP < 0.01,"

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 1.5-month-old Wistar control rats,"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   762   C0034716:Rats, Wistar [Mammal]
   745   C1514732:Rat-1 [Cell]
   742   C0034693:rats [Mammal]
   742   C0034721:Rats [Mammal]
   742   C0205409:Isolated [Functional Concept]
   742   C0243148:control [Qualitative Concept]
   742   C0439231:month [Temporal Concept]
   742   C0439507:/month [Temporal Concept]
   742   C0580836:Old [Temporal Concept]
   742   C1548221:Isolated [Idea or Concept]
   742   C1550141:Control [Substance]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C2700262:Wistar [Mammal]
   742   C3274648:Control [Qualitative Concept]
   708 E C0370215:Isolate [Substance]
   708 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of A2535"

Phrase: ";"
Processing 00000000.tx.166: kP < 0.001, when compared with mitochondria isolated from 1.5-month-old GK rats, in the presence of A140; 

Phrase: "kP < 0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022772:KP [Geographic Area]
   827   C1881334:kp [Quantitative Concept]

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 1.5-month-old GK rats,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   745   C1514732:Rat-1 [Cell]
   742   C0034693:rats [Mammal]
   742   C0034721:Rats [Mammal]
   742   C0205409:Isolated [Functional Concept]
   742   C0439231:month [Temporal Concept]
   742   C0439507:/month [Temporal Concept]
   742   C0580836:Old [Temporal Concept]
   742   C1548221:Isolated [Idea or Concept]
   708 E C0370215:Isolate [Substance]
   708 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of A140"

Phrase: ";"
Processing 00000000.tx.167: lP < 0.001; 

Phrase: "lP < 0.001"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037943:LP [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C0228341:LP [Body Part, Organ, or Organ Component]
   827   C2239920:LP [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.168: mP < 0.01, when compared with mitochondria isolated from 24-month-old Wistar control rats.  

Phrase: "mP < 0.01,"

Phrase: "when"

Phrase: "compared with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1707455:Compared [Activity]

Phrase: "isolated from 24-month-old Wistar control rats."
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   767   C0034716:Rats, Wistar [Mammal]
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0205409:Isolated [Functional Concept]
   744   C0243148:control [Qualitative Concept]
   744   C0439231:month [Temporal Concept]
   744   C0439507:/month [Temporal Concept]
   744   C0580836:Old [Temporal Concept]
   744   C1548221:Isolated [Idea or Concept]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C2700262:Wistar [Mammal]
   744   C3274648:Control [Qualitative Concept]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.169: Effect of aging and A on the induction of mitochondrial permeability transition pore. 

Phrase: "Effect of aging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "A on the induction of mitochondrial permeability transition pore."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   818   C0908146:mitochondrial permeability transition pore [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C2000322:permeability transition pore, mitochondrial [Amino Acid, Peptide, or Protein]
   790   C3158983:mitochondrial permeability transition [Cell Function]
   742   C0026237:Mitochondrial [Cell Component]
   742   C0031164:Permeability [Natural Phenomenon or Process]
   742   C0205263:Induction [Functional Concept]
   742   C0521451:Mitochondrial [Functional Concept]
   742   C0599156:Transition [Cell or Molecular Dysfunction]
   742   C0857127:induction [Therapeutic or Preventive Procedure]
   742   C1325742:Pore [Cell Component]
   742   C2700061:Transition [Activity]
Processing 00000000.tx.170: The drop of m is a typical phenomenon that leads to the induction of permeability transition pore (PTP). 

Phrase: "The drop of m"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1321095:Drop [Quantitative Concept]
   770   C1705648:Drop [Activity]
   770   C2347093:Drop [Quantitative Concept]
   770   C2348338:Drop [Quantitative Concept]

Phrase: "is"

Phrase: "a typical phenomenon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "that"

Phrase: "leads to the induction of permeability transition pore (PTP)."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0031164:Permeability [Natural Phenomenon or Process]
   744   C0181586:leads [Medical Device]
   744   C0205263:Induction [Functional Concept]
   744   C0599156:Transition [Cell or Molecular Dysfunction]
   744   C0857127:induction [Therapeutic or Preventive Procedure]
   744   C1325742:Pore [Cell Component]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C2700061:Transition [Activity]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.171: Figures 5 and 6 show the alteration of brain mitochondrial electric potential (m) induced by age and A2535, respectively. 

Phrase: "Figures"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "6"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the alteration of brain mitochondrial electric potential"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0544926:Mitochondrial alteration [Cell or Molecular Dysfunction]
   748   C1515926:Alteration [Idea or Concept]

Phrase: "("

Phrase: "m)"

Phrase: "induced by age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001779:Age [Organism Attribute]
   790   C0205263:Induced [Functional Concept]

Phrase: "and"

Phrase: "A2535,"

Phrase: "respectively."
Processing 00000000.tx.172: View larger version (19K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.173: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.174: Effect of age on PTP induction: susceptibility to Ca2+ addition. 

Phrase: "Effect of age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on PTP induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205263:Induction [Functional Concept]
   812   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "susceptibility to Ca2+ addition."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]
Processing 00000000.tx.175: Freshly isolated brain mitochondria (0.8 mg) in 1 ml of the standard medium supplemented with 3 mol/l TPP+ and 2 mol/l rotenone were energized with 5 mmol/l succinate. 

Phrase: "Freshly isolated brain mitochondria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C0026237:Mitochondria [Cell Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(0.8 mg) in 1 ml of the standard medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0439294:mg ml [Quantitative Concept]
   739   C0439269:mg% [Quantitative Concept]
   739   C1960952:mg % [Quantitative Concept]
   739   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "supplemented with 3 mol/l TPP+"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0347982:mol/L [Quantitative Concept]
   753   C0027960:Mole [Neoplastic Process]
   753   C0076326:tetraphenylphosphonium [Indicator, Reagent, or Diagnostic Aid,Organophosphorus Compound]
   753   C0324740:Mole [Mammal]
   753   C0439189:Mole [Quantitative Concept]
   753   C1456781:mole [Neoplastic Process]
   753   C1824986:mol [Gene or Genome]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "2 mol/l rotenone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035871:Rotenone [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "were"

Phrase: "energized with 5 mmol/l succinate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0038617:succinate [Organic Chemical]
   753   C0220918:succinate [Organic Chemical,Pharmacologic Substance]
   753   C0439190:MMOLE [Quantitative Concept]
Processing 00000000.tx.176: A: Mitochondria isolated from 1.5-month-old GK rats. 

Phrase: "A"

Phrase: ":"

Phrase: "Mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "isolated from 1.5-month-old GK rats."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   745   C1514732:Rat-1 [Cell]
   742   C0034693:rats [Mammal]
   742   C0034721:Rats [Mammal]
   742   C0205409:Isolated [Functional Concept]
   742   C0439231:month [Temporal Concept]
   742   C0439507:/month [Temporal Concept]
   742   C0580836:Old [Temporal Concept]
   742   C1548221:Isolated [Idea or Concept]
   708 E C0370215:Isolate [Substance]
   708 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.177: B: Mitochondria isolated from 12-month-old GK rats. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "isolated from 12-month-old GK rats."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0205409:Isolated [Functional Concept]
   744   C0439231:month [Temporal Concept]
   744   C0439507:/month [Temporal Concept]
   744   C0580836:Old [Temporal Concept]
   744   C1548221:Isolated [Idea or Concept]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.178: C: Mitochondria isolated from 24-month-old GK rats. 

Phrase: "C"

Phrase: ":"

Phrase: "Mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "isolated from 24-month-old GK rats."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0205409:Isolated [Functional Concept]
   744   C0439231:month [Temporal Concept]
   744   C0439507:/month [Temporal Concept]
   744   C0580836:Old [Temporal Concept]
   744   C1548221:Isolated [Idea or Concept]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.179: Ca2+ was added 1.5 min after mitochondria energization. 

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "1.5 min after mitochondria energization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1301862:Min 1 [Temporal Concept]
   753   C0702093:/min [Temporal Concept]
Processing 00000000.tx.180: The traces are typical of three experiments.  

Phrase: "The traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0442822:Trace [Quantitative Concept]
   966   C1524031:Trace [Qualitative Concept]
   966   C1883002:Trace [Functional Concept]

Phrase: "are"

Phrase: "typical of three experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3538928:Typical [Qualitative Concept]
Processing 00000000.tx.181: View larger version (14K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.182: 6. 

Phrase: "6."
Processing 00000000.tx.183: Effect of A2535 on m of mitochondria isolated from 24-month-old GK rats. 

Phrase: "Effect of A2535"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "of mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "isolated from 24-month-old GK rats."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0205409:Isolated [Functional Concept]
   744   C0439231:month [Temporal Concept]
   744   C0439507:/month [Temporal Concept]
   744   C0580836:Old [Temporal Concept]
   744   C1548221:Isolated [Idea or Concept]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.184: Freshly isolated brain mitochondria (0.8 mg) in 1 ml of the standard medium supplemented with 3 mol/l TPP+ and 2 mol/l rotenone were energized with 5 mmol/l succinate. 

Phrase: "Freshly isolated brain mitochondria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C0026237:Mitochondria [Cell Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(0.8 mg) in 1 ml of the standard medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0439294:mg ml [Quantitative Concept]
   739   C0439269:mg% [Quantitative Concept]
   739   C1960952:mg % [Quantitative Concept]
   739   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "supplemented with 3 mol/l TPP+"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0347982:mol/L [Quantitative Concept]
   753   C0027960:Mole [Neoplastic Process]
   753   C0076326:tetraphenylphosphonium [Indicator, Reagent, or Diagnostic Aid,Organophosphorus Compound]
   753   C0324740:Mole [Mammal]
   753   C0439189:Mole [Quantitative Concept]
   753   C1456781:mole [Neoplastic Process]
   753   C1824986:mol [Gene or Genome]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "2 mol/l rotenone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035871:Rotenone [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "were"

Phrase: "energized with 5 mmol/l succinate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0038617:succinate [Organic Chemical]
   753   C0220918:succinate [Organic Chemical,Pharmacologic Substance]
   753   C0439190:MMOLE [Quantitative Concept]
Processing 00000000.tx.185: A: Control. 

Phrase: "A"

Phrase: ":"

Phrase: "Control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.186: B: 50 mol/l A2535 was preincubated for 5 min at 30C before mitochondria energization. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "50 mol/l A2535"

Phrase: "was"

Phrase: "preincubated for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "at 30C"

Phrase: "before mitochondria energization."
Processing 00000000.tx.187: Ca2+ (100 mol/l) was added 1 min after mitochondria energization. 

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(100 mol/l)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0347982:mol/L [Quantitative Concept]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "1 min after mitochondria energization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1301862:Min 1 [Temporal Concept]
   760   C0702093:/min [Temporal Concept]
Processing 00000000.tx.188: The traces are typical of three experiments.  

Phrase: "The traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0442822:Trace [Quantitative Concept]
   966   C1524031:Trace [Qualitative Concept]
   966   C1883002:Trace [Functional Concept]

Phrase: "are"

Phrase: "typical of three experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3538928:Typical [Qualitative Concept]
Processing 00000000.tx.189: In mitochondria isolated from 1.5-month-old GK rats, after energizing with succinate, the first pulse of 50 mol/l Ca2+ led to a rapid depolarization followed by a partial repolarization. 

Phrase: "In mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "isolated from 1.5-month-old GK rats,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   745   C1514732:Rat-1 [Cell]
   742   C0034693:rats [Mammal]
   742   C0034721:Rats [Mammal]
   742   C0205409:Isolated [Functional Concept]
   742   C0439231:month [Temporal Concept]
   742   C0439507:/month [Temporal Concept]
   742   C0580836:Old [Temporal Concept]
   742   C1548221:Isolated [Idea or Concept]
   708 E C0370215:Isolate [Substance]
   708 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "after"

Phrase: "energizing with succinate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0038617:succinate [Organic Chemical]
   790   C0220918:succinate [Organic Chemical,Pharmacologic Substance]

Phrase: "the first pulse of 50 mol/l Ca2+"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0232117:PULSE [Clinical Attribute]
   744   C0391850:Pulse [Physiologic Function]
   744   C1947910:Pulse [Phenomenon or Process]

Phrase: "led to a rapid depolarization"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   760   C0439831:Rapid [Qualitative Concept]
   760   C1708698:LED [Manufactured Object]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C1522538:Lead [Functional Concept]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "followed by a partial repolarization."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0728938:Partial [Quantitative Concept]
   760   C1550516:partial [Idea or Concept]
   726 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.190: However, a second pulse of Ca2+ led to an irreversible depolarization (Fig. 5A). 

Phrase: "However,"

Phrase: "a second pulse of Ca2+"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0232117:PULSE [Clinical Attribute]
   760   C0391850:Pulse [Physiologic Function]
   760   C1947910:Pulse [Phenomenon or Process]
   756   C0556967:pulses/second [Quantitative Concept]

Phrase: "led to an irreversible depolarization"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   760   C1708698:LED [Manufactured Object]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C1522538:Lead [Functional Concept]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.191: Mitochondria isolated from 12- and 24-month-old GK rats showed a smaller capacity to accumulate Ca2+. 

Phrase: "Mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "isolated from 12-"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "24-month-old GK rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0034693:rats [Mammal]
   799   C0034721:Rats [Mammal]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a smaller capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1516240:Capacity [Quantitative Concept]

Phrase: "accumulate"

Phrase: "Ca2+."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.192: They undergo PTP induction after two pulses of 25 mol/l Ca2+ or 10 mol/l Ca2+, respectively (Figs. 5B and 5C). 

Phrase: "They"

Phrase: "undergo"

Phrase: "PTP induction after two pulses of 25 mol/l Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0205263:Induction [Functional Concept]
   736   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "10 mol/l Ca2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "respectively"

Phrase: "(Figs. 5B"

Phrase: "and"

Phrase: "5C"

Phrase: ")."
Processing 00000000.tx.193: The collapse of m was prevented by adding EGTA or oligomycin plus ADP, which completely restored m to the state 4 level (e.g., before Ca2+ addition) (Fig. 5B). 

Phrase: "The collapse of m"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0036974:collapse [Pathologic Function]
   770   C0332521:Collapse [Phenomenon or Process]
   770   C0344329:Collapse [Finding]
   770   C1880118:COLLAPSE [Phenomenon or Process]

Phrase: "was"

Phrase: "prevented by adding EGTA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   737   C0309872:PREVENT [Pharmacologic Substance]
   737   C1883712:Add [Functional Concept]

Phrase: "or"

Phrase: "oligomycin plus ADP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0523452:ADP [Laboratory Procedure]

Phrase: "which completely restored m to the state 4 level"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441923:M+ [Intellectual Product]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "before"

Phrase: "Ca2+ addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1883712:Addition [Functional Concept]
   789 E C1524062:Additional [Functional Concept]

Phrase: ")"

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.194: In mitochondria isolated from 24-month-old rats, A2535 (50 mol/l; Fig. 6) induced a significant decrease of m measured after mitochondria energization. 

Phrase: "In mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "isolated from 24-month-old rats,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0205409:Isolated [Functional Concept]
   753   C0439231:month [Temporal Concept]
   753   C0439507:/month [Temporal Concept]
   753   C0580836:Old [Temporal Concept]
   753   C1548221:Isolated [Idea or Concept]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "A2535"

Phrase: "(50 mol/l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0347982:mol/L [Quantitative Concept]

Phrase: "; Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a significant decrease of m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "measured after mitochondria energization."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0026237:Mitochondria [Cell Component]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.195: These mitochondria were more susceptible to the amount of Ca2+ added, because they undergo PTP in the presence of lower Ca2+ concentrations. 

Phrase: "These mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "were"

Phrase: "more susceptible to the amount of Ca2+ added,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0231204:Susceptible [Functional Concept]
   744   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "because"

Phrase: "they"

Phrase: "undergo"

Phrase: "PTP in the presence of lower Ca2+ concentrations."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0031164:Permeability [Natural Phenomenon or Process]
   739   C0599156:Transition [Cell or Molecular Dysfunction]
   739   C1325742:Pore [Cell Component]
   739   C2700061:Transition [Activity]
Processing 00000000.tx.196: The higher susceptibility to Ca2+ addition induced by A2535 also occurred in mitochondria isolated from 1.5- and 12-month-old GK rats (data not shown). 

Phrase: "The higher susceptibility to Ca2+ addition"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0012655:Susceptibility [Clinical Attribute]
   753   C0220898:Susceptibility [Organism Attribute]
   753   C1264642:Susceptibility [Functional Concept]
   753   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "induced by A2535 also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205263:Induced [Functional Concept]

Phrase: "occurred in mitochondria"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1709305:Occurred [Activity]
   756 E C2745955:OCCUR [Temporal Concept]

Phrase: "isolated from 1.5-"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "12-month-old GK rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0034693:rats [Mammal]
   799   C0034721:Rats [Mammal]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.197: The presence of 0.85 mol/l cyclosporin A (CsA; specific inhibitor of PTP) added 2 min before Ca2+ afforded a clear protection of mitochondria because it prevents the depolarization induced by Ca2+ (Fig. 7A). 

Phrase: "The presence of 0.85 mol/l cyclosporin A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(CsA"

Phrase: "; specific inhibitor of PTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "2 min before Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "afforded"

Phrase: "a clear protection of mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1545588:Protection [Finding]

Phrase: "because"

Phrase: "it"

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the depolarization"

Phrase: "induced by Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205263:Induced [Functional Concept]
   790   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.198: In addition, the preincubation (2 min) of mitochondria with 1 mmol/l ADP plus 2 g/ml oligomycin completely prevented mitochondria depolarization by increasing dramatically the repolarization capacity of mitochondrial membrane after Ca2+ accumulation (Fig. 7B). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the preincubation"

Phrase: "(2 min) of mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "with 1 mmol/l ADP plus 2 g/ml oligomycin completely prevented mitochondria depolarization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C1816452:mitochondria depolarization [Cell Function]

Phrase: "by increasing dramatically"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
   861   C0442808:Increasing [Functional Concept]
   827 E C0442805:Increase [Functional Concept]
   789 E C1517378:Gain [Quantitative Concept]
   768 E C0205217:Increased [Quantitative Concept]
   768 E C0439661:Acquired [Temporal Concept]
   768 E C1301820:Obtain [Functional Concept]
   768 E C1706701:Acquire [Activity]
   768 E C3245488:acquired [Intellectual Product]

Phrase: "the repolarization capacity of mitochondrial membrane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1516240:Capacity [Quantitative Concept]

Phrase: "after Ca2+ accumulation"

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.199: View larger version (16K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.200: 7. 

Phrase: "7."
Processing 00000000.tx.201: Inhibitory effect of CsA (A) and oligomycin plus ADP (B) on Ca2+-dependent PTP opening. 

Phrase: "Inhibitory effect of CsA (A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "oligomycin plus ADP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0523452:ADP [Laboratory Procedure]

Phrase: "(B) on Ca2+-dependent PTP opening."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.202: Mitochondria were incubated in 0.8 mg protein/ml under standard conditions as described in RESEARCH DESIGN AND METHODS. 

Phrase: "Mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "were"

Phrase: "incubated in 0.8 mg protein/ml"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0439294:mg ml [Quantitative Concept]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439269:mg% [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1960952:mg % [Quantitative Concept]
   748   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "under standard conditions"
Meta Candidates (Total=14; Excluded=9; Pruned=0; Remaining=5)
   861   C1442989:Standard [Qualitative Concept]
   861   C2828392:Standard [Intellectual Product]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "as"

Phrase: "described in RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0035171:Research Design [Research Activity]
   770   C0035168:research [Research Activity]
   770   C0242481:Research [Research Activity]
   770   C1552738:described [Idea or Concept]
   770   C1707689:Design [Activity]
   770   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.203: A total of 0.85 mol/l CsA and 1 mmol/l ADP plus 2 g/ml oligomycin were incubated with mitochondria for 2 min before adding Ca2+. 

Phrase: "A total of 0.85 mol/l CsA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "1 mmol/l ADP plus 2 g/ml oligomycin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0028951:Oligomycin [Antibiotic,Organic Chemical]
   700   C0347982:mmol/mL [Quantitative Concept]

Phrase: "were"

Phrase: "incubated with mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 2 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "before adding Ca2+."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.204: The traces are typical of three experiments.   

Phrase: "The traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0442822:Trace [Quantitative Concept]
   966   C1524031:Trace [Qualitative Concept]
   966   C1883002:Trace [Functional Concept]

Phrase: "are"

Phrase: "typical of three experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3538928:Typical [Qualitative Concept]
Processing 00000000.tx.205: DISCUSSION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  The effect of A on the function of brain mitochondria was analyzed in GK rats at different ages (1.5, 12, and 24 months). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The effect of A on the function of brain mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "analyzed in GK rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0936012:Analyzed [Research Activity]

Phrase: "at different ages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "(1.5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "12,"

Phrase: "and"

Phrase: "24 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.206: We observed that aging renders diabetic brain mitochondria more susceptible to toxic insults such as the neurotoxic A. 

Phrase: "We"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "renders"

Phrase: "diabetic brain mitochondria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0026237:Mitochondria [Cell Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "more susceptible to toxic insults"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0231204:Susceptible [Functional Concept]
   760   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "such as the neurotoxic A."
Processing 00000000.tx.207: The characterization of diabetes in GK rats was performed by determining the blood levels of glucose and glycated hemoglobin (HbA1C and GHb). 

Phrase: "The characterization of diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]

Phrase: "in GK rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "was"

Phrase: "performed by determining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C1550369:Performed By [Qualitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "the blood levels of glucose"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   835   C0428554:blood glucose levels [Laboratory or Test Result]
   797   C0005802:Blood Glucose [Carbohydrate]
   797   C0428548:glucose levels [Laboratory or Test Result]
   781 E C0337438:glucose level [Laboratory Procedure]
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0229664:Blood [Body Substance]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "glycated hemoglobin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017853:Glycated haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0019046:Haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(HbA1C"

Phrase: "and"

Phrase: "GHb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000503:GHB [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.208: A significant increase in GHb and also in glycemia was observed (Table 1). 

Phrase: "A significant increase in GHb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "also in glycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0005802:glycemia [Carbohydrate]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.209: We should note the decrease, although not significant, in glycemia of 24-month-old GK rats, which is associated with weight loss, i.e., 24-month-old GK rats presented a loss in body weight, which may be responsible for glycemia decrement. 

Phrase: "We"

Phrase: "should"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the decrease,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "although"

Phrase: "not significant,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "in glycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005802:glycemia [Carbohydrate]

Phrase: "of 24-month-old GK rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0034693:rats [Mammal]
   799   C0034721:Rats [Mammal]

Phrase: "which"

Phrase: "is"

Phrase: "associated with weight loss,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   833   C0043096:WEIGHTLOSS [Finding]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C2911645:Weight loss [Finding]
   770   C0005910:weight [Organism Attribute]
   770   C0043100:Weight [Quantitative Concept]
   770   C1305866:weight [Diagnostic Procedure]
   770   C1517945:Loss [Quantitative Concept]
   770   C1705104:Weight [Idea or Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "i.e.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "24-month-old GK rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0034693:rats [Mammal]
   799   C0034721:Rats [Mammal]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "a loss in body weight,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0043096:Weight Loss [Finding]
   797   C2911645:Weight loss [Finding]
   760   C1517945:Loss [Quantitative Concept]

Phrase: "which"

Phrase: "may"

Phrase: "be"

Phrase: "responsible for glycemia decrement."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]
Processing 00000000.tx.210: Besides the genetic predisposition, obesity is the most important risk factor for the development of type 2 diabetes. 

Phrase: "Besides the genetic predisposition,"
Meta Candidates (Total=20; Excluded=15; Pruned=0; Remaining=5)
  1000   C0314657:Genetic Predisposition [Organism Attribute]
   861   C0012655:Predisposition [Clinical Attribute]
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0220898:Predisposition [Organism Attribute]
   861   C0314603:Genetic [Functional Concept]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   789 E C0231203:Predisposed [Functional Concept]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "is"

Phrase: "the most important risk factor for the development of type 2 diabetes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0035648:Risk factor [Quantitative Concept]
   751   C1171304:diabetes risk [Quantitative Concept]
   736   C0035647:Risk [Qualitative Concept]
   736   C1521761:Factor [Functional Concept]
   736   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.211: Data from the literature indicate that weight loss can result in a significant improvement in blood glucose levels (29). 

Phrase: "Data from the literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that weight loss"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0043096:WEIGHTLOSS [Finding]
  1000   C2911645:Weight loss [Finding]
   861   C0005910:weight [Organism Attribute]
   861   C0043100:Weight [Quantitative Concept]
   861   C1305866:weight [Diagnostic Procedure]
   861   C1517945:Loss [Quantitative Concept]
   861   C1705104:Weight [Idea or Concept]

Phrase: "can"

Phrase: "result in a significant improvement"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0237881:significant [Quantitative Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   760   C2825142:Result [Finding]
   760   C2986411:Improvement [Conceptual Entity]

Phrase: "in blood glucose levels"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
  1000   C0428554:blood glucose levels [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.212: The isolation procedure used in this study does not allow separation of mitochondria from different cell types. 

Phrase: "The isolation procedure"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0204727:Isolation procedure [Therapeutic or Preventive Procedure]
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "separation of mitochondria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036679:Separation [Pathologic Function]
   790   C0237868:Separation [Social Behavior]
   790   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "from different cell types."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0449475:Cell types [Intellectual Product]
   867 E C0007634:Cell Type [Cell]
           Cell
   827   C0332307:Types [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.213: Consequently, the observed alterations in mitochondrial function may derive from changes in one or more cell types. 

Phrase: "Consequently,"

Phrase: "the observed alterations in mitochondrial function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0544926:Mitochondrial alteration [Cell or Molecular Dysfunction]
   719   C1515926:Alteration [Idea or Concept]

Phrase: "may"

Phrase: "derive from changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "more cell types."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0449475:Cell types [Intellectual Product]
   867 E C0007634:Cell Type [Cell]
           Cell
   827   C0332307:Types [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.214: They include the three types of insulin-sensitive cells in the brain: vascular epithelial cells, astrocytes, and some neurons. 

Phrase: "They"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the three types of insulin-sensitive cells"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   814   C0457592:Types of insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           insulin types
   782   C0449475:Type of cell [Intellectual Product]
           cells types
   748   C0332307:Types [Qualitative Concept]
   741 E C0007634:Cell Type [Cell]
   714 E C1547052:*Type [Quantitative Concept]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "vascular epithelial cells,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   901   C0014597:Epithelial Cells [Cell]
   901   C1273342:Epithelial Cells [Laboratory Procedure]
   863   C0005773:Blood Cells [Cell]
   855 E C2328697:Hemal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0221908:Epithelial [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "astrocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "and"

Phrase: "some neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.215: All three of these cell types are affected in diabetes. 

Phrase: "All three of these cell types"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   803   C0449475:Type of cell [Intellectual Product]
           Cell types
   756 E C0007634:Cell Type [Cell]
           Cell
   753   C0205449:Three [Quantitative Concept]
   753   C0332307:Types [Qualitative Concept]
   753   C0444868:All [Quantitative Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C3539085:All [Idea or Concept]
   719 E C1547052:*Type [Quantitative Concept]

Phrase: "are"

Phrase: "affected in diabetes."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]
Processing 00000000.tx.216: Of great interest here, however, are astrocytes and neurons, because mitochondria in these cell types are known to suffer morphological changes in diabetic rats (30,31). 

Phrase: "Of great interest here,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0543488:Interest [Mental Process]

Phrase: "however,"

Phrase: "are"

Phrase: "astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "and"

Phrase: "neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "because"

Phrase: "mitochondria in these cell types"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0026237:Mitochondria [Cell Component]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "suffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683278:suffer [Mental or Behavioral Dysfunction]

Phrase: "morphological changes in diabetic rats"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   760   C0543482:morphological [Spatial Concept]
   739   C1260954:Morphologic change [Anatomical Abnormality]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "(30,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.217: Astrocytes, which are intimately involved in neuronal function, play an important role in brain glucose metabolism (32) and thus merit as much attention as neurons in subsequent studies of brain mitochondrial changes in GK rats. 

Phrase: "Astrocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "which"

Phrase: "are"

Phrase: "intimately"

Phrase: "involved in neuronal function,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0031843:function [Physiologic Function]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1314939:Involved [Functional Concept]
   770   C1705273:Function [Intellectual Product]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in brain glucose metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "(32"

Phrase: ")"

Phrase: "and"

Phrase: "thus"

Phrase: "merit as much attention"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0004268:Attention [Mental Process]

Phrase: "as neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in subsequent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "of brain mitochondrial changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]

Phrase: "in GK rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.218: Hyperglycemia in GK rats could cause brain mitochondrial impairment via oxidative stress compromising brain function. 

Phrase: "Hyperglycemia in GK rats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "could"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "brain mitochondrial impairment via oxidative stress compromising brain function."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0684336:Impairment [Pathologic Function]
Processing 00000000.tx.219: Data from the literature show that hyperglycemia induces oxidative damage in rat brain (23,33). 

Phrase: "Data from the literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "oxidative damage in rat brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0270611:Brain damage [Injury or Poisoning]
   760   C0010957:Damage [Injury or Poisoning]
   760   C1883709:Damage [Functional Concept]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.220: It was also shown that lipid peroxidation products are increased in the brain of type 2 diabetic mice, whereas the activity of antioxidant enzymes, such as catalase and superoxide dismutase, is decreased (34,35). 

Phrase: "It"

Phrase: "was"

Phrase: "also"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that lipid peroxidation products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]
   734   C0023775:Lipid Peroxidation [Molecular Function]

Phrase: "are"

Phrase: "increased in the brain of type 2 diabetic mice,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   764   C0441730:Type 2 [Classification]
   762   C1310510:Brain-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   745   C1521713:Mouse Brain [Tissue]
   742   C0006104:Brain [Body Part, Organ, or Organ Component]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0205217:Increased [Quantitative Concept]
   742   C0241863:DIABETIC [Finding]
   742   C0332307:Type [Qualitative Concept]
   742   C0442805:Increased [Functional Concept]
   742   C1269537:Brain [Body Part, Organ, or Organ Component]
   742   C1547052:*Type [Quantitative Concept]

Phrase: "whereas"

Phrase: "the activity of antioxidant enzymes,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C1148564:antioxidant activity [Molecular Function]
   781   C0243102:enzyme activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "such as catalase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "and"

Phrase: "superoxide dismutase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038838:Superoxide Dismutase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0038836:Superoxide [Element, Ion, or Isotope]

Phrase: "is"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "(34,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.221: The presence of lipid peroxidation products, such as 4-hydroxynonenal (HNE), reduces the activity of a variety of enzymes that are critical to normal function of neurons, including glucose transporters (36). 

Phrase: "The presence of lipid peroxidation products,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "such as 4-hydroxynonenal (HNE),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0048297:4-hydroxynonenal [Organic Chemical,Pharmacologic Substance]

Phrase: "reduces"

Phrase: "the activity of a variety of enzymes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0243102:enzyme activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "are"

Phrase: "critical to normal function of neurons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1511545:Critical [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "glucose transporters"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0596902:transporters [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.222: HNE has been demonstrated to have the capacity to impair mitochondrial function in brain synaptosomes (36). 

Phrase: "HNE"

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "the capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "impair"

Phrase: "mitochondrial function in brain synaptosomes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0678908:brain function [Organ or Tissue Function]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.223: The specific mitochondrial enzymes -ketoglutarate dehydrogenase and pyruvate dehydrogenase have been shown to be targets for HNE protein conjugation, resulting in a decrease of the activity of both enzymes (37). 

Phrase: "The specific mitochondrial enzymes -ketoglutarate dehydrogenase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "pyruvate dehydrogenase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0034343:pyruvate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0034354:pyruvate [Organic Chemical]
   861   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "targets for HNE protein conjugation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1159372:protein target [Molecular Function]
   726   C1521840:Target [Functional Concept]
   726   C2986546:TARGET [Diagnostic Procedure]

Phrase: "resulting in a decrease of the activity of both enzymes"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   760   C0332294:Resulting in [Functional Concept]
   741   C0243102:enzyme activity [Molecular Function]
   739   C0014442:Enzymes [Enzyme,Organic Chemical]
   739   C0014445:enzymes [Functional Concept]
   739   C0205177:Activity [Functional Concept]
   739   C0392756:Decrease [Qualitative Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C0547047:Decrease [Quantitative Concept]
   739   C0678226:resulting [Functional Concept]
   739   C1561536:*Activity [Idea or Concept]
   706 E C1274040:Result [Functional Concept]
   706 E C1546471:Result [Idea or Concept]
   706 E C2825142:Result [Finding]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.224: Dysfunction of the mitochondrial respiratory chain has been described in diabetes (38). 

Phrase: "Dysfunction of the mitochondrial respiratory chain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1260922:RESPIRATORY DYSFUNCTION NOS [Sign or Symptom]
   753   C0031847:dysfunction [Functional Concept]
   753   C0277785:Dysfunction, NOS [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "described in diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C1552738:described [Idea or Concept]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.225: Accordingly, our data show an age-related impairment of the respiratory chain (decrease of RCR; Fig. 1A) and an uncoupling of oxidative phosphorylation (OXPHOS; decrease of ADP/O ratio; Fig. 2A) in brain mitochondria isolated from GK rats. 

Phrase: "Accordingly,"

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "an age-related impairment of the respiratory chain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0684336:Impairment [Pathologic Function]

Phrase: "(decrease of RCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "; Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "an"

Phrase: "uncoupling of oxidative phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0030013:Oxidative Phosphorylation [Molecular Function]
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0311404:Oxidative [Functional Concept]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "(OXPHOS"

Phrase: "; decrease of ADP/O ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "; Fig. 2A"

Phrase: ")"

Phrase: "in brain mitochondria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0026237:Mitochondria [Cell Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "isolated from GK rats."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0205409:Isolated [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.226: Inhibition of cellular energy production has been shown to reduce or abolish both insulin secretion and action (39). 

Phrase: "Inhibition of cellular energy production"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "or"

Phrase: "abolish"

Phrase: "both insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441472:Action [Functional Concept]
  1000   C3266814:Action [Activity]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.227: In addition, the decrement in OXPHOS efficiency is related to a loss in the control of glucose homeostasis as evidenced by the increase in tissue and blood lactate levels, as well as by the change in glucose tolerance (Table 1). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the decrement in OXPHOS efficiency"

Phrase: "is"

Phrase: "related to a loss"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C1517945:Loss [Quantitative Concept]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "in the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of glucose homeostasis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1326961:glucose homeostasis [Physiologic Function]
   861   C0019868:Homeostasis [Biologic Function]

Phrase: "as"

Phrase: "evidenced by the increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442805:Increase [Functional Concept]
   737   C0332120:Evidence [Functional Concept]

Phrase: "in tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "blood lactate levels,"
Meta Candidates (Total=18; Excluded=10; Pruned=0; Remaining=8)
   901   C0428445:lactate levels [Laboratory Procedure]
   901   C1304767:lactate levels [Laboratory or Test Result]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0022924:lactate [Organic Chemical]
   827   C0229664:Blood [Body Substance]
   827   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "as well as by the change"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205170:Well [Qualitative Concept]
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]
   753   C3146287:Well [Manufactured Object]

Phrase: "in glucose tolerance"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0178665:Glucose tolerance [Physiologic Function]
   861   C0013220:Tolerance [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0020963:Tolerance [Pathologic Function]
   861   C0220929:tolerance [Mental Process]
   861   C0231197:Tolerance [Physiologic Function]
   861   C1704410:Tolerance [Qualitative Concept]
   805 E C0680282:toleration [Social Behavior]
   789 E C0231198:Tolerant [Functional Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.228: The impairment of the respiratory chain (Fig. 1A) and the uncoupling of OXPHOS (Fig. 2A) are not accompanied by a decrease in m (Table 2). 

Phrase: "The impairment of the respiratory chain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0684336:Impairment [Pathologic Function]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "the"

Phrase: "uncoupling of OXPHOS"

Phrase: "(Fig. 2A"

Phrase: ")"

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "accompanied by a decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "in"

Phrase: "m ("

Phrase: "Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.229: However, an age-related decrease in ATP/ADP ratio of mitochondria isolated from diabetic rats occurred (Fig. 4A). 

Phrase: "However,"

Phrase: "an age-related decrease in ATP/ADP ratio of mitochondria"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   739   C0001779:Age [Organism Attribute]
   739   C0392756:Decrease [Qualitative Concept]
   739   C0439849:Related [Qualitative Concept]
   739   C0445223:Related [Finding]
   739   C0547047:Decrease [Quantitative Concept]
   706 E C0163712:Relate [Organic Chemical]

Phrase: "isolated from diabetic rats"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0205409:Isolated [Functional Concept]
   770   C0241863:DIABETIC [Finding]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.230: Cybrid cells constructed from individuals with maternally inherited diabetes exhibited lactic acidosis, poor respiration, and marked defects in mitochondrial morphology and respiratory chain complex I and IV activities (40). 

Phrase: "Cybrid cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "constructed from individuals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0027361:Individual [Population Group]
   756   C0237401:Individual [Human]
   756   C2827421:Construct [Classification]

Phrase: "with maternally inherited diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "lactic acidosis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001125:Acidosis, Lactic [Disease or Syndrome]
   861   C0001122:Acidosis [Pathologic Function]
   861   C0220981:Acidosis [Pathologic Function]

Phrase: "poor respiration,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035203:Respiration [Physiologic Function]
   861   C0282636:respiration [Cell Function]
   861   C1160636:respiration [Biologic Function]

Phrase: "and"

Phrase: "marked defects in mitochondrial morphology"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0243067:defects [Functional Concept]
   726 E C1457869:Defect [Functional Concept]
   726 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "and"

Phrase: "respiratory chain complex I"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C1167290:respiratory chain complex I [Cell Component]
   923   C2363240:Respiratory Complex I [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0162362:Respiratory Chain [Molecular Function]
   861   C1325653:respiratory chain [Cell Component]
   861   C2245017:Complex I [Cell Component]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0337112:Chain [Manufactured Object]
   812   C0439855:Complex [Qualitative Concept]
   812   C0521346:respiratory [Functional Concept]
   812   C1524075:Chain [Idea or Concept]
   812   C1546767:Respiratory [Intellectual Product]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "IV activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.231: Because CNS depends so heavily on ATP production, the inhibition of OXPHOS will affect this system before any other system. 

Phrase: "Because"

Phrase: "CNS"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "depends"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0725813:depend [Medical Device]

Phrase: "so heavily on ATP production,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033268:production [Occupational Activity]
   760   C0037640:SO [Geographic Area]

Phrase: "the inhibition of OXPHOS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "will"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "this system before any"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449913:System [Functional Concept]
   770   C1553451:System [Manufactured Object]
   770   C1704459:System [Medical Device]

Phrase: "other system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0449913:System [Functional Concept]
  1000   C1553451:System [Manufactured Object]
  1000   C1704459:System [Medical Device]
   928 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.232: For example, CNS requires a large amount of ATP for the transmission of impulses along the neural pathway; 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "CNS"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "requires"

Phrase: "a large amount of ATP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "for the transmission"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040722:transmission [Idea or Concept]
  1000   C0242781:Transmission [Pathologic Function]
  1000   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "of impulses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0443235:Impulse [Therapeutic or Preventive Procedure]

Phrase: "along the neural pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027792:Neural Pathway [Body Part, Organ, or Organ Component]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.233: thus, mitochondrial function impairment will result in neurodegeneration and loss in neuronal metabolic control (41,42). 

Phrase: "thus,"

Phrase: "mitochondrial function impairment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0684336:Impairment [Pathologic Function]

Phrase: "will"

Phrase: "result in neurodegeneration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]

Phrase: "and"

Phrase: "loss in neuronal metabolic control"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C1850496:Neuronal loss [Finding]
   762 E C0598940:neuron loss [Finding]
   760   C1517945:Loss [Quantitative Concept]

Phrase: "(41,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.234: Bioenergetic complications induced by diabetes are exacerbated by aging. 

Phrase: "Bioenergetic complications"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009566:Complications [Pathologic Function]
   861   C1171258:complications [Pathologic Function]
   827 E C2362589:Complication [Idea or Concept]
   777 E C0231242:Complicated [Functional Concept]

Phrase: "induced by diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0205263:Induced [Functional Concept]

Phrase: "are"

Phrase: "exacerbated by aging."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0001811:Ageing [Organism Function]
   790   C0436331:Exacerbated [Finding]
   790   C1444749:Exacerbated [Qualitative Concept]
Processing 00000000.tx.235: Our data show a more pronounced mitochondrial dysfunction in older GK rats (12 and 24 months old) (Figs. 1A, 2A, and 4A) when compared with Wistar control rats of the same age (Figs. 1B, 2B, and 4B). 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "pronounced"

Phrase: "mitochondrial dysfunction in older GK rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031847:dysfunction [Functional Concept]
   748   C0277785:Dysfunction, NOS [Qualitative Concept]

Phrase: "(12"

Phrase: "and"

Phrase: "24 months old) (Figs. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0450344:1A [Intellectual Product]
   804   C1553633:1a [Medical Device]

Phrase: "2A,"

Phrase: "and"

Phrase: "4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450373:4a [Intellectual Product]
  1000   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: "when"

Phrase: "compared with Wistar control rats of the same age (Figs. 1B,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   754   C0034716:Rats, Wistar [Mammal]
   738   C0001779:Age [Organism Attribute]
   738   C0034693:rats [Mammal]
   738   C0034721:Rats [Mammal]
   738   C0243148:control [Qualitative Concept]
   738   C0349966:Figs [Food]
   738   C0445247:Same [Qualitative Concept]
   738   C0450345:1B [Intellectual Product]
   738   C1550141:Control [Substance]
   738   C1707455:Compared [Activity]
   738   C1882979:Control [Conceptual Entity]
   738   C2587213:Control [Functional Concept]
   738   C2700262:Wistar [Mammal]
   738   C3274648:Control [Qualitative Concept]
   704 E C1337208:FIG [Food]

Phrase: "2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450354:2b [Intellectual Product]
  1000   C1706096:2B [Research Activity]

Phrase: "and"

Phrase: "4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.236: This indicates that aging is a risk factor for diabetes increasing the susceptibility to neurotoxic agents. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "is"

Phrase: "a risk factor for diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0035648:Risk factor [Quantitative Concept]
   797   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   797   C0960756:factor A [Organic Chemical]
   797   C1171304:diabetes risk [Quantitative Concept]
   760   C0035647:Risk [Qualitative Concept]
   760   C1521761:Factor [Functional Concept]
   760   C2827422:Factor [Conceptual Entity]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the susceptibility to neurotoxic agents."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]
Processing 00000000.tx.237: Diabetes leads to functional and structural changes in the brain that seem to be most pronounced in the elderly. 

Phrase: "Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "leads to functional"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0181586:leads [Medical Device]
   790   C0205245:Functional [Functional Concept]
   790   C0542341:Functional [Functional Concept]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C2700217:Functional [Conceptual Entity]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "structural changes in the brain"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   760   C0678594:Structural [Spatial Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "that"

Phrase: "seem"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "pronounced in the elderly."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001792:Elderly [Population Group]
   770   C1999167:elderly [Population Group]
Processing 00000000.tx.238: Increased age is associated with insulin resistance (43). 

Phrase: "Increased age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "is"

Phrase: "associated with insulin resistance"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.239: Increasing data support the idea that mitochondrial function declines with aging and in age-related diseases such as diabetes and AD (41,42). 

Phrase: "Increasing data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "that mitochondrial function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "declines with aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001811:Ageing [Organism Function]

Phrase: "and in age-related diseases"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0001779:Age [Organism Attribute]
   760   C0012634:Diseases [Disease or Syndrome]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C1515981:And [Idea or Concept]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "such as diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(41,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.240: Brain mitochondria of GK rats presented an age-related susceptibility to Ca2+, indicating that aging predisposes diabetic rat mitochondria to the opening of the PTP (Fig. 5). 

Phrase: "Brain mitochondria of GK rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0026237:Mitochondria [Cell Component]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "an age-related susceptibility to Ca2+,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0012655:Susceptibility [Clinical Attribute]
   753   C0220898:Susceptibility [Organism Attribute]
   753   C1264642:Susceptibility [Functional Concept]
   753   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "indicating"

Phrase: "that aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "predisposes"

Phrase: "diabetic rat mitochondria to the opening of the PTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0026237:Mitochondria [Cell Component]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.241: PTP induction is a well-characterized process that results in a nonselective increase in the permeability of the inner mitochondrial membrane to solutes smaller than 1.5 kDa. 

Phrase: "PTP induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205263:Induction [Functional Concept]
   812   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "a well-characterized process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "that results in a nonselective increase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "in the permeability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031164:Permeability [Natural Phenomenon or Process]
   928 E C0205326:Permeable [Functional Concept]

Phrase: "of the inner mitochondrial membrane"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0230840:Inner mitochondrial membrane [Cell Component]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0205102:Inner [Spatial Concept]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "to solutes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597488:solutes [Chemical Viewed Structurally]

Phrase: "smaller than 1.5 kDa."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0547044:Smaller [Qualitative Concept]
   760   C0700321:Smaller [Quantitative Concept]
Processing 00000000.tx.242: Criterial attributes of the PTP include the dependence on matrix Ca2+ concentration and inhibition by the immunosuppressant CsA (44). 

Phrase: "Criterial attributes of the PTP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0449234:Attribute [Idea or Concept]
   714   C1704772:Attribute [Conceptual Entity]
   714   C1882133:Attribute [Qualitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the dependence on matrix Ca2+ concentration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011546:Dependence [Mental Process]
   753   C0439857:Dependence [Mental or Behavioral Dysfunction]
   753   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "and"

Phrase: "inhibition by the immunosuppressant CsA (44"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: ")."
Processing 00000000.tx.243: The maintenance of calcium homeostasis represents a major expenditure within neurons and, through respiratory control mechanisms, is tightly coupled to the rates of OXPHOS and the generation of reactive oxygen species. 

Phrase: "The maintenance of calcium homeostasis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0024501:Maintenance [Activity]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a major expenditure within neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0015316:expenditure [Quantitative Concept]

Phrase: "and"

Phrase: ","

Phrase: "through respiratory control mechanisms,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   913   C0457994:Respiratory mechanisms [Finding]
   827   C0243148:control [Qualitative Concept]
   827   C0441712:Mechanisms [Functional Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "tightly"

Phrase: "coupled to the rates of OXPHOS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C1948027:Coupled [Functional Concept]
   719 E C0010222:couple [Family Group]
   719   C0871208:Rate [Activity]
   719   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "the generation of reactive oxygen species."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]
Processing 00000000.tx.244: Recently, we demonstrated that A and/or Ca2+ induce PTP opening of brain mitochondria (45,46). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "we"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "A"

Phrase: "and/or"

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "PTP opening of brain mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0175566:Opening [Spatial Concept]
   748   C1882151:Opening [Spatial Concept]

Phrase: "(45,"

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.245: However, the opening of PTP may be avoided in the presence of CsA (specific inhibitor of PTP) and ADP plus oligomycin (Fig. 7), as previously described (4749). 

Phrase: "However,"

Phrase: "the opening of PTP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0175566:Opening [Spatial Concept]
   753   C1882151:Opening [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "avoided in the presence of CsA (specific inhibitor of PTP"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   736   C0031164:Permeability [Natural Phenomenon or Process]
   736   C0205369:Specific [Qualitative Concept]
   736   C0392148:Presence [Therapeutic or Preventive Procedure]
   736   C0599156:Transition [Cell or Molecular Dysfunction]
   736   C1325742:Pore [Cell Component]
   736   C1552740:specific [Intellectual Product]
   736   C1999216:Inhibitor [Qualitative Concept]
   736   C2700061:Transition [Activity]

Phrase: ")"

Phrase: "and"

Phrase: "ADP plus oligomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028951:Oligomycin [Antibiotic,Organic Chemical]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(4749"

Phrase: ")."
Processing 00000000.tx.246: Another interesting feature is the effect of A on brain bioenergetics of GK rats. 

Phrase: "Another interesting feature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1521970:Feature [Qualitative Concept]
   861   C1706388:Feature [Conceptual Entity]
   861   C2346469:Feature [Qualitative Concept]
   861   C2348519:Feature [Qualitative Concept]

Phrase: "is"

Phrase: "the effect of A on brain bioenergetics of GK rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1280500:Effect [Qualitative Concept]
   738   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.247: Our results indicate that amyloid -peptides exacerbate the effects of age-related diabetes. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that amyloid -peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "exacerbate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0436331:exacerbate [Finding]

Phrase: "the effects of age-related diabetes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.248: They potentiate respiratory chain impairment (Fig. 1), uncoupling of OXPHOS (Fig. 2), a decrease in ATP levels (Fig. 4), and the susceptibility to PTP opening (Fig. 6). 

Phrase: "They"

Phrase: "potentiate"

Phrase: "respiratory chain impairment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0684336:Impairment [Pathologic Function]
   734   C0162362:Respiratory Chain [Molecular Function]
   734   C1325653:respiratory chain [Cell Component]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "uncoupling of OXPHOS"

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "a decrease in ATP levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the susceptibility to PTP opening"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0012655:Susceptibility [Clinical Attribute]
   748   C0220898:Susceptibility [Organism Attribute]
   748   C1264642:Susceptibility [Functional Concept]
   748   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.249: Several comparisons can be made between the chronic effects of diabetes and the neurological impairments observed in AD. 

Phrase: "Several comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707455:Comparison [Activity]

Phrase: "can"

Phrase: "be"

Phrase: "made between the chronic effects of diabetes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0205191:chronic [Temporal Concept]
   748   C1280500:effects [Qualitative Concept]
   714   C1881534:Make [Functional Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "the neurological impairments"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0521654:neurological impairment [Finding]
   861   C0205494:Neurological [Qualitative Concept]
   861   C0684336:Impairments [Pathologic Function]
   861   C2598156:Impairments [Clinical Attribute]
   861   C2707261:Neurological [Clinical Attribute]

Phrase: "observed in AD."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1441672:Observed [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.250: In patients with AD, an increase in cognitive function in response to glucose administration and insulin therapy has been demonstrated (50), presumably as a result of an increase in hippocampal glucose utilization. 

Phrase: "In patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with AD,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "an increase in cognitive function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to glucose administration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001554:Administration [Occupational Activity]
   861   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "insulin therapy"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0039798:therapy [Functional Concept]
   861   C0087111:Therapy [Therapeutic or Preventive Procedure]
   861   C1363945:Therapy [Finding]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "(50"

Phrase: ")"

Phrase: ","

Phrase: "presumably as a result of an increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0442805:Increase [Functional Concept]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]

Phrase: "in hippocampal glucose utilization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0042153:utilization [Functional Concept]
Processing 00000000.tx.251: Neuronal glucose transport and utilization have been shown to be reduced in AD (51). 

Phrase: "Neuronal glucose transport"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0178766:neuronal transport [Cell Function]
   901   C0178666:glucose transport [Cell Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "utilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042153:utilization [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "reduced in AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0392756:Reduced [Qualitative Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.252: In streptozotocin-treated rats, a model of type 1 diabetes, -amyloid toxicity is potentiated in the hippocampus (52). 

Phrase: "In streptozotocin-treated rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "a model of type 1 diabetes, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "amyloid toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "is"

Phrase: "potentiated in the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   770   C0949582:Hippocampus [Fish]
   770   C1029104:Hippocampus [Fish]
   770   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(52"

Phrase: ")."
Processing 00000000.tx.253: Furthermore, diabetes and AD have been shown to be associated with mitochondrial dysfunction. 

Phrase: "Furthermore,"

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with mitochondrial dysfunction."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0026237:Mitochondrial [Cell Component]
   770   C0031847:dysfunction [Functional Concept]
   770   C0277785:Dysfunction, NOS [Qualitative Concept]
   770   C0521451:Mitochondrial [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C0231174:Malfunction [Functional Concept]
   715 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.254: Both diseases occur with impaired glucose utilization and deficits in mitochondrial activity, and metabolic dysfunction is an important component in both diseases (38,41). 

Phrase: "Both diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "occur with impaired glucose utilization"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0042153:utilization [Functional Concept]
   760   C0221099:Impaired [Functional Concept]
   760   C0684336:Impaired [Pathologic Function]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "deficits in mitochondrial activity,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C2987487:deficits [Qualitative Concept]
   737 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "and"

Phrase: "metabolic dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "is"

Phrase: "an important component in both diseases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "(38,"

Phrase: "41"

Phrase: ")."
Processing 00000000.tx.255: The similarities between AD and the neurological consequences of diabetes raised the hypothesis that the life-long effects of hyperglycemia may predispose patients with diabetes to AD (53). 

Phrase: "The similarities between AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C2348205:Similarity [Qualitative Concept]

Phrase: "and"

Phrase: "the neurological consequences of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "raised"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442818:Raised [Quantitative Concept]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that"

Phrase: "the life-long effects of hyperglycemia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "predispose"

Phrase: "patients with diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: "to AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(53"

Phrase: ")."
Processing 00000000.tx.256: In AD, the desensitization of the neuronal insulin receptor similar to what occurs in type 2 diabetes may be of pivotal significance. 

Phrase: "In AD,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "the desensitization of the neuronal insulin receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1709852:Receptor Desensitization [Molecular Function]
           Desensitization
   748   C0178702:Desensitization [Therapeutic or Preventive Procedure]

Phrase: "similar to what"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "occurs in type 2 diabetes"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "may"

Phrase: "be of pivotal significance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0237881:Significance [Quantitative Concept]
   770   C0750502:Significance [Idea or Concept]
   770   C2987476:Be [Conceptual Entity]
Processing 00000000.tx.257: This abnormality, along with a reduction in brain insulin concentration, is assumed to induce several disturbances, including changes in cellular glucose, acetylcholine, cholesterol, and ATP, which are associated with abnormalities in cellular homeostasis and with the formation of both amyloidogenic derivatives and hyperphosphorylated tau protein (13). 

Phrase: "This abnormality,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704258:Abnormality [Finding]
   928 E C0205161:Abnormal [Qualitative Concept]
   928 E C2347472:% Abnormal [Quantitative Concept]
   928 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "along with a reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in brain insulin concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "is"

Phrase: "assumed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3242379:Assumed [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "several disturbances,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2699787:Disturbance [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "changes in cellular glucose,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "acetylcholine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "cholesterol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "and"

Phrase: "ATP,"

Phrase: "which"

Phrase: "are"

Phrase: "associated with abnormalities"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0000768:Abnormalities [Congenital Abnormality]
   790   C0000769:abnormalities [Functional Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1704258:Abnormality [Finding]
   756 E C1706221:Associate [Professional or Occupational Group]
   706 E C0205161:Abnormal [Qualitative Concept]
   706 E C2347472:% Abnormal [Quantitative Concept]
   706 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "in cellular homeostasis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2244223:cellular homeostasis [Cell Function]
   861   C0019868:Homeostasis [Biologic Function]

Phrase: "and with the formation of both amyloidogenic derivatives"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   744   C0220781:formation [Biologic Function]
   744   C0243072:derivatives [Chemical Viewed Structurally]
   744   C0439634:formation [Spatial Concept]
   744   C1515981:And [Idea or Concept]
   744   C1522492:Formation [Functional Concept]
   711 E C1527240:Derivative [Functional Concept]

Phrase: "and"

Phrase: "hyperphosphorylated tau protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.258: Our results are consistent with the view that diabetes-related mitochondrial dysfunction is exacerbated by aging and/or by the presence of neurotoxic agents, such as A, suggesting that diabetes and aging are risk factors for the neurodegeneration induced by these peptides. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with the view"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that diabetes-related mitochondrial dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0031847:dysfunction [Functional Concept]
   812   C0277785:Dysfunction, NOS [Qualitative Concept]
   756 E C0231174:Malfunction [Functional Concept]
   756 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "is"

Phrase: "exacerbated by aging"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0001811:Ageing [Organism Function]
   790   C0436331:Exacerbated [Finding]
   790   C1444749:Exacerbated [Qualitative Concept]

Phrase: "and/or by the presence of neurotoxic agents,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0260049:Neurotoxic agents [Hazardous or Poisonous Substance]
   770   C1706528:And/Or [Conceptual Entity]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C1515981:And [Idea or Concept]
   711   C0450442:Agent [Chemical Viewed Functionally]
   711   C1254351:Agent [Pharmacologic Substance]
   711   C1521826:Agent [Intellectual Product]

Phrase: "such as A,"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "are"

Phrase: "risk factors for the neurodegeneration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0035648:risk factors [Quantitative Concept]
   806   C1553898:risk factors [Idea or Concept]
   760   C0035647:Risk [Qualitative Concept]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "induced by these peptides."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C0205263:Induced [Functional Concept]
Processing 00000000.tx.259: This study supports the idea, previously suggested by others (13,16), that a strong correlation exists between both age-related pathologies, diabetes and AD, mitochondria being a fundamental link in this process.  

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the idea,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "previously"

Phrase: "suggested by others"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1955473:Others [Finding]
   756   C1705535:Suggest [Idea or Concept]

Phrase: "(13,"

Phrase: "16"

Phrase: ")"

Phrase: ","

Phrase: "that"

Phrase: "a strong correlation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707520:Correlation [Qualitative Concept]

Phrase: "exists between both age-related pathologies,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0001779:Age [Organism Attribute]
   753   C0030664:Pathologies [Biomedical Occupation or Discipline]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   753   C2987476:Exist [Conceptual Entity]
   719 E C0163712:Relate [Organic Chemical]
   719 E C0205469:pathology [Functional Concept]
   719 E C0677042:pathology [Pathologic Function]

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "AD,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "being"

Phrase: "a fundamental link in this process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1517892:Link [Intellectual Product]
   753   C1704666:Link [Intellectual Product]
Processing 00000000.tx.260: ACKNOWLEDGMENTS  This work was supported by FCT (Portuguese Research Council). 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by FCT (Portuguese Research Council"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   783   C0035176:research supported [Quantitative Concept]
   753   C0032730:Portuguese [Population Group]
   753   C0035168:research [Research Activity]
   753   C0242481:Research [Research Activity]
   753   C1521721:Supported [Conceptual Entity]
   753   C1551807:Council [Population Group]
   719 E C0183683:Support [Medical Device]

Phrase: ")."
Processing 00000000.tx.261: P.M. is the recipient of grant SFRH/BD/5320/2001.  

Phrase: "P.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "is"

Phrase: "the recipient of grant SFRH/BD/5320/2001."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1709854:Recipient [Human]
Processing 00000000.tx.262: FOOTNOTES  Address correspondence and reprint requests to Catarina Resende de Oliveira, Center for Neuroscience of Coimbra, Institute of Biochemistry, Faculty of Medicine, University of Coimbra, 3004-504 Coimbra, Portugal. 

Phrase: "FOOTNOTES  Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Catarina Resende de Oliveira,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0011198:DE [Geographic Area]
   753   C0017480:DE [Geographic Area]
   753   C0686900:request [Functional Concept]
   753   C1272683:Request [Functional Concept]
   753   C1522634:Request [Intellectual Product]
   753   C3541240:DE [Idea or Concept]

Phrase: "Center for Neuroscience of Coimbra,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205099:Center [Spatial Concept]

Phrase: "Institute of Biochemistry,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021622:institute [Organization]
   790   C1272753:Institute [Idea or Concept]

Phrase: "Faculty of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0015535:Faculty [Professional or Occupational Group]

Phrase: "University of Coimbra,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0041740:University [Manufactured Object,Organization]

Phrase: "3004-504 Coimbra,"

Phrase: "Portugal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032729:Portugal [Geographic Area]
Processing 00000000.tx.263: E-mail: catarina{at}cnc.cj.uc.pt Received for publication 14 November 2002 and accepted in revised form 24 February 2003. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "catarina{at}cnc.cj.uc.pt"

Phrase: "Received for publication 14 November 2002"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0034036:Publication [Intellectual Product,Manufactured Object]
   753   C0034037:Publication [Occupational Activity]
   753   C1514756:Received [Qualitative Concept]
   753   C1704324:Publication [Intellectual Product]

Phrase: "and"

Phrase: "accepted in revised form 24 February 2003."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1272684:Accepted [Qualitative Concept]
   748   C1522492:Form [Functional Concept]
   748   C1527075:Revised [Therapeutic or Preventive Procedure]
   748   C1548435:Accepted [Idea or Concept]
   714 E C1548601:Accept [Idea or Concept]
Processing 00000000.tx.264: m, transmembrane potential; 

Phrase: "m,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "transmembrane potential"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0025251:Transmembrane Potential [Cell Function]
   861   C1167322:transmembrane [Cell Component]
   861   C2752508:transmembrane [Cell Component]
   861   C3245505:Potential [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.265: AD, Alzheimers disease; 

Phrase: "AD,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.266: CNS, central nervous system; 

Phrase: "CNS,"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "central nervous system"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.267: CsA, cyclosporin A; 

Phrase: "CsA,"

Phrase: "cyclosporin A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010592:Cyclosporin A [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Ciclosporin

Phrase: ";"
Processing 00000000.tx.268: HNE, 4-hydroxynonenal; 

Phrase: "HNE,"

Phrase: "4-hydroxynonenal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0048297:4-hydroxynonenal [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.269: OXPHOS, oxidative phosphorylation; 

Phrase: "OXPHOS,"

Phrase: "oxidative phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0030013:Oxidative Phosphorylation [Molecular Function]
   861   C0031715:Phosphorylation [Molecular Function]
   861   C0311404:Oxidative [Functional Concept]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: ";"
Processing 00000000.tx.270: PTP, permeability transition pore; 

Phrase: "PTP,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0031164:Permeability [Natural Phenomenon or Process]
   827   C0599156:Transition [Cell or Molecular Dysfunction]
   827   C1325742:Pore [Cell Component]
   827   C2700061:Transition [Activity]
   755 E C0205326:Permeable [Functional Concept]
   755 E C1182674:Transitional [Spatial Concept]
   755 E C1548597:Transitional [Idea or Concept]

Phrase: "permeability transition pore"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0031164:Permeability [Natural Phenomenon or Process]
   827   C0599156:Transition [Cell or Molecular Dysfunction]
   827   C1325742:Pore [Cell Component]
   827   C2700061:Transition [Activity]
   755 E C0205326:Permeable [Functional Concept]
   755 E C1182674:Transitional [Spatial Concept]
   755 E C1548597:Transitional [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.271: RCR, respiratory control ratio; 

Phrase: "RCR,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   913   C0429743:Respiratory ratio [Finding]
   827   C0243148:control [Qualitative Concept]
   827   C0456603:Ratio [Quantitative Concept]
   827   C0521346:respiratory [Functional Concept]
   827   C1546767:Respiratory [Intellectual Product]
   827   C1547037:Ratio [Intellectual Product]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "respiratory control ratio"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   913   C0429743:Respiratory ratio [Finding]
   827   C0243148:control [Qualitative Concept]
   827   C0456603:Ratio [Quantitative Concept]
   827   C0521346:respiratory [Functional Concept]
   827   C1546767:Respiratory [Intellectual Product]
   827   C1547037:Ratio [Intellectual Product]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.272: TPP+, tetraphenylphosphonium.  

Phrase: "TPP+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076326:tetraphenylphosphonium [Indicator, Reagent, or Diagnostic Aid,Organophosphorus Compound]

Phrase: "tetraphenylphosphonium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076326:tetraphenylphosphonium [Indicator, Reagent, or Diagnostic Aid,Organophosphorus Compound]
Processing 00000000.tx.273: REFERENCES TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Gavin JR III, Alberti KGMM, Davidson MB, DeFronzo RA, Drash A, Gabbe SG, Genuth S, Harris MI, Kahn R, Keen H, Knowler WC, Lebovitz H, Maclaren NK, Palmer JP, Raskin P, Rizza RA, Stern MP: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Gavin JR III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439070:III [Intellectual Product]
   827   C1705160:III [Qualitative Concept]

Phrase: "Alberti KGMM,"

Phrase: "Davidson MB,"

Phrase: "DeFronzo RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Drash A,"

Phrase: "Gabbe SG,"

Phrase: "Genuth S,"

Phrase: "Harris MI,"

Phrase: "Kahn R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Keen H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Knowler WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Lebovitz H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Maclaren NK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022688:NK [Cell]

Phrase: "Palmer JP,"

Phrase: "Raskin P,"

Phrase: "Rizza RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Stern MP"

Phrase: ":"

Phrase: "Report of the Expert Committee"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0684224:Report [Intellectual Product]
   760   C0700287:Report [Health Care Activity]
   760   C3273238:Report [Intellectual Product]

Phrase: "on the Diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "and"

Phrase: "Classification of Diabetes Mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0008902:Classification [Classification]
   770   C0008903:classification [Functional Concept]
   770   C0678229:classification [Occupational Activity]
Processing 00000000.tx.274: Diabetes Care20 :1183 1197,1997[Medline] Biessels GJ, van der Heide LP, Kamal A, Bleys RLAW, Gispen WH: Ageing and diabetes: implications for brain function. 

Phrase: "Diabetes Care20"

Phrase: ":"

Phrase: "1183 1197,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Biessels GJ,"

Phrase: "van der Heide LP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0037943:LP [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   812   C0228341:LP [Body Part, Organ, or Organ Component]
   812   C2239920:LP [Gene or Genome]

Phrase: "Kamal A,"

Phrase: "Bleys RLAW,"

Phrase: "Gispen WH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349143:Wh [Quantitative Concept]

Phrase: ":"

Phrase: "Ageing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "and"

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "implications for brain function."
Processing 00000000.tx.275: Eur J Pharmacol441 :1 14,2002[Medline] Pardridge WM, Eisenberg J, Yang J: Human blood brain barrier insulin receptor. 

Phrase: "Eur J Pharmacol441"

Phrase: ":"

Phrase: "1 14,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pardridge WM,"

Phrase: "Eisenberg J,"

Phrase: "Yang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "J"

Phrase: ":"

Phrase: "Human blood brain barrier insulin receptor."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   904   C1448132:insulin receptor, human [Amino Acid, Peptide, or Protein,Receptor]
   876   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   858   C0853230:blood insulin [Laboratory Procedure]
   827   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   827   C1334133:INSULIN RECEPTOR [Gene or Genome]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.276: J Neurochem44 :1771 1778,1985[Medline] Vannucci SJ, Maher F, Simpson IA: Glucose transporter proteins in brain: delivery of glucose to neurons and glia. 

Phrase: "J Neurochem44"

Phrase: ":"

Phrase: "1771 1778,"

Phrase: "1985"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Vannucci SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Maher F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Simpson IA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1947960:Ia [Mammal]

Phrase: ":"

Phrase: "Glucose transporter proteins in brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0007292:Transporter Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C2599779:Glucose & Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Carbohydrate]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "delivery of glucose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011209:Delivery [Therapeutic or Preventive Procedure]
   790   C0559563:delivery [Finding]
   790   C1705822:Delivery [Activity]

Phrase: "to neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "glia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027836:Glia [Cell]
  1000   C1087003:Glia [Plant]
Processing 00000000.tx.277: Glia21 :2 21,1997[Medline] Ngarmukos C, Baur EL, Kumagai AK: Co-localisation of GLUT1 and GLUT4 in the blood brain barrier of the ventromedial hypothalamus. 

Phrase: "Glia21"

Phrase: ":"

Phrase: "2 21,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1412940:2-21 [Gene or Genome]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ngarmukos C,"

Phrase: "Baur EL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416870:EL [Gene or Genome]
   861   C1823249:EL [Gene or Genome]

Phrase: "Kumagai AK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]

Phrase: ":"

Phrase: "Co-localisation of GLUT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "GLUT4 in the blood brain barrier of the ventromedial hypothalamus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1420175:GLUT4 [Gene or Genome]
   739   C2982484:GLUT4 [Gene or Genome]
Processing 00000000.tx.278: Brain Res900 :1 8,2001[Medline] Cheng CM, Cohen M, Wang J, Bondy CA: Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex. 

Phrase: "Brain Res900"

Phrase: ":"

Phrase: "1 8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cheng CM,"

Phrase: "Cohen M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Wang J,"

Phrase: "Bondy CA"

Phrase: ":"

Phrase: "Estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "augments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "glucose transporter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "IGF1 expression in primate cerebral cortex."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.279: FASEB J15 :907 915,2001[Abstract/Free FullText] Choeiri C, Staines W, Messier C: Immunohistochemical localization and quantification of glucose transporters in the mouse brain. 

Phrase: "FASEB J15"

Phrase: ":"

Phrase: "907 915,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Choeiri C,"

Phrase: "Staines W,"

Phrase: "Messier C"

Phrase: ":"

Phrase: "Immunohistochemical localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "quantification of glucose transporters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantification [Quantitative Concept]

Phrase: "in the mouse brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1521713:Mouse Brain [Tissue]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.280: Neuroscience111 :19 34,2002[Medline] Bingham EM, Hopkins D, Smith D, Pernet A, Hallett W, Reed L, Marsden PK, Amiel SA: The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study. 

Phrase: "Neuroscience111"

Phrase: ":"

Phrase: "19 34,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bingham EM,"

Phrase: "Hopkins D,"

Phrase: "Smith D,"

Phrase: "Pernet A,"

Phrase: "Hallett W,"

Phrase: "Reed L,"

Phrase: "Marsden PK,"

Phrase: "Amiel SA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: ":"

Phrase: "The role of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in human brain glucose metabolism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0596215:brain metabolism [Organ or Tissue Function]
   861   C0596620:glucose metabolism [Molecular Function]
   812   C0025519:Metabolism [Organism Function]
   812   C0025520:metabolism [Functional Concept]

Phrase: ":"

Phrase: "an 18fluoro-deoxyglucose positron emission tomography study."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0032743:Positron-Emission Tomography [Diagnostic Procedure]
   799   C0032744:Positron [Quantitative Concept]
   799   C0040395:tomography [Diagnostic Procedure]
   799   C0040405:tomography [Diagnostic Procedure]
   799   C0233929:Emission [Body Substance]
   799   C0557651:Study [Manufactured Object]
   799   C2349995:Emission [Substance]
   799   C2603343:Study [Research Activity]
Processing 00000000.tx.281: Diabetes51 :3384 3390,2002[Abstract/Free FullText] Gerbitz KD, van den Ouweland JM, Maassen JA, Jaksch M: Mitochondrial diabetes mellitus: a review. 

Phrase: "Diabetes51"

Phrase: ":"

Phrase: "3384 3390,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gerbitz KD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026691:KD [Disease or Syndrome]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]

Phrase: "van den Ouweland JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0022337:JM [Geographic Area]

Phrase: "Maassen JA,"

Phrase: "Jaksch M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Mitochondrial diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   827   C0011847:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "a review."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]
Processing 00000000.tx.282: Biochim Biophys Acta1271 :253 260,1995[Medline] Wallace DC: Mitochondrial diseases in man and mouse. 

Phrase: "Biochim Biophys Acta1271"

Phrase: ":"

Phrase: "253 260,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wallace DC"

Phrase: ":"

Phrase: "Mitochondrial diseases in man"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0751651:Mitochondrial Diseases [Disease or Syndrome]
   770   C0012634:Diseases [Disease or Syndrome]
   770   C0026237:Mitochondrial [Cell Component]
   770   C0521451:Mitochondrial [Functional Concept]

Phrase: "and"

Phrase: "mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]
Processing 00000000.tx.283: Science283 :1482 1488,1999[Abstract/Free FullText] Hoyer S: Abnormalities of glucose metabolism in Alzheimers disease. 

Phrase: "Science283"

Phrase: ":"

Phrase: "1482 1488,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hoyer S"

Phrase: ":"

Phrase: "Abnormalities of glucose metabolism"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   777   C0580546:Abnormal glucose [Finding]
   770   C0000768:Abnormalities [Congenital Abnormality]
   770   C0000769:abnormalities [Functional Concept]
   737 E C1704258:Abnormality [Finding]

Phrase: "in Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.284: Ann N Y Acad Sci640 :53 58,1991[Abstract] Frlich L, Blum-Degen D, Bernstein HG, Engelsberger S, Humrich J, Laufer S, Muschner D, Thalheimer A, Turk A, Hoyer S, Zochling R, Boissl KW, Jellinger K, Riederer P: Brain insulin and insulin receptors in aging and sporadic Alzheimers disease. 

Phrase: "Ann N Y Acad Sci640"

Phrase: ":"

Phrase: "53 58,"

Phrase: "1991"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Frlich L,"

Phrase: "Blum-Degen D,"

Phrase: "Bernstein HG,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0025424:Hg [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   861   C2347108:Hg+ [Element, Ion, or Isotope]
   861   C2347109:Hg++ [Element, Ion, or Isotope]
   861   C2348272:Hg [Element, Ion, or Isotope]

Phrase: "Engelsberger S,"

Phrase: "Humrich J,"

Phrase: "Laufer S,"

Phrase: "Muschner D,"

Phrase: "Thalheimer A,"

Phrase: "Turk A,"

Phrase: "Hoyer S,"

Phrase: "Zochling R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Boissl KW,"

Phrase: "Jellinger K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Riederer P"

Phrase: ":"

Phrase: "Brain insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin receptors in aging"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   819   C0487013:aging insulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "sporadic Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0002395:Alzheimers disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.285: J Neural Transm105 :423 438,1998[Medline] Hoyer S: The aging brain. 

Phrase: "J Neural Transm105"

Phrase: ":"

Phrase: "423 438,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hoyer S"

Phrase: ":"

Phrase: "The aging brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.286: Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). 

Phrase: "Changes in the neuronal insulin/insulin receptor signal transduction cascade"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   739   C0392747:changes [Functional Concept]
   739   C0443172:changes [Quantitative Concept]
   706 E C1705241:Change [Quantitative Concept]

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "late-onset sporadic Alzheimer disease (SAD)."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   924   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0205422:Sporadic [Temporal Concept]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.287: J Neural Transm109 :991 1002,2002 Selkoe DJ: Alzheimers disease: genes, proteins, and therapy. 

Phrase: "J Neural Transm109"

Phrase: ":"

Phrase: "991 1002,"

Phrase: "2002 Selkoe DJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012836:DJ [Geographic Area]

Phrase: ":"

Phrase: "Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "therapy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039798:therapy [Functional Concept]
  1000   C0087111:Therapy [Therapeutic or Preventive Procedure]
  1000   C1363945:Therapy [Finding]
Processing 00000000.tx.288: Physiol Rev81 :741 766,2001[Abstract/Free FullText] Hppener JWM, Ahrn B, Lips CJM: Mechanisms of disease: islet amyloid and type 2 diabetes mellitus. 

Phrase: "Physiol Rev81"

Phrase: ":"

Phrase: "741 766,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hppener JWM,"

Phrase: "Ahrn B,"

Phrase: "Lips CJM"

Phrase: ":"

Phrase: "Mechanisms of disease"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0441712:Mechanisms [Functional Concept]
   756 E C1706376:Mechanism [Manufactured Object]

Phrase: ":"

Phrase: "islet amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "type 2 diabetes mellitus."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
  1000   C2984301:Type II diabetes mellitus [Functional Concept]
   875   C1320657:type diabetes [Finding]
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0441730:Type 2 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.289: N Engl J Med343 :411 419,2000[Free FullText] Hoyer S: Risk factors for Alzheimers disease during aging: impacts of glucose/energy metabolism. 

Phrase: "N Engl J Med343"

Phrase: ":"

Phrase: "411 419,"

Phrase: "2000"

Phrase: "[Free FullText"

Phrase: "] Hoyer S"

Phrase: ":"

Phrase: "Risk factors for Alzheimers disease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   835   C0850664:disease factors risk [Finding]
   806   C0035648:risk factors [Quantitative Concept]
   806   C1553898:risk factors [Idea or Concept]
   797   C0679238:disease factors [Functional Concept]
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "during aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: ":"

Phrase: "impacts of glucose/energy metabolism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1825598:IMPACT [Gene or Genome]
Processing 00000000.tx.290: J Neurol Transm54 :187 194,1998 Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, OBrien PC, Palumbo PJ: Risk of dementia among persons with diabetes mellitus and the risk of dementia: a population-based cohort study. 

Phrase: "J Neurol Transm54"

Phrase: ":"

Phrase: "187 194,"

Phrase: "1998 Leibson CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Rocca WA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043038:WA [Geographic Area]

Phrase: "Hanson VA,"

Phrase: "Cha R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kokmen E,"

Phrase: "OBrien PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: "Palumbo PJ"

Phrase: ":"

Phrase: "Risk of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035647:Risk [Qualitative Concept]

Phrase: "among persons"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027361:Persons [Population Group]
   966 E C2347489:Person [Group]
   916 E C1519021:Personal [Organism Attribute]

Phrase: "with diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "the risk of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: ":"

Phrase: "a population-based cohort study."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1709599:Population Based Study [Research Activity]
   902   C0681876:Population Study [Research Activity]
   861   C0009247:Cohort Study [Quantitative Concept]
   812   C0557651:Study [Manufactured Object]
   812   C0599755:Cohort [Population Group]
   812   C2603343:Study [Research Activity]
Processing 00000000.tx.291: Am J Epidemiol145 :301 308,1997[Abstract] Ott A, Stolk RP, van Harskamp F, Pols HAP, Hofman A, Breteler MMB: Diabetes mellitus and the risk of dementia: the Rotterdam Study. 

Phrase: "Am"

Phrase: "J Epidemiol145"

Phrase: ":"

Phrase: "301 308,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ott A,"

Phrase: "Stolk RP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1538326:RP [Gene or Genome]
   861   C3541325:RP [Idea or Concept]

Phrase: "van Harskamp F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Pols HAP,"

Phrase: "Hofman A,"

Phrase: "Breteler MMB"

Phrase: ":"

Phrase: "Diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "the risk of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: ":"

Phrase: "the Rotterdam Study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.292: Neurology53 :1937 1942,1999[Abstract/Free FullText] Serradas P, Gangnerau MN, Giroix MH, Saulnier C, Portha B: Impaired pancreatic beta cell function in the fetal GK rat: impact of diabetic inheritance. 

Phrase: "Neurology53"

Phrase: ":"

Phrase: "1937 1942,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Serradas P,"

Phrase: "Gangnerau MN,"

Phrase: "Giroix MH,"

Phrase: "Saulnier C,"

Phrase: "Portha B"

Phrase: ":"

Phrase: "Impaired pancreatic beta cell function in the fetal GK rat"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0007613:Cell Function [Cell Function]
   754   C0232786:Pancreatic function [Organ or Tissue Function]
   738   C0031843:function [Physiologic Function]
   738   C0542341:Function [Functional Concept]
   738   C0700205:FUNCTION [Classification]
   738   C1705273:Function [Intellectual Product]

Phrase: ":"

Phrase: "impact of diabetic inheritance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1825598:IMPACT [Gene or Genome]
Processing 00000000.tx.293: J Clin Invest101 :899 904,1998[Abstract/Free FullText] Goto Y, Kakizaki M: The spontaneous diabetic rat a model of non-insulin dependent diabetes mellitus. 

Phrase: "J Clin Invest101"

Phrase: ":"

Phrase: "899 904,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Goto Y,"

Phrase: "Kakizaki M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "The spontaneous diabetic rat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C0241863:DIABETIC [Finding]

Phrase: "a model of non-insulin dependent diabetes mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C3161035:Model [Intellectual Product]
   703   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
   703   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
Processing 00000000.tx.294: Proc Jpn Acad57 :381 384,1981 Mark RJ, Pang Z, Geddes JW, Uchida K, Mattson MP: Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. 

Phrase: "Proc Jpn Acad57"

Phrase: ":"

Phrase: "381 384,"

Phrase: "1981 Mark RJ,"

Phrase: "Pang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413561:PANG [Gene or Genome]

Phrase: "Z,"

Phrase: "Geddes JW,"

Phrase: "Uchida K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Mattson MP"

Phrase: ":"

Phrase: "Amyloid beta-peptide"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0078939:Amyloid beta-Peptide [Amino Acid, Peptide, or Protein]
  1000   C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   901   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "impairs"

Phrase: "glucose transport in hippocampal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0178666:glucose transport [Cell Function]
   770   C0005528:Transport, NOS [Cell Function]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: ":"

Phrase: "involvement of membrane lipid peroxidation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]
Processing 00000000.tx.295: J Neurosci17 :1046 1054,1997[Abstract/Free FullText] Bonilla E, Tanji K, Hirano M, Vu TH, DiMauro S, Schon EA: Mitochondrial involvement in Alzheimers disease. 

Phrase: "J Neurosci17"

Phrase: ":"

Phrase: "1046 1054,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bonilla E,"

Phrase: "Tanji K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hirano M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Vu TH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039725:TH [Geographic Area]
   861   C0039738:Th [Element, Ion, or Isotope]
   861   C1420718:TH [Gene or Genome]

Phrase: "DiMauro S,"

Phrase: "Schon EA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: ":"

Phrase: "Mitochondrial involvement in Alzheimers disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]
Processing 00000000.tx.296: Biochim Biophys Acta1410 :171 182,1999[Medline] Santos MS, Santos DL, Palmeira CM, Seia R, Moreno AJ, Oliveira CR: Brain and liver mitochondria isolated from diabetic Goto-Kakizaki rats show different susceptibility to induced oxidative stress. 

Phrase: "Biochim Biophys Acta1410"

Phrase: ":"

Phrase: "171 182,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Santos MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Santos DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Palmeira CM,"

Phrase: "Seia R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Moreno AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Oliveira CR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: ":"

Phrase: "Brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "liver mitochondria"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0026239:Mitochondria, Liver [Cell Component]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0026237:Mitochondria [Cell Component]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "isolated from diabetic Goto-Kakizaki rats"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0205409:Isolated [Functional Concept]
   753   C0241863:DIABETIC [Finding]
   753   C1548221:Isolated [Idea or Concept]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "different susceptibility to induced oxidative stress."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0012655:Susceptibility [Clinical Attribute]
   753   C0220898:Susceptibility [Organism Attribute]
   753   C1264642:Susceptibility [Functional Concept]
   753   C1547045:*Susceptibility [Quantitative Concept]
Processing 00000000.tx.297: Diabetes Metab Res Rev17 :223 230,2001[Medline] Rosenthal RE, Hamud F, Fiskum G, Varghese PJ, Sharpe S: Cerebral ischemia and reperfusion: prevention of brain mitochondrial injury by lidoflazine. 

Phrase: "Diabetes Metab Res Rev17"

Phrase: ":"

Phrase: "223 230,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rosenthal RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Hamud F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Fiskum G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Varghese PJ,"

Phrase: "Sharpe S"

Phrase: ":"

Phrase: "Cerebral ischemia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007785:Cerebral Ischemia [Disease or Syndrome]
  1000   C0917798:Cerebral Ischemia [Disease or Syndrome]
   861   C0022116:Ischaemia [Disease or Syndrome]
   789 E C0475224:Ischaemic [Functional Concept]

Phrase: "and"

Phrase: "reperfusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035124:Reperfusion [Therapeutic or Preventive Procedure]
  1000   C0684253:reperfusion [Biologic Function]

Phrase: ":"

Phrase: "prevention of brain mitochondrial injury"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0150638:Injury prevention [Therapeutic or Preventive Procedure]
   760   C0199176:Prevention [Therapeutic or Preventive Procedure]
   760   C1706420:PREVENTION [Research Activity]
   760   C2700409:prevention [Qualitative Concept]

Phrase: "by lidoflazine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023665:Lidoflazine [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.298: J Cereb Blood Flow Metab7 :752 758,1987[Medline] Gornall AG, Bardawill CJ, David MM: Determination of serum proteins by means of the biuret reaction. 

Phrase: "J Cereb Blood Flow Metab7"

Phrase: ":"

Phrase: "752 758,"

Phrase: "1987"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gornall AG,"

Phrase: "Bardawill CJ,"

Phrase: "David MM"

Phrase: ":"

Phrase: "Determination of serum proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1148554:determination [Laboratory Procedure]

Phrase: "by means of the biuret reaction."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005668:Biuret Reaction [Laboratory Procedure]
   861   C0005667:Biuret [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.299: J Biol Chem177 :751 766,1949[Free FullText] Kamo N, Muratsugu M, Hongoh R, Kobatake V: Membrane potential of mitochondria measured with an electrode sensitive to tetraphenylphosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state. 

Phrase: "J Biol Chem177"

Phrase: ":"

Phrase: "751 766,"

Phrase: "1949"

Phrase: "[Free FullText"

Phrase: "] Kamo N,"

Phrase: "Muratsugu M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hongoh R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kobatake V"

Phrase: ":"

Phrase: "Membrane potential of mitochondria"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   870   C0596952:Membrane of mitochondrion [Cell Component]
           Mitochondrion membrane
   833   C0025251:Membrane Potential [Cell Function]
   770   C0025255:Membrane [Tissue]
   770   C0596901:Membrane [Cell Component]
   770   C1706182:Membrane [Manufactured Object]
   770   C3245505:Potential [Qualitative Concept]

Phrase: "measured with an electrode"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0013812:electrode [Medical Device]
   770   C0444706:Measured [Qualitative Concept]
   770   C1705652:Electrode [Medical Device]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "sensitive to tetraphenylphosphonium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332324:Sensitive to [Functional Concept]
           Sensitive
   790   C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "relationship between proton electrochemical potential"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "phosphorylation potential in steady state."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]
   760   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.300: J Membr Biol49 :105 121,1979[Medline] Moreno AJM, Madeira VMC: Mitochondrial bioenergetics as affected by DTT. 

Phrase: "J Membr Biol49"

Phrase: ":"

Phrase: "105 121,"

Phrase: "1979"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Moreno AJM,"

Phrase: "Madeira VMC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0279452:VMC [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "Mitochondrial bioenergetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005486:Bioenergetics [Organism Function]
   861   C2945659:bioenergetics [Therapeutic or Preventive Procedure]

Phrase: "as"

Phrase: "affected by DTT."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0012789:DTT [Carbohydrate,Pharmacologic Substance]
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]
Processing 00000000.tx.301: Biochim Biophys Acta1060 :166 174,1991[Medline] Estabrook RE: Mitochondrial respiratory control and the polarographic measurement of ADP/O ratios. 

Phrase: "Biochim Biophys Acta1060"

Phrase: ":"

Phrase: "166 174,"

Phrase: "1991"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Estabrook RE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: ":"

Phrase: "Mitochondrial respiratory control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "the polarographic measurement of ADP/O ratios."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0201800:Polarographic measurement [Laboratory Procedure]
   757   C1261161:Ratio measurement [Laboratory Procedure]
   748   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.302: Methods Enzymol10 :41 47,1967 Carapetis M, Phillips P: Eat less, walk more: enjoyable eating for type 2 diabetes. 

Phrase: "Methods Enzymol10"

Phrase: ":"

Phrase: "41 47,"

Phrase: "1967 Carapetis M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Phillips P"

Phrase: ":"

Phrase: "Eat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013470:Eat [Organism Function]

Phrase: "less,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "walk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080331:Walk [Daily or Recreational Activity]

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: ":"

Phrase: "enjoyable eating for type 2 diabetes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0013470:Eating [Organism Function]
Processing 00000000.tx.303: Aust Fam Physician31 :1065 1071,2002[Medline] McCuskey PA, McCuskey RS: In vivo and electron microscopic study of the development of cerebral diabetic microangiography. 

Phrase: "Aust Fam Physician31"

Phrase: ":"

Phrase: "1065 1071,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McCuskey PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "McCuskey RS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539879:RS [Idea or Concept]

Phrase: ":"

Phrase: "In vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "electron microscopic study of the development of cerebral diabetic microangiography."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   782   C0026019:Electron microscopic study [Laboratory Procedure]
           Electron Microscopy
   739   C0013852:Electron [Quantitative Concept]
   739   C0205288:Microscopic [Qualitative Concept]
   739   C0557651:Study [Manufactured Object]
   739   C2603343:Study [Research Activity]
   739   C3463986:Electron [Bird]
   724   C2984656:ELECTRON MICROSCOPY [Functional Concept]
Processing 00000000.tx.304: Microcirc Endothelium Lymphatics1 :221 241,1984[Medline] Piotrowski P, Gajkowska B, Olszewska H, Smialek M: Electron microscopy studies on experimental diabetes and cerebral ischemia in the rat brain. 

Phrase: "Microcirc Endothelium Lymphatics1"

Phrase: ":"

Phrase: "221 241,"

Phrase: "1984"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Piotrowski P,"

Phrase: "Gajkowska B,"

Phrase: "Olszewska H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Smialek M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Electron microscopy studies on experimental diabetes"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   798   C0026019:Electron microscopic study [Laboratory Procedure]
           Electron Microscopy
   790   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   783   C0681814:experimental studies [Research Activity]
   753   C0013852:Electron [Quantitative Concept]
   753   C0026018:Microscopy [Laboratory Procedure]
   753   C0947630:studies [Laboratory Procedure]
   753   C3463986:Electron [Bird]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "cerebral ischemia in the rat brain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0007785:Cerebral Ischemia [Disease or Syndrome]
   790   C0917798:Cerebral Ischemia [Disease or Syndrome]
   783   C0007786:Brain Ischemia [Disease or Syndrome]
   753   C0022116:Ischaemia [Disease or Syndrome]
Processing 00000000.tx.305: Folia Neuropathol37 :256 263,1999[Medline] Forsyth RJ: Astrocytes and the delivery of glucose from plasma to neurons. 

Phrase: "Folia Neuropathol37"

Phrase: ":"

Phrase: "256 263,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Forsyth RJ"

Phrase: ":"

Phrase: "Astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "and"

Phrase: "the delivery of glucose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011209:Delivery [Therapeutic or Preventive Procedure]
   770   C0559563:delivery [Finding]
   770   C1705822:Delivery [Activity]

Phrase: "from plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "to neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.306: Neurochem Int28 :231 241,1996[Medline] Ceriello A, Giugliano D, Quatrapo A, Dello Russo P, Lefbvre PJ: Metabolic control may influence the increased superoxide generation in diabetic serum. 

Phrase: "Neurochem Int28"

Phrase: ":"

Phrase: "231 241,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ceriello A,"

Phrase: "Giugliano D,"

Phrase: "Quatrapo A,"

Phrase: "Dello Russo P,"

Phrase: "Lefbvre PJ"

Phrase: ":"

Phrase: "Metabolic control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1513158:Metabolic Control [Molecular Function]
   861   C0243148:control [Qualitative Concept]
   861   C0311400:Metabolic [Functional Concept]
   861   C1524026:Metabolic [Cell Function]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2707259:Metabolic [Clinical Attribute]
   861   C3274648:Control [Qualitative Concept]

Phrase: "may"

Phrase: "influence"

Phrase: "the increased superoxide generation in diabetic serum."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079411:Generation [Temporal Concept]
   748   C3146294:Generation [Activity]
Processing 00000000.tx.307: Diabet Med8 :540 542,1991[Medline] Kumar JSS, Menon VP: Effect of diabetes on levels of lipid peroxides and glycolipids in rat brain. 

Phrase: "Diabet Med8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1426572:MED8 [Gene or Genome]

Phrase: ":"

Phrase: "540 542,"

Phrase: "1991"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kumar JSS,"

Phrase: "Menon VP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883540:{VP} [Quantitative Concept]

Phrase: ":"

Phrase: "Effect of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "of lipid peroxides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023776:Lipid Peroxides [Lipid]
   861   C0023779:Lipid [Lipid]
   861   C0031180:Peroxides [Inorganic Chemical]

Phrase: "and"

Phrase: "glycolipids in rat brain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017950:Glycolipids [Biologically Active Substance,Lipid]
Processing 00000000.tx.308: Metabolism42 :1435 1439,1993[Medline] Makar TK, Hungund BL, Cook GA, Kashfi K, Cooper AJL: Lipid metabolism and membrane composition are altered in the brains of type II diabetic mice. 

Phrase: "Metabolism42"

Phrase: ":"

Phrase: "1435 1439,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Makar TK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220928:TK [Geographic Area]

Phrase: "Hungund BL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006413:BL [Neoplastic Process]
   861   C1552663:BL [Idea or Concept]
   861   C2827109:BL [Geographic Area]

Phrase: "Cook GA,"

Phrase: "Kashfi K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Cooper AJL"

Phrase: ":"

Phrase: "Lipid metabolism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0598783:Lipid Metabolism [Molecular Function]
  1000   C1517898:Lipid Metabolism [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "membrane composition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0486616:Composition [Clinical Attribute]
   861   C1555710:composition [Idea or Concept]

Phrase: "are"

Phrase: "altered in the brains of type II diabetic mice."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   764   C0441730:Type II [Classification]
   742   C0006104:Brains [Body Part, Organ, or Organ Component]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0241863:DIABETIC [Finding]
   742   C0332307:Type [Qualitative Concept]
   742   C0392747:Altered [Functional Concept]
   742   C1547052:*Type [Quantitative Concept]
   728   C1521713:Mouse Brain [Tissue]
   708 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.309: J Neurochem64 :2159 2168,1995[Medline] Mattson MP: Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptative plasticity. 

Phrase: "J Neurochem64"

Phrase: ":"

Phrase: "2159 2168,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mattson MP"

Phrase: ":"

Phrase: "Modification of ion homeostasis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392747:Modification [Functional Concept]
   770   C1554963:modification [Qualitative Concept]

Phrase: "by lipid peroxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023775:Lipid Peroxidation [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0178796:peroxidation [Phenomenon or Process]

Phrase: ":"

Phrase: "roles in neuronal degeneration"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "adaptative plasticity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0678558:Plasticity [Natural Phenomenon or Process]
   789 E C0032167:Plastic [Substance]
Processing 00000000.tx.310: Trends Neurosci21 :53 57,1998[Medline] Humphries KM, Szweda LI: Selective inactivation of -ketoglutarate dehydrogenase and pyruvate dehydrogenase: reaction of lipoic acid with 4-hydroxy-2-nonenal. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci21"

Phrase: ":"

Phrase: "53 57,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Humphries KM,"

Phrase: "Szweda LI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: ":"

Phrase: "Selective inactivation of -ketoglutarate dehydrogenase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "pyruvate dehydrogenase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0034343:pyruvate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0034354:pyruvate [Organic Chemical]
   861   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: ":"

Phrase: "reaction of lipoic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0443286:Reaction [Functional Concept]
   770   C1114821:Reaction [Clinical Attribute]

Phrase: "with 4-hydroxy-2-nonenal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0048297:4-hydroxy-2-nonenal [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.311: Biochemistry37 :15835 15841,1998[Medline] Kristal BS, Jackson CT, Chung HY, Matsuda M, Nguyen HD, Yu BP: Defects at center P underlie diabetes-associated mitochondrial dysfunction. 

Phrase: "Biochemistry37"

Phrase: ":"

Phrase: "15835 15841,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kristal BS,"

Phrase: "Jackson CT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: "Chung HY,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1539791:HY [Gene or Genome]

Phrase: "Matsuda M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Nguyen HD,"

Phrase: "Yu BP"

Phrase: ":"

Phrase: "Defects at center P"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0243067:defects [Functional Concept]
   737 E C1457869:Defect [Functional Concept]
   737 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "underlie"

Phrase: "diabetes-associated mitochondrial dysfunction."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0031847:dysfunction [Functional Concept]
   812   C0277785:Dysfunction, NOS [Qualitative Concept]
   756 E C0231174:Malfunction [Functional Concept]
   756 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.312: Free Radic Biol Med22 :823 833,1997[Medline] Gerbitz KD, Gempel K, Brdiczka D: Mitochondria and diabetes: genetic, biochemical, and clinical implications of the cellular energy circuit. 

Phrase: "Free Radic Biol Med22"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1420530:MED22 [Gene or Genome]

Phrase: ":"

Phrase: "823 833,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gerbitz KD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026691:KD [Disease or Syndrome]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]

Phrase: "Gempel K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Brdiczka D"

Phrase: ":"

Phrase: "Mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "and"

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "genetic, biochemical,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205474:Biochemical [Functional Concept]

Phrase: "and"

Phrase: "clinical implications of the cellular energy circuit."
Processing 00000000.tx.313: Diabetes45 :113 126,1996[Abstract] van den Ouweland JM, Maechler P, Wollheim CB, Attardi G, Maassen JA: Functional and morphological abnormalities of mitochondria harboring the tRNA (Leu) (UUR) mutation in mitochondrial DNA derived from patients with maternally inherited diabetes and deafness (MIDD) and progressive kidney disease. 

Phrase: "Diabetes45"

Phrase: ":"

Phrase: "113 126,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] van den Ouweland JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0022337:JM [Geographic Area]

Phrase: "Maechler P,"

Phrase: "Wollheim CB,"

Phrase: "Attardi G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Maassen JA"

Phrase: ":"

Phrase: "Functional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205245:Functional [Functional Concept]
  1000   C0542341:Functional [Functional Concept]
  1000   C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "morphological abnormalities of mitochondria"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   777   C3278399:Abnormal mitochondria [Finding]
   770   C0000768:Abnormalities [Congenital Abnormality]
   770   C0000769:abnormalities [Functional Concept]
   766   C0332447:Morphologic abnormality, NOS [Anatomical Abnormality]
   737 E C1704258:Abnormality [Finding]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "the tRNA (Leu)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035724:tRNA(Leu) [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0035711:tRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1537998:trnA [Gene or Genome]

Phrase: "(UUR"

Phrase: ")"

Phrase: "mutation in mitochondrial DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C2315666:Mitochondrial mutation [Genetic Function]
   770   C0026882:Mutation [Genetic Function]
   770   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "derived from patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]

Phrase: "with maternally inherited diabetes and deafness (MIDD)"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   799   C0011053:Deafness [Disease or Syndrome]
   799   C0011847:Diabetes [Disease or Syndrome]
   799   C0011849:Diabetes [Disease or Syndrome]
   799   C0018772:deafness [Finding]
   799   C0332287:With [Qualitative Concept]
   799   C0439660:Inherited [Functional Concept]
   799   C0581883:Deafness [Disease or Syndrome]
   799   C1705690:With [Intellectual Product]
   727 E C0525064:DEAF [Patient or Disabled Group]
   727 E C1547302:Deaf [Intellectual Product]

Phrase: "and"

Phrase: "progressive kidney disease."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   913   C0677932:progressive disease [Neoplastic Process]
   913   C1335499:Progressive Disease [Finding]
   913   C3539781:Progressive Disease [Disease or Syndrome]
   901   C0022658:Kidney disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0022646:Kidney [Body Part, Organ, or Organ Component]
   827   C0227665:kidney [Body Part, Organ, or Organ Component]
   827   C1278978:Kidney [Body Part, Organ, or Organ Component]
   827   C1514845:KIDNEY [Tissue]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   734 E C0027697:Nephritides [Disease or Syndrome]
Processing 00000000.tx.314: Diabetologia42 :485 492,1999[Medline] Calabrese V, Scapagnini G, Giuffrida Stella AM, Bates TE, Clark JB: Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity. 

Phrase: "Diabetologia42"

Phrase: ":"

Phrase: "485 492,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Calabrese V,"

Phrase: "Scapagnini G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Giuffrida Stella"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0995242:Stella [Bacterium]
   861   C1426084:Stella [Gene or Genome]
   861   C2986872:Stella [Gene or Genome]
   805 E C1825825:STARS [Gene or Genome]

Phrase: "AM"

Phrase: ","

Phrase: "Bates"

Phrase: "TE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039462:Te [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C1705540:TE [Conceptual Entity]

Phrase: "Clark JB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: ":"

Phrase: "Mitochondrial involvement in brain function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "and"

Phrase: "dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0031847:dysfunction [Functional Concept]
  1000   C0277785:Dysfunction, NOS [Qualitative Concept]
   944 E C0231174:Malfunction [Functional Concept]
   944 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: ":"

Phrase: "relevance to aging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2347946:Relevance [Qualitative Concept]

Phrase: "neurodegenerative disorders"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
  1000   C1522560:Neurodegenerative Disorders [Functional Concept]
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "and"

Phrase: "longevity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023980:Longevity [Temporal Concept]
Processing 00000000.tx.315: Neurochem Res26 :739 764,2001[Medline] Orth M, Schapira HA: Mitochondria and degenerative disorders. 

Phrase: "Neurochem Res26"

Phrase: ":"

Phrase: "739 764,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Orth M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Schapira HA"

Phrase: ":"

Phrase: "Mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "and"

Phrase: "degenerative disorders."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1285162:degenerative disorders [Disease or Syndrome]
   861   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.316: Am J Med Genet106 :27 36,2001[Medline] Hollenbeck CB, Reaven GM: Treatment of patients with non-insulin-dependent diabetes mellitus: diabetic control and insulin secretion and action after different treatment modalities. 

Phrase: "Am"

Phrase: "J Med Genet106"

Phrase: ":"

Phrase: "27 36,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hollenbeck CB,"

Phrase: "Reaven GM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: ":"

Phrase: "Treatment of patients"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "with non-insulin-dependent diabetes mellitus"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
  1000   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
  1000   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   937   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   840   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1518422:Non [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "diabetic control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "action after different treatment modalities."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441472:Action [Functional Concept]
   760   C3266814:Action [Activity]
Processing 00000000.tx.317: Diabet Med4 :311 316,1987[Medline] Zoratti M, Szabo I: The mitochondrial permeability transition. 

Phrase: "Diabet Med4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1537675:MED4 [Gene or Genome]

Phrase: ":"

Phrase: "311 316,"

Phrase: "1987"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zoratti M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Szabo I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "The mitochondrial permeability transition."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C3158983:mitochondrial permeability transition [Cell Function]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0031164:Permeability [Natural Phenomenon or Process]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0599156:Transition [Cell or Molecular Dysfunction]
   827   C2700061:Transition [Activity]
   755 E C0205326:Permeable [Functional Concept]
   755 E C1182674:Transitional [Spatial Concept]
   755 E C1548597:Transitional [Idea or Concept]
Processing 00000000.tx.318: Biochim Biophys Acta1241 :139 176,1995[Medline] Moreira PI, Sancha MS, Moreno A, Oliveira C: Amyloid -peptide promotes permeability transition pore in brain mitochondria. 

Phrase: "Biochim Biophys Acta1241"

Phrase: ":"

Phrase: "139 176,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Moreira PI,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0429863:PI [Clinical Attribute]
   861   C3537219:PI [Gene or Genome]
   861   C3539772:PI [Intellectual Product]

Phrase: "Sancha MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Moreno A,"

Phrase: "Oliveira C"

Phrase: ":"

Phrase: "Amyloid -peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "permeability transition pore in brain mitochondria."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031164:Permeability [Natural Phenomenon or Process]
   753   C0599156:Transition [Cell or Molecular Dysfunction]
   753   C1325742:Pore [Cell Component]
   753   C2700061:Transition [Activity]
Processing 00000000.tx.319: Biosci Rep21 :789 800,2001[Medline] Moreira PI, Sancha MS, Rego AC, Moreno A, Oliveira C: Effect of amyloid -peptide on the permeability transition pore: a comparative study. 

Phrase: "Biosci Rep21"

Phrase: ":"

Phrase: "789 800,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Moreira PI,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0429863:PI [Clinical Attribute]
   861   C3537219:PI [Gene or Genome]
   861   C3539772:PI [Intellectual Product]

Phrase: "Sancha MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Rego AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: "Moreno A,"

Phrase: "Oliveira C"

Phrase: ":"

Phrase: "Effect of amyloid -peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the permeability transition pore"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0031164:Permeability [Natural Phenomenon or Process]
   827   C0599156:Transition [Cell or Molecular Dysfunction]
   827   C1325742:Pore [Cell Component]
   827   C2700061:Transition [Activity]
   755 E C0205326:Permeable [Functional Concept]
   755 E C1182674:Transitional [Spatial Concept]
   755 E C1548597:Transitional [Idea or Concept]

Phrase: ":"

Phrase: "a comparative study."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009491:Comparative Study [Intellectual Product]
  1000   C1579762:comparative study [Research Activity]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.320: J Neurosci Res69 :257 267,2002[Medline] Murphy AN, Bredesen DE, Cortopassi G, Wang E, Fiskum G: Bcl-2 potentiates the maximal calcium uptake capacity of neuronal cell mitochondria. 

Phrase: "J Neurosci Res69"

Phrase: ":"

Phrase: "257 267,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Murphy"

Phrase: "AN,"

Phrase: "Bredesen DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Cortopassi G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Wang E,"

Phrase: "Fiskum G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "potentiates"

Phrase: "the maximal calcium uptake capacity of neuronal cell mitochondria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1516240:Capacity [Quantitative Concept]
Processing 00000000.tx.321: Proc Natl Acad Sci U S A93 :9893 9898,1996[Abstract/Free FullText] Dubinsky JM, Levi Y: Calcium-induced activation of the mitochondrial permeability transition in hippocampal neurons. 

Phrase: "Proc Natl Acad Sci U S A93"

Phrase: ":"

Phrase: "9893 9898,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "] Dubinsky JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Levi Y"

Phrase: ":"

Phrase: "Calcium-induced activation of the mitochondrial permeability transition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1879547:Activation [Activity]

Phrase: "in hippocampal neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.322: J Neurosci Res53 :728 741,1998[Medline] Brustovetsky N, Dubinsky J: Dual responses of CNS mitochondria to elevated calcium. 

Phrase: "J Neurosci Res53"

Phrase: ":"

Phrase: "728 741,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Brustovetsky N,"

Phrase: "Dubinsky J"

Phrase: ":"

Phrase: "Dual responses of CNS mitochondria"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0871261:responses [Organism Attribute]
   714 E C1704632:Response [Finding]
   714 E C1706817:Response [Intellectual Product]
   714 E C2911692:Response [Mental Process]

Phrase: "to elevated calcium."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0006726:Calcium [Inorganic Chemical]
   861   C2936886:Calcium [Pharmacologic Substance]
Processing 00000000.tx.323: J Neurosci20 :103 113,2000[Abstract/Free FullText] Craft S, Newcomer J, Kanne S, Dagogo-Jack SE, Cryer P, Sheline Y, Luby J, Dagoogo-Jack A, Anderson A: Memory improvement following induced hyperinsulinaemia in Alzheimers disease. 

Phrase: "J Neurosci20"

Phrase: ":"

Phrase: "103 113,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Craft S,"

Phrase: "Newcomer J,"

Phrase: "Kanne S,"

Phrase: "Dagogo-Jack SE,"

Phrase: "Cryer P,"

Phrase: "Sheline Y,"

Phrase: "Luby J,"

Phrase: "Dagoogo-Jack A,"

Phrase: "Anderson A"

Phrase: ":"

Phrase: "Memory improvement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986411:Improvement [Conceptual Entity]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "induced hyperinsulinaemia in Alzheimers disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0020459:Hyperinsulinaemia [Disease or Syndrome]
Processing 00000000.tx.324: Neurobiol Aging17 :123 130,1996[Medline] Piert M, Koeppe RA, Giordani B, Berent S, Kuhl DE: Diminished glucose transport and phosphorylation in Alzheimers disease determined by dynamic FDG-PET. 

Phrase: "Neurobiol Aging17"

Phrase: ":"

Phrase: "123 130,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Piert M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Koeppe RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Giordani B,"

Phrase: "Berent S,"

Phrase: "Kuhl DE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: ":"

Phrase: "Diminished glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0178666:glucose transport [Cell Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "phosphorylation in Alzheimers disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "determined by dynamic FDG-PET."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0872169:FDG PET [Diagnostic Procedure]
   806   C3641247:FDG-PET [Diagnostic Procedure]
   760   C0031268:Pet [Animal]
   760   C0046056:FDG [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0729333:Dynamic [Functional Concept]
   760   C1822794:FDG [Gene or Genome]
Processing 00000000.tx.325: J Nucl Med37 :201 208,1996[Abstract] Smyth MD, Kesslak JP, Cummings BJ, Cotman CW: Analysis of brain injury following intrahippocampal administration of beta-amyloid in streptozotocin-treated rats. 

Phrase: "J Nucl Med37"

Phrase: ":"

Phrase: "201 208,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Smyth MD,"

Phrase: "Kesslak JP,"

Phrase: "Cummings BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "Cotman CW"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454665:CW [Geographic Area]

Phrase: ":"

Phrase: "Analysis of brain injury"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "intrahippocampal administration of beta-amyloid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0001554:Administration [Occupational Activity]
   760   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "in streptozotocin-treated rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.326: Neurobiol Aging15 :153 159,1994[Medline] Messier C, Gagnon M: Glucose regulation and cognitive functions: relation to Alzheimers disease. 

Phrase: "Neurobiol Aging15"

Phrase: ":"

Phrase: "153 159,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Messier C,"

Phrase: "Gagnon M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Glucose regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "cognitive functions"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
  1000   C0392335:Cognitive functions [Mental Process]
   861   C0542341:Functions [Functional Concept]
   861   C1516691:Cognitive [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]

Phrase: ":"

Phrase: "relation to Alzheimers disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0080103:Relation [Family Group]
   770   C0869014:relation [Social Behavior]
Processing 00000000.tx.327: Neurobiol Aging18 :153 159,1996

Phrase: "Neurobiol Aging18"

Phrase: ":"

Phrase: "153 159,"

Phrase: "1996"

